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Nitric oxide (NO) is recognized as the most important small signaling molecule in the
human body. An imbalance of NO is closely associated with many serious diseases
such as neurological disorders, cardiovascular diseases, chronic inflammations and
cancers. Herein two chemiluminescence-based devices (a real-time NO measurement
device and a controllable NO delivery device) were developed to facilitate the NO
quantitative study and obtain information for NO related drug design.
The first device used for real-time measuring NO(g) flux from living cells was de-
veloped and validated. The principle was to use a two-chamber design, with a cell
culture chamber and a gaseous sampling chamber separated by a selective PDMS-
based (polydimethylsiloxane-based) membrane. The membrane was polydopamine
coated to improve the cell adhesion and growth. The signal response of the devices
was validated by using the controlled NO releasing polymer SNAP-PDMS (S-Nitroso-
N-acetyl-D-penicillamine covalently linked to PDMS). The real-time NO generation
profiles of the macrophage cell-line RAW264.7 stimulated by lipopolysaccharide (LPS)
and/or interferon-γ (IFN-γ) were successfully measured. Data also shows that the
change of NO generation by different exogenous factors can also be tracked in real-
time by the device. The maximum NO flux characterized by the device varies from
approximately 2.5 to 9 pmol/106cell/s under 100 ng/ml LPS and 10 ng/ml IFN-γ
xlix
stimulation depending on different culture conditions, indicating the current NO re-
porting method by using one single NO flux value is not sufficient to represent the
dynamic character of NO in biological samples. By using the similar principle and
device characterization processes, an innovative cross-membrane delivery system was
developed to successfully deliver NO to the cultured cells in a dose and temporally
controlled manner. Different levels and durations of NO were delivered to the smooth
muscle cell line MOVAS cultured in the device to validate the controllability of the
NO delivery. The device characterized an NO flux of 1.0× 10−10mol/cm2/min as
a threshold level, above which NO may cause MOVAS death, and the effect of this
lethal level was also duration and cell-type dependent. To further show the utilization
of the two devices, the NO measurement device was used to systematically study dif-
ferent NO donors’ potencies. It is suggested that measuring the real-time NO profiles
of specific NO donors in specific biological conditions can help us avoid generating
confusing data and understand the potencies of NO releasing drugs.
Current methods for NO quantitative experiment lack the means to understanding
the time-related aspects of NO in biological environment and controlling the actual
NO level and duration that cells experience. The two innovative devices solved these
problems in cell culture models, achieving quantitatively studying the behavior of NO





Nitric oxide (NO) was first prepared and characterized by Joseph Priestley in 1772
by the chemical reaction of metals and diluted nitric acid [1]. NO is a highly reactive
free radical, with an odd number of valence electrons, allowing it to readily undergo
autoxidation to form NO2 in the atmosphere.
Before NO was clearly identified in a variety of mammalian physiological processes
in 1980’s, NO was only considered to be an significant air pollutant or bacterial
metabolite. In 1818, Prout W. reported a significantly different level of nitrogen in
urine samples between healthy people and diabetic patients [2]. Unfortunately at that
time no indication of NO’s involvement was noted and no progress was made in the NO
field until 100 years later. Mitchell et al. [3] discussed nitrite/nitrates origin in detail
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in their 1916 paper, pointing out that nitrate in human urine might be not only from
food, indicating the existence of potential nitrite/nitrate synthesis pathways in the
human body. To prove this hypothesis, two papers were published by Tannenbaum’s
group in 1981 to explore this speculated pathway [4, 5]. They controlled human
volunteers’ daily nitrate intake and found that nitrate in urine greatly exceeded the
intake. Data from 15NO−3 tracking showed the majority of nitrate in urine was from
endogenous biosynthesis. They further used germ-free/conventional rats to run the
similar nitrate balance experiment, strongly supporting the existence of a certain
nitrate source in our body [5]. In 1985 Stuehr and Marletta then further identified the
LPS (lipopolysacharide) activated macrophage as the nitrate biosynthesis unit, which
was responsible for the elevated nitrate in urine, by using LPS-treated mice model [6].
By studying blood and vascular relaxation and contraction, Furchgott et al. reported
the relationship between smooth muscle cell (SMC) mediated vascular relaxation and
the acetylcholine (ACh) concentration-dependent relaxation reported in the 1950s
[7, 8], and further pointed out this effect is dependent on the endothelial cell resided
at the surface of intima. This demonstrated the long sought after endothelium-derived
relaxing factor (EDRF) was not ACh itself, but more likely to be certain downstream
factors derived from endothelium cells [9]. In 1987, Hibbs et al. elaborated the
L-arginine-dependent pathway with L-citrulline and nitrite generated in cytotoxin
activated macrophage mediated tumor cell metabolic inhibition [10]. Also in 1987,
Palmar et al. and Ignarro et al. characterized it is NO from L-arginine that plays the
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role as the EDFR [11, 12]. Since then one of the most important and classic molecular
pathway, NO-cGMP mediated vasodilation was fully unveiled. In 1998, the discovery
of NO’s regulating cardiovascular conditions earned the 3 scientists who elucidated
this the Nobel Prize, which greatly inspired NO work and caused an explosion in
research related to NO and the related health problems, especially chronic diseases
[13, 14, 15]. It is interesting that the two opposite effects of this signal molecule, one
to maintain vascular system health, the other to kill cells, were discovered at almost
the same time! From this history, it is important to always remember that NO is a
double-edged sword, as both beneficial agent and the cause of pathological conditions.
Another interesting question might be raised here, that is, why it took us over 200
years to realize this extremely simple molecule turned out to be so essential that
it constitutively functions throughout our body every day? There might be some
historical reasons, for example, the lack of molecular and cellular biology in the 18th
century, and NO is more related to chronic diseases and multiple-factor diseases, which
are not the primary, or life threatening problems for people living over one hundred
years ago, who may have had to fight against bacterial infection and scurvy at that
time, which are the types of conditions modern medicine has essentially solved. Other
reasons also include the preconception of the cytotoxicity of NO and the limitation
due to the detection challenges. The detection and quantification method can greatly
facilitate the development of certain field and good measurement method helps us
explain and integrate controversial results. This chapter will briefly introduce NO’s
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chemical and biological basis and how NO is quantified and controlled in actual
experiments.
1.1 NO and biological functions
Free radical NO is a multiple-functional molecule prevalently existing in almost all the
organs in the human body. Its main functions include vascular tone regulation [16],
inactivation of platelet adhesion [17, 18], feedback regulation of synaptic processes
[19], cell cycle manipulation [20, 21, 22], angiogenesis [23], and immune response [24].
The underlying basis of all those biological events is the biochemical characteristics
of NO and the molecules that react with it. The unpaired electron on NO makes
it very reactive. It potentially reacts with other free radicals[25], hemeproteins [26],
species with thiol groups [27], oxygen[28, 29] and lipids [30]. However, the specific re-
action(s) NO will undergo depend on the chemical kinetics, redox microenvironment,
and availability of substrates and cofactors.
1.1.1 NO generation in the human body
Like all other signaling molecules in the human body, NO levels are precisely con-
trolled. This control is multiphasic, including the rate of generation, NO consumption,
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and localization. EDRF’s vasodilation effect was discovered as L-arginine dependent
associated with L-citrulline generation. This dependency was very specific, “not
D-arginine or other close structural analogues”, and can be inhibited by NG-methyl-
L-arginine (L-NMMA) [31]. To date NO has been discovered to be synthesized both
enzymatically and non-enzymatically. Enzymatic NO generation is the most impor-
tant and classic NO generation pathway. Three isoforms of nitric oxide synthase
(NOS) are responsible for this process (reviewed in [32]). Researchers initially had
great difficulties in investigating NOS, since the enzyme lost its activity during purifi-
cation. The first experiment was reported by Bret and Snyder in 1990 [33]. NOS with
arginine to citrulline conversion activity was successfully purified from the cerebellum
tissue. And at that time they also pointed out calmoduline as the important moiety
for iNOS function, which explained why NOS function was observed as Ca2+ depen-
dent. Yui et al. purified NOS from rat macrophage in 1991 for the first time, showing
that it was different from constitutive NOS (cerebellar and endothelial NOS), the ac-
tivity of the inducible NOS purified from macrophage was not calmoduline-dependent
[34]. Later Pollock et al. published their work on eNOS purification from bovine aor-
tic endothelial cells [35]. And they claimed that three NOSs share the same chemical
reaction as shown in Fig 1.1. The terminal guanidino nitrogen of L-arginine undergoes
a 5-electron oxidation to form L-citrulline and the free radical NO [36, 37]. Other
reactants include O2 molecule and NADPH. Co-factors including FAD (flavin ade-
nine dinucleotide), (FMN) flavin mononucleotide, BH4 (tetrahydrobiopterin), heme
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Figure 1.1: NO biological synthesis by NOS
and calmodulin, which helps with electron transference and ultimately activates NOS
respectively [36]. The ultimate product is the same, however, we have to keep in
mind that different isoforms have their own tissue distributions and produce differ-
ent quantities of NO, and also NO synthesis by different NOSs can be controlled by
different mechanisms in different levels [38]. Initially, NOSs were named according to
their tissue distributions, such as brain NOS or hepatocyte-inducible NOS. Molecular
clone revealed their sequences and guided the current classification. Immunoblotting
and in situ probing greatly enriched our knowledge of the localization of NOS [39].
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1.1.2 Biological functions of NO
According to NO’s tissue distribution, NO maintains vascular homeostasis, regulates
immune responses [24], and participates in nerve stimulation [19, 40, 41]. NO ini-
tiates the relaxation of SMCs by responding shear stress and pulsatile blood flow
[11, 12], so that to auto-regulate both the overall and local blood flow distributions
and regulate vascular and myocardial tones [18, 42]; changes vascular permeability
[43]; deactivates platelet and immune cells (more likely a synergistic actions with
prostacyclin) [17, 18], prevent cell adhesion to blood vessels and inhibition of throm-
bogenesis [44]. According to the regulatory regions of iNOS gene and iRNA, iNOS
transcription and post-transcription processes are thought to be precisely regulated
(reviewed in [38]). One of the most important components in the promoter region is
the LPS/IFN− γ–responsive element, which is directly related to mononuclear leuko-
cytes’ foreign infection defense properties, including macrophages and neutrophils
[45]; the hypoxia-responsive element lies in -226 to -212 conferring iNOS low-oxygen
environment inducibility [46], which is consistent with the observation that iNOS was
expressed in infarction tissues and focal ischemia during surgery [47, 48]; different
iNOS mRNAs can be generated through alternative splicing in different tissues show-
ing different translational activities; meanwhile the discovery of iNOS mRNA with
different a 3’ end from RAW264.7 provided important proof for the idea that iNOS
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mRNA with different stability produced by alternating splicing might be an impor-
tant regulatory strategy to control the NO generation profile [49]; additionally, NO
participates in immune surveillance over cancer cells [50] and other chronical inflam-
matory diseases [51], either by inducing immune cell transformation or modulating
immune-cell activity and cytokine levels [51]. NO’s function as a neurotransmitter is
more indirect compared with the traditional neurotransmitter. NO, indirectly gen-
erates nerve signals, by modifying those electric signals or changing the intensity it
originally elicits, so called LTP and LTD (long-term potentiation and long-term de-
pression) in neuroscience [52], such as altering systemic blood pressure [53], respiration
tone [54], and pain thresholds [55], reviewed in [40]. This change of synaptic plasticity
might be through NO’s diffusion from the postsynaptic cell to the presynaptic cell
after NMDA receptor-mediated excitation [41].
The complexity of NO’s role is that NO’s physiological function is essential but at the
same time it was observed to be cytotoxic in many instances. Although NO can sen-
sitize many types of cancer cells to help with cancer treatment [56, 57], NOS within
tumor tissue inhibits or even kills T-cells to allow the tumor to escape from the host
immune reactions [58], and initiates angiogenesis to assist tumor growth [59]. NO
from macrophage can cause tissue damage, apoptosis and necrosis, in immunopatho-
logical conditions through nitrosative stress during inflammation [60]. Similar to
oxidative stress, nitrosative stress has comprehensive effects on cells, where NO+ (ni-
trosonium equivalent) is relatively nonspecifically added to thiols, secondary amines
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and hydroxyl groups, modifying structures and functions of lipid [30], protein [61, 62],
and DNA molecules [63, 64]. Since NO’s effect is broad, able to target both “good”
and “bad” molecules, its ultimate consequence becomes hard to predict. For ex-
ample although high flux of NO indicates its cytotoxicity as a general trend [65], in
some tissues with oxidative stress, NO was claimed as a potential anti-oxidative agent
[66]. Also iNOS was post-mortem detected in neurodegeneration patients, suggesting
that a potential cause-and-effect relationship existing between NO and those diseases
[24, 67]. At the same time NO can potentially protect neurons by counterbalancing
oxidative stress, and limit calcium level, presumably by restricting the activity of
NMDA channel via nitrosation, as a feedback control mechanism [68, 69] (reviewed
in [65]).
Dysfunction of NOS is closely related to cardiovascular pathology, immune malfunc-
tion, and neurological diseases, including hypertension, reperfusion injury, atheroscle-
rosis, thrombosis, hypercholesterolemia, diabetes mellitus, myocardial depression,
various chronic inflammations, and various neuronal degeneration disease such as
Alzheimer’s disease, amyotrophic lateral sclerosis, Huntington’s disease and Parkin-
son’s disease [70, 71, 72].
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1.1.3 Quantitative study of NO
Why can this simple chemical can function as such a powerful factor that regulates so
many biological processes? Since all the metabolic activities rely on the correspond-
ing biochemical reactions, factors that determine the kinetics and dynamics of NO’s
chemical reactions determine NO’s ultimate biological effects. Physiological status is
relatively stable, which means factors such as temperature (normally 37 ◦C), pressure
(normal pressure), and physical state (such as ionic strength in aqueous condition)
will minimally affect the biochemistry, while the nature of the reactants (which species
NO will react with), concentration (both NO and its targets) and time (when and
how long these conditions persist to allow the reactions to proceed) need to be care-
fully evaluated. One general hypothesis to explain the pleiotropy of NO could be that
NO’s concentration, timing and duration of its production and the specific cellular
environment (or tissue-specificity, where different reactants and reaction conditions
such as pH and redox environment may present) determine the ultimate biological
effect of the NO. To ensure the correct physiological functions of NO, our body has
developed corresponding mechanisms to precisely balance those factors. When our
body fails to do so, NO chemistry can be disrupted and diseases can occur. The
ultimate goal of this work is to artificially manipulate NO levels (or other factors)
within the physiological environment to help the body recover from the pathological
NO conditions. To do so, several questions need to be answered:
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1. What are the correct physiological NO levels?
2. What are the NO generation patterns in specific cell & tissue?
3. Where, when and how much NO is needed?
4. What kind and how much NO releasing drug is need to achieve specific goals?
Although they appear straight-forward, answers to these questions are not known.
A body of experimental data has shown that NO concentrations vary by several
orders of magnitude while it serves these different roles (reviewed in [65, 73, 74],
generally speaking, lower NO doses (< 400 nanomolar) indicates a certain normal
or protective property, while higher doses (>400 nanomolar) suggests a potential
cytotoxic outcome [65]). However, the quantitative data especially with respect to
the time variable information is still missing. Without systematic study, it is hard to
draw a general threshold level, above which is dangerous and below which is absolutely
safe. For example, it is reported that very low NO level (approximately 1nM) in
endothelial cells is able to induce endothelium proliferation, which is very important
for vasculogenesis and tissue repair [75]. However if this occurs in cancer tissue, it
will bring about serious problems such as angiogenesis which provides more nutrients
to cancer cells, and promote the development of vessels with structural defects which
leads to the leakage of blood. As a result, it is hard to predict the necessary NO
level without systematically studying the NO chemistry present on a case by case
basis. The development of NO measurement methods and NO-delivery materials has
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contributed greatly to facilitating these studies.
1.2 NO measurement in biological samples
Measuring NO in biological samples is important simply because NO participates
in so many diverse biological processes. Without accurately knowing whether NO
is present or how much NO is there, it is hard to evaluate NO’s contribution to
those processes. NO measurement in the biological samples is not easy. The most
common problems associated with measuring NO in biological experiment include low
physiological NO level, high reactivity and diffusivity of NO, aqueous environment,
and biological perturbation caused by the measurement method itself.
1.2.1 Current problems associated with NO measurement
Physiological NO level must be low, because even the micromolar range of NO can
be cytotoxic. It is reported that NO’s physiological concentration is normally in
nanomolar range or even subnanomolar range [65]. Sometimes under nitrosative
stress conditions, cells produce high NO fluxes where micromolar NO environment
can be formed, causing tissue damages. So the measuring method needs to have both
a low limit of detection and a large dynamic range.
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NO is a free radicals, which potentially reacts with numerous species including other
free radicals, thiol groups, heme, some metal ions, and oxygen, which widely abound
in the physiological environment. That means once NO is generated, it can be con-
sumed very rapidly (the half-life of NO is on the order of seconds [76, 77]). So even if
a method measures NO concentration accurately, from such result it is still likely to
underestimate the total amount of NO generated, because some of the NO is rapidly
consumed. This might be acceptable in some cases since NO concentration strongly
suggests the likelihood of the occurrence of the specific events, and it is important
to determine the relationships between NO concentration and the specific molecular
pathways. However, it might be not detailed enough information for pharmaceutical
use, because if the total amount of NO that is needed is unknown, insufficient ad-
ministration of NO could change the molecular pathway and the ultimate metabolic
activity of NO.
NO is gaseous under standard temperature and pressure. Under these conditions,
reliable and sensitive methods for NO detection have been developed and used for a
long time, such as chemiluminascence. Unfortunately NO generated from biological
sources always goes into the surrounding aqueous environment that baths cells and
tissues, making the conventional gas phase chemiluminescence detection impractical
for measuring NO in biological systems.
Different from experiments run under the ideal in vitro case, assays applicable to the
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complicated condition is always difficult. For example, NO concentrations in living
cells within the aqueous solutions can be well quantified in a sample holder such as
a cuvette by using different methods such as an NO probe, colorimeter methods, or
chemiluminescence, because we can use deoxygenated buffer, homogenize the sample
solution, and pour the sample in and out freely etc.. However, in real biological cases,
the NO source is relatively small, and the NO concentration gradient distribution can
be very complicated depending on the NO source and the environment. NO also dif-
fuses very rapidly. Successfully measuring NO at one time point becomes relatively
meaningless, because there is no way to understand the dynamic NO production. So it
is important to achieve real-time NO monitoring for each specific biological condition
under examination to truly understand the role of NO in dynamic physiological sys-
tems. This requires that the method itself be non-invasive so after NO measurement
the same biological sample can be examined by other assays. Any physical probe
or chemical reagent potentially brings about contamination and changes to the bio-
logical system under investigation, making real-time NO measurement a challenging
task.
1.2.2 NO measurement technology
Currently several different assays are used to quantify NO levels in biological samples
in different labs. Several recent reviews developed very comprehensive summaries to
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those methods [73, 74]. Unfortunately, real-time, commercially available, widely used
tools are still limited. Here Table 1.1 shows some commercially available and most
commonly used strategies in research to detect NO. Some points must be emphasized
here:
1. not all the methods actually quantify NO levels; methods such as Western blot
and mRNA real-time PCR only directly indicate the present of NOS enzyme;
2. it is important to distinguish the difference between direct/indirect NO mea-
surement and real-time/instant/cumulative data.
So none of these methods are successful technique for real-time NO measurement
for living organelles. The associated problems will be discussed in the following
chapters. Some groups successfully estimated the NO levels in living cells, dissected
tissues and conscious animals by different NO spin-trapping techniques and EPR
(electron spin resonance) spectrometry [89, 90]. However, problems still exist such
as complicated calibration and processing steps, bringing about new variables and
changes to organelles, resulting in uncertain effects. If we can easily compare NO
generated from endothelium cells in health people with hypertension patients with
different genetic background, measure NO levels in different tumor tissues during their
different development stages, accurately understand the behavior of NO in neuron
degeneration cases etc., we could be able to determine and confirm the etiological
factors and guide therapeutic strategy decisions. A reliable, accurate method to
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Table 1.1
Current commercially available NO measurement methods
Class Technique D. M. RT. M. Comments Ref.
NOS assays
Western blot No No
Real-time RNA No No
Absorbance
Griess assay No No
LOD 500 nM
whether real-time






Yes No LOD < 2 nM [81]
Electron spin
resonance















Yes Yes LOD 1 nM [84, 85]
Carbon-fiber
electrode
Yes Yes LOD 10 nM [84, 86]
Chemiluminescence
O3 −NO reaction Yes Yes By using NOALOD 0.5 ppb [87]
Luminol-NO Yes Yes LOD 100 fM [88]
D.M. indicates whether the assay is direct measurement or not; RT. M.
indicates whether real-time measurement can be applied; DAF,
Diaminofluorescein; Pt-Ag/AgCl, platinum-silver/silver chloride as
electrode; LOD, limit of detection.
directly measure NO from cells under physiological conditions is urgently needed to
allow a deep understanding of the role NO plays in many health conditions with
straightforward principles and experiment procedures.
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1.3 NO releasing chemicals
To study NO’s effect on different biological conditions, the most straight forward
method is to keep other variables unchanged and observe the performance of the
organelles under different NO treatment. Currently it is relatively easy to observe
NO’s biological effect in cases where NO production is eliminated. Several mature
strategies such as gene knock-out and knock-down techniques, series of NOS inhibitors
(including L-arginine analogs and antagonist such as L-NG-nitroarginine methyl ester
(L-NAME), L-NG-monomethyl arginine (L-NMMA), L-N5-(1-iminoethyl)ornithine
(L-NIO), Calbiochem) with different specificity and Ki values can been applied to
prevent the generation of NO in the living organelles [91]. However, problems on how
to deliver known amounts of NO to the biological systems still remain. Since NO is a
reactive and dynamic gas under physiological condition, instead of directly bubbling
NO into biological systems, chemicals that contain NO generating moiety are used
widely for NO delivery.
1.3.1 Small-molecule NO donor
Small drug molecules that releases NO have a long history of use. The most famous
example might be glycerin-trinitrate (trinitroglycerin, GTN), which has been used
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to relieve the symptoms from angina pectoris and other heart problems for over 150
years. Though at that time the underlying pharmaceutical mechanism was not clear,
its potency and ease of preparation procedure still make it the most popular NO drug
used to date.





























Scheme 1.1: Chemical Structure of NO releasing molecules.
and best-studied organic nitrate drug, whose NO releasing can be initiated through
multiple complicated mechanisms (probably both enzymatically and nonenzymati-
cally), which even today have not been thoroughly described. But after adminis-
trating GTN, NO generation in a variety of tissues was positively observed. Three
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nitro-oxy ester groups are present in one molecule, but only one group will release NO,
generating 1,2-glyceryldinitrate and NO via an S-nitrosothiol or nitrite intermediate
pathway [92]. It is believed that GTN needs to be bio-activated in vivo by certain
agents before it actually functions. Identification of those bio-activators has been a
challenging work for some time. In Miller & Megson’s paper [93], they reviewed the
work regarding to the most suitable bio-activator identified to date, mitochondrial
aldehyde dehydrogenase (mtADH) [94]. Though contradictions and some other prob-
lems still exist, on the broad level, we know that the potency of organic nitrate as an
NO releasing drug depends on multiple intracellular and extracellular pathways. Dys-
functions of those molecular/cellular pathway brings about nitrate tolerance, which
is one of the most common and series problems associated with organic nitrate drugs.
Though by supplying ascorbate, low-molecular-weight thiols, folate and L-arginine,
nitrate tolerance can be reversed to some degrees, other limitations, including lack of
selectivity, adverse hemodynamic effect, and inducing oxidative stress in vasculature
still exist.
New generations of NO releasing donors have been developed including other or-
ganic nitrates, iron nitrosyls, inorganic nitrate, s-nitrosothiol drugs, diazeniumdi-
olates (NONOates) reviewed in [93]. S-nitrosothiols and diazeniumdiolates are the
most popular NO generators in current NO studies (Scheme 1.1 (2)–(4)). Both classes
have relative clear NO generation mechanisms and stoichiometry. S-nitrosothiols, in-
nately present in the human body as physiological NO stabilizers, reservoirs and
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transporters, is an attractive class of NO donor to be developed for NO delivery
[93, 95]. The NO moiety connects with the adducts through an S-N bond, which
can be broken by a variety of controllable factors such as temperature, visible light,
presents of transition metal irons and other biological molecules such as ascorbic acid









2Cu2+ + 2RS− 2Cu++RSSR
Cu+ +RS NO Cu2+ +RS−+NO
Scheme 1.2: S-nitrosothiol NO generation mechanisms.
Another aspect of S-nitrosothiols’ pharmaceutical effects that needs to be pointed
out is that in addition to directly generating NO, S-nitrosothiols participate in other
reactions such as nucleophilic substitution and transnitrosation, whose effects should
be distinguished from NO’s effect. Also while S-nitrosothiols undergo heterolytic
cleavage, NO+ and NO− will be generated. As a result, S-nitrosothiols has been
widely used as NO generator and even as NO probe calibration reagents, but its
pharmacological application is limited compared with organic nitrates.
NONOates are a relatively new class of NO drugs compared with other NO donors.
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NONOates are normally highly soluble in aqueous solution, spontaneously undergo
decomposition reactions in the aqueous environment (physiological condition) to re-
lease NO, generating a nucleophile and 2 mol equivalent of NO per mol of donor. The
reaction rate is pH dependent, suggesting the nucleophilic reaction property. This
property makes NONOates easy to store in alkaline stock solution. And for applica-
tions, the stock solution is mixed with excessive physiological buffer to form desired
concentrations and at the same time the basic storage buffer will be neutralized.
By introducing NO generating groups (normally nitrate esters and S-nitroso groups)
to conventional drugs, these drugs can possess NO releasing property, improving
the potencies and reducing drug’s side effect. NO-releasing aspirin and NO releas-
ing diclofenac have been shown to have both anti-inflammatory and anti-thrombotic
properties [96].
1.3.2 NO releasing polymers
To this point, there are no ideally functionalized NO releasing drugs. Serious prob-
lems such as NO payload, control over the rate of release, targeting properties, and
potential cytotoxicity still exist with all the current NO donors. To overcome these
problems or offset some of their negative effects, the most common strategy employed
is to bind the NO donors to special scaffold molecules, either physically or chemically,
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to obtain control over specific properties such as NO generation rate, targeting abili-
ties, ease of administration and biocompatibility. Scaffolds employed can be diverse,
such as relatively large molecules or even polymers, allowing scaffold properties to be
tuned for specific NO delivery applications.
The concept of non-covalently blending of small NO donors within polymers is
straightforward. Blending small NO donor with a polymer base has been used to
increase the bio-compatibility of materials [97]. For example NONOates diethylamine
(DEA/N2O2) and diazeniumdiolated-spermine (SPER/N2O2) were blended with hy-
drophilic biodegradable polymer base polyethylene glycol (PEG) and polycaprolac-
tone [98, 99]; S-nitrosothiol GSNO and S-nitroso-N-acetylcystein SNAC were blended
with PEG or PEG/PPG (poly propylene glycol) copolymer to introduce controllabil-
ity over NO release rate and administration site [100, 101]. Applying the NO releasing
material produced from blending the NO donor SPER/N2O2 with a biodegradable
polymer has been shown to reduce neointimal hyperplasia [99, 102]. Also instead
of applying discrete NO donors, even gaseous NO can be encapsulated and applied
as a whole macromolecular vesicle to increase the available NO payload and reduce
spontaneous loss of NO. The major drawback of this strategy is the uncontrollable
leaching of the NO drugs, resulting in a very high local NO concentration or a gen-
eration of high level of by-products such as nitrosamines, a well known carcinogen
class [103]. To limit this leaching process, several strategies can be applied such as
increasing hydrophobicity of the NO donors (introducing alkyl groups) which reduces
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leaching when incorporated into relative lipophilic polymers base and developing bio-
safe NO donors, which themselves do not form carcinogenic by-products and can be
easily metabolized [103, 104].
To completely solve the leaching problem, NO donors were covalently link to the
polymer backbones. Because of their chemical structures and the controllability of
NO releasing mechanisms, NONOates and S-nitrosothiols became the most popular
choices for such work.
Polymers with secondary amine are potentially available for preparing stable N-
diazeniumdiolates once a second basic residue (either exogenous cation or unreacted
amine species within the polymers) is present and available. Meanwhile polymers
with thiol groups are potentially good candidates for introducing S-nitroso groups.
For example polyethyleneimine PEI microsphere and fumed silica particles with alky-
lamine were reacted to form N-diazenimdiolates respectively by Pulfur and Zhang,
obtaining NO generating vehicles that can be further embedded with other matrix
[105, 106].
Also by targeting cysteine, an important mammalian amino acid abounding in our
body, NO releasing materials through incorporation of S-nitrocysteine sites were syn-
thesized. Backbone materials include PEG hydrogels, BSA [107] and silica particles
[108]. Both primary/secondary RSNOs and tertiary RSNOs have been formed on
these different backbone materials that produce NO with different rates [108].
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By embedding the NO releasing particles in different polymer bases (PU and SR),
Frost et al. observed that the NO triggering mechanisms can differ greatly (reviewed
in [102]), which suggested that NO release could be significantly controlled by choos-
ing proper scaffold properties and manipulating the triggering factors. By chemical
design of the scaffold molecules, NO payload can be greatly enhanced. Stasko et al.
[109] designed polypropylenimine dendrimer based N-diazeniumdiolates, showing a
prolonged NO releasing pattern (up to 16 h releasing) and high NO storage capacity
(up to 5.6 µmol NO/mg). NO generation properties reduced platelet adhesion onto
those materials, and significantly improved the biocompatibility of this material [109].
By surface treating of function implantable biomedical devices with NO generation
coating, for example pH, oxygen, carbon dioxide and glucose sensors, devices can
function longer in the body because of NO’s anti-thrombosis properties [102, 110].
Meanwhile NO release has been shown not interfering with devices’ original functions.
1.4 Statement of purpose
A quantitative understanding of NO and its role in biological systems is crucial to
understanding the functions NO plays in normal physiology and pathology. Real-time
NO measurement and the control of the level of NO delivered are essential in this
field. The development of tools and methodologies to accurately measure and deliver
NO will allow the therapeutic potential of NO to be achieve.
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Work presented here is focusing on straightforward and universal means to under-
standing and achieving better control over factors that related to NO research, i.e.
developing and validating real-time NO measurement device and controllable NO de-
livery device for cell culture work. Chapter 2 describes the principle of how the mea-
surement and delivery devices function and the mathematical basis. This real-time
NO measurement device is the first method ever report to achieve direct measurement
of NO gas generated from living cells without influencing normal cellular activities or
introducing new variables into the original biological system.
To validate and show the usefulness of the new devices, a series of biological exper-
iments were designed including, measuring NO generation profiles of macrophages
after LPS and IFN− γ stimulation that are presented in Chapter 3 and the real-time
measurement of NO profiles generated by different NO donors at different biological
conditions is presented in Chapter 4.
By using similar principles, an innovative NO delivery system that achieves dose, tem-
poral and spatial control of NO delivery for culturing cells is presented in Chapter
5. SMCs line MOVAS cells was used as the biological model. The effective diffusion
distance of NO and its decay with the diffusion in different buffer were measured
and visualized by experiments using the real-time NO measurement device. Conclu-
sions and preliminary work on quantitatively investigating NO kinetics in different
biological reactions and the potential use of the two devices for cancer research are
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introduced in Chapter 6.
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Chapter 2
Theoretical Description of the
Devices1
2.1 Principles of the NO measurement device
2.1.1 Challenges of NO measurement in biological systems
Biological samples are normally fragile, making almost all the measurement operations
difficult. There is a great need and desire to quantitatively measure cellular derived
proteins and signaling molecules in order to better understand many physiological
1Part of the content in this chapter will be submitted to a journal for possible publication in the
near future.
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processes. In general, the method itself needs to properly sample objects of interest
and correctly evaluate the homogeneity of the biological systems. The quantification
method also should not damage the system of interest. An even stricter requirement
would be that the quantification method itself should not introduce changes to the
sample of interest, and keep tracking the individual trend of each sample in real-time,
which are very challenging.
2.1.2 Basic concept of the two-chamber system
The question that we are facing now is how to measure NO generated from the
living cells. Collecting NO (which will also be in other forms such as NO−2 , S-NO,
hemoglobin-NO) is a must. The desire is that the sample collection process itself will
not affect the original cell growth, not introduce new variables to the cells or change
cellular NO production. If the sampling process can be a continuous process, it is
possible to develop corresponding measuring processes for real-time measuring. If we
consider a cell layer is the source of NO, an NO gradient will be generated around the
cells. The strategy applied here is to sample a part of NO passing through a certain
surface area around the NO source, measure this NO, and determine the relationship
between the amount of NO measured and the total amount generated. To realize
this, NO production must be examined.
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Cultured cells form a cell layer attached to the bottom of the culture dish and produce
NO, which diffuses into the media within the dish and also decays because of the auto-
oxidation of NO (Fig. 2.1 A). If the dish were removed, NO produced from the cell
layer would diffuse to both direction (as shown in Fig. 2.1 B).
(A)
(B) (C)
Figure 2.1: NO generated from cells in different cell culture models can
potentially form different NO concentration gradients. (A) adhesive cells in
the cultured vessel; (B)an imaginary cell culture environment without cell
substrate; (C)cells cultured on the NO permeable membrane.
By placing an NO permeable but media impermeable membrane at one side of the
cell layer (as shown in Fig. 2.1 C), two relatively separated compartments will be
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created (a liquid part with culturing cells and a gas phase). Once NO diffuses across
the membrane and enters the gas phase chamber, NO can be collected and swept to
the chemiluminescent nitric oxide analyzer (NOA) for quantification. NO generation,
diffusion and sweep gas sampling are all continuous processes, based on which real-
time NO measurement can be achieved. And if the correct relationship between the
sampled NO signal and the total NO signal can be determined, the total amount of
NO production can be calculated.
This concept is not new in other biological field and has been widely applied to
investigating cell signaling. Boyden co-culture chamber is one good example that
has very similar design concept. Boyden chamber was initially used for investigating
”the relative chemotactic effect of soluble substances” [111]. In brief, the cell culture
chambers are separated by a semipermeable membrane which has a defined pore size
allowing for free chemical diffusion of soluble signaling molecules, but not allowing
cells to pass through unless the cells actively migrate. Cells, normally leukocytes,
are seeded in the upper chamber and the chemical of interest is dissolved in the
low chamber. Because of the chemotactic signaling, cells will migrate through the
membrane and into the lower chamber. And the chemotactic effects of different
soluble substances can be quantitatively compared and analyzed by examining the
cell migration (cell number in the lower chamber). Currently Boyden chambers are
also used in studying cell-cell interaction. In this case, instead of applying soluble
chemicals in the lower chamber, another cell type is seeded in the lower chamber.
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Different cell types do not directly contact each other, but they can interact with
each other through soluble factors that they produce. When cell Type 1 receives a
chemical signal generated from Type 2, cell Type 1 undergoes a series of biochemical
activities (Fig. 2.2 A). This allows interaction between different cell types to be
investigated by setting up proper controls.
In the NO measurement device, cell Type 2 was replaced by NO measurement meth-
ods (specifically, a chemiluminescent analyzer here). Once NO is produced by cell
Type 1 and passes through the semipermeable membrane, it will be continuously
detected, which can be used to calculate the real-time cellular NO generation profile
if the relation between this measured value and the total NO can be found (Fig. 2.2
B).
Over all, cells cultured in media and attached to certain substrate in the measurement
device for growth and proliferate (except for some suspending culture cell), and NO
production in real-time can be quantitatively measured. The following assumptions
are made:
1. NO will be generated by this cell layer, entering the aqueous environment as
soon as it diffuse out from cells. And it is reasonable to assume this NO gen-





Figure 2.2: Cross-membrane measurement method inspired from Boyden
Chamber (A) design of Boyden chamber, applied to study cell-cell interaction
by free diffusion of the soluble molecules secreted by cell; (B)adapted from
Boyden chamber, NO can be filtered out for chemiluminescent assay by NOA
2. After generation, NO diffuses homogeneously in only two directions in the one
dimension model (Fig. 2.1 B). So part of the NO generated remained in media
solution in the form of its oxidation product, while the other part will diffuse
into the lower chamber.
3. The NO that diffuse into the lower chamber can be quantified in real-time by
NOA sampling.
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4. During NO diffusion, it undergoes chemical reaction because of the presence of
O2 under physiological conditions, meaning there is NO signal loss during the
traveling of NO.
So in theory, as for NO quantification, as long as we can determine the correct way
to guide NO out from the cultured cell layer and measure its flux from the gaseous
side and determine the mathematical expression of NO distribution (the relation of
NO in upper chamber and lower chamber), then the measured value can be used to
calculate the total NO generated.
2.1.3 Cellular NO measurement device design
Because real-time NO measurement should be feasible, detailed operation procedures
will be discussed focusing on:
1. What material is appropriate to be used to separate the upper culturing cham-
ber from the lower gas-phase measurement chamber?
2. How to quantitate NO diffusion in real-time?
3. How to use the detected NO signal to determine the total NO emission?
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The design constraints for the filtering material used to separate the chambers is first
considered. To selectively allow specific molecules to pass through a certain surface
is not easy, especially when there is phase discrepancy (extract gas molecule from
the aqueous environment). Materials that are hydrophobic and gas permeable are of
interest, since the hydrophobicity can sustain the aqueous solutions to ensure correct
cell culture conditions and gas permeability allows NO passing through the polymer
layer. According to Mowery et al. [112], NO has the highest transfer rate (diffusion
coefficient D, as high as 3.0×10−5 cm2/s) within silicone rubber compared with
other polymers (polyurethane, polyvinyl chloride, and plasticized cellulose triacetate).
Other properties also make this candidate attractive including high hydrophobicity,
which prevents media from leaking, good biocompatibility, which allows for normal
cell culture, and readiness for manufacturing. Many medical grade silicone rubbers
for lab use are commercially available (such as SYLGARD®and RTV-3140 silicone
rubber, Dow Corning).
Since we are directly targeting NO gas, this problem becomes relatively easy. Chemi-
luminescence is a well characterized and robust method to quantitate gaseous NO
production. Gaseous NO is continuously swept into a reaction chamber, where
ozone will react with NO generating light signal that can be detected by pho-
tomultiplier tube (PMT). The detection limit is generally 0.5 ppb, which corre-
sponds to around 0.5× 10−13 mol/sec (or 30× 10−13 mol/min). According the
existing simulation estimation and EPR data, NO generation from endothelium
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is 1× 10−10 mol/cm2/min [113] and 8.3± 2.1× 10−12 mol/cm2/min [82] respec-
tively, which means the chemiluminescent system is sufficient to allow the NO flux
to be directly determined (Detailed calculation and experiment will be discussed in
Chapter 3 3.4.2.).
The third aspect of developing this device that must be considered is the fact that
other molecules present in the biological environment affect NO chemistry. NO will be
consumed during the diffusion process via reaction with O2, and to use the measured
value of NO detected in the lower chamber of the device to calculate the total, it
is necessary to account for these relations. To mathematically express this behavior,
Lancaster et al. [77] established a model describing the NO gradient generated from a
point NO source in biological system expressed by using Fick’s law and NO’s oxidation
chemical rate term. Laurent et al. [114] used similar hypotheses to simulate NO
concentration gradient made from a plane source (homogeneous cell layer).
According to Fick’s second law, which describes the molecule concentration gradient







where D is the diffusion coefficient; t represents diffusion time; x stands for distance
from site of interest to the source; [NO] is the concentration of NO. In physiological
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condition, the NO diffusion coefficient can be roughly approximated to NO diffusion
in DMEM media 4.5× 10−5 cm2/s [115]. Other groups have used similar values
such as 3.3× 10−5 cm2/s [116], and 3.0× 10−5 cm2/s [117], which are very close
to the value of diffusion coefficient of O2 in PBS at 25
◦C, which is 2.0× 10−5 cm2/s
[118].
The distance NO travels is restricted by its chemical consumption. To simplify this
problem, only auto-oxidization of NO, which is the main reaction of this process, is





where k1 is the oxidation reaction rate constant, and [O2] presents the oxygen con-
centration. To simplify this equation, the treatment of Laurent et al.[114] was used.
Since in the cell culture system, the culture device will be exposed to air in the incuba-
tor, O2 concentration in culture media is relatively stable (0.22× 10−3 M) [119]. So
by using k1= 6× 106 M−2/s [120], then the following pseudo-second order reaction






where k0= 1.32× 103 M−2/s is the effective reaction constant.








which takes NO generation, diffusion and consumption into consideration to express
NO level at any given site and given time.
To show the NO status in the cell culture model, NO concentration was calculated
according to Eqn(2.4). The following assumptions were made:
(1) homogeneous thin cultured cell layer is the only NO source, where x = 0, with a
constant NO generation rate v = 1.7× 10−8M/s [77], while t > 0;
(2) while x > 0, it is an aqueous media environment; and while x < 0, there is no
NO diffusion;
(3) NO diffusion is driven by concentration gradient and the time-dependent diffusion
according to Fick’s second law described as Eqn(2.1):
(4) NO diffusion is hindered by NO’s chemical consumption, and here only auto-
oxidization of NO was considered, which is the third-order chemical reaction overall
shown as Eqn(2.2):
(5) The whole process is continuous without instantaneous change or other boundary
effects.
Only considering at source x= 0, the term expressing NO’s x diffusion is eliminated
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and the equation becomes an ordinary differential equation as:
d[NO]x,t
dt
= v − k1[O2][NO]2x,t (2.5)



































According to this mathematical model, Laurent et al.’s work was reproduced by
using FlexPDE 6 finite element builder for partial differential equation to calculate
Eqn(2.4). Results were summarized in Fig. 2.3 B. Good agreement was observed
with their results [114], suggesting that:
(1) the maximum NO concentration is immediately next to the monolayer;
(2) maximum value occurred in the steady-state, where NO concentration gradually
reached a plateau and no longer changed with time;
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(3) small changes of distance to the source plans can cause significant change of NO
concentration;
(4) steady-state level of NO can be reached quickly when NO generation is constant
(around 10 min).
This information is important in indicating how awkward the current methods of NO
data report are. By using probes, such as electrochemical sensors, different positions
(x value) from the cell layer as well as the time point when the probe is placed for
measurement will greatly affect the final result. Reporting the average value of NO
produced ignores the natural inhomogeneity of the NO concentration. An instant
measurement overlooks NO’s temporal change information, so the value can mislead
researchers and the data is not very meaningful unless the accurate distance between
the probe, the source, and time variables are precisely controlled. Moreover, it is
noticed that even tens of micrometer of deviation can cause great changes in the NO
concentration. Without robust spacial control, current probe operation methods can
be very problematic.
When looking at the NO measurement from the proposed two-chamber device shown
in Fig. 2.2 B and 2.4 A, rather than calculating NO concentration only, NO flux was
also determined according to Eqn(2.4). Using similar assumption as Laurent et al.
[114]:




Figure 2.3: Repeating Laurent et al.’s work, modeling the formation of
the NO concentration gradient generated by a single cell layer in the culture
plate. (A) illustration of NO generation by cells cultured in the culture
plate. (B) the simulation result, showing how NO concentration changes
with distance x and time t.
0, with a constant NO flux rate out from the source plane of 5 pmol/cm2/sec (a
physiological NO flux level, which will be mentioned again in 3.6.2) while t > 0;
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(2) while x > 0, it is an aqueous media environment, while x < 0, the diffusion media
is PDMS; net NO diffuse only in x direction but not paralleled to the cell layer; so
this question becomes a one dimension problem;
(3) NO diffusion is driven by concentration gradient expressed by Fick’s second law
as Eqn(2.2);
(4) NO diffusion is hindered by NO chemical consumption as Eqn(2.2);
(5) The whole process is continuous without instant change or other boundary effect.
Results were summarized in Fig. 2.4. These results suggest that:
(1) the maximal NO concentration and flux is right next to the mono cell layer;
meaning that by measuring NO close to NO source is important, because NO loss is
minimized and the measurement method will be more sensitive, which is beneficial
for detection and calculation;
(2) maximum values of NO concentration and flux occurred in the steady-state as well;
the value in the steady-state might be the most valuable information, because the
detection method shows the highest sensitivity here and less fluctuation can provide
high quality signal;
(3) small changes of distance to the source plane can cause significant changes in the
NO concentration and flux; controlling how long the molecule travels (affecting the
extent of NO consumption) before it is sampled or detected is important;




Figure 2.4: Modeling the formation of the NO concentration gradient gen-
erated by a single cell layer in the NOmeasurement device. (A) illustration of
NO generation by cells cultured in the NO measurement device; (B) NO con-
centration gradient at the steady-state in the two phase (media and PDMS)
model; the simulation results show that the measured NO concentration (C)
and NO flux (D) change with distance x and time t.
reached quickly (around 10 min); this directly determines the correlation between the
measured value and the actual value, and is changeable depending on the specific
environment which will be discussed later in 2.2.
The proposed advantages of the new detection method include:
(1) by precisely controlling the property of PDMS layer which NO needs to migrate
42
through for NO sampling, the distance between the NO detection method and NO
source can be controlled, greatly reducing the variation because of uncontrollably
placing probes at different locations;
(2) the same as NO generation, diffusion and consumption, the whole measurement
method is continuous, NO data will be reported as surface flux-time curve, tracking
NO change with time;
(3) experimental operation is easy and will not influence normal cell behavior, which
is totally biocompatible.
These results suggest by using chemiluminescent to cross-membrane measure NO flux
generated from the cultured cells in real-time is feasible. However, it is noted that
this measured value is not the total NO generated by cells. Since it is depending on
the NO cross-membrane diffusion, the measured value only represents a part of NO
generated by the cells. The next question is what this part of NO means to the total
level of NO produced. The ultimate goal is to estimate the total NO generated from
the cells, which requires the correlation of the measured value to the total. To solve
this problem, simulations on how much NO will diffused out from the membrane were
performed.
To do this, culture media-PDMS model was used again. By plugging into different
total NO generation rates (physiologically relevant level), NO flux measured by cross-
membrane measurement and NO concentration at source (x = 0) were calculated (by
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Figure 2.5: Simulation of the different NO generation rates from the single
layer NO source (x = 0) result in different measured results (NO concentra-
tion at x= 0 µm is represented by circles; measured NO flux is represented
by solid triangles) at x= 20 µm at steady-state.
finite element analysis software FlexPDE) to determine the relationship between the
measured NO value and the total NO generation. Conditions used include:
(1) different NO generation rates (from 1 pmol/cm2/sec to 10 pmol/cm2/sec) were
repeatedly set as the NO generation rate from the monolayer cell source (where x = 0);
(2) it is assumed that the PDMS NO permeable membrane has a thickness of 20µm;
so the NO flux value calculated at x = 20 µm was used to represent the measured
value by NOA;
(3) all data points were only collected at steady-state;
(4) the system is a continuous system so there is no boundary effect or interface effect.
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The result was summarized in Fig. 2.5. Linear regression analysis clearly showed
that at steady-state the NO flux (solid triangles) was directly proportional to the
total NO generated, and NO concentration at x = 0 was also directly proportional
to the total NO generation. The theoretical measured NO flux through a 20 µm
PDMS membrane was shown to be only 18% of the total. This indicates that by
testing NO flux through a specific thickness of PDMS polymer total NO generation
can be calculated by simply multiplying a factor to the measured values.
However, in practice, this is difficult to achieve. This is related to some characters of
the device membrane including:
(1) membrane was manually cast from PDMS organic solution, which may introduce
variations between each different membrane;
(2) instead of using perfectly even, thin polymer layers as the cell substrate, the ul-
timate membrane in use has a sponge-like structure (see 3.4.1.), which differs a little
from the calculation assumption above but ending up with a better experiment result;
(3) the assumption that NO only undergoes auto-oxidation in the culturing system
and O2 concentration is a constant during the whole culture processes may not be
true;
(4) a real cell system is not a homogeneous single phase system but with other dif-
ferent phases (culture media, cell, polymer layer and gas phase sampling chamber)
and interfaces, creating a noncontinuous system, potentially causing the ultimate
experiment results differ from the calculation.
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So to use the NO measured from the lower gaseous chamber to estimate the total NO
flux, precisely calibration of each specific device/membrane is essential. The detailed
operation processes will be introduced in Chapter 3 (Session 3.3 to 3.6).
2.2 Principle of the NO delivery device
To investigate the effect of certain chemicals on biological systems, the most impor-
tant step is to achieve variable control and precisely adjust the parameter of interest
and scientifically evaluate the data. For NO research, manipulating NO level that
biological subject experiences is a critical step. However, because NO is a gas and
so reactive, control of the NO level that cells experience in the experiment has long
been a significant challenge. The most commonly used method of NO delivery is to
use soluble NO donors. Depending on the specific chemistry of each donor, NO gen-
eration ability (duration time, rate, and stoichiometry) will be different. In general,




where [D] is the donor’s concentration and eNO represents the mole(s) of NO released
per mole of donor. In case of soluble NO donors, kD mainly determines the NO gener-
ation of the specific donor and concentration that is applied. After NO is released, it
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goes into the surrounding environment and is consumed by reacting with the species
in the solutions. Eqn(2.2) expresses its consumption. Only the main reaction, auto-
oxidation, is considered at this point. Considering the high reactivity of NO, it will
be consumed and generated at nearly the same time. So combining Eqn(2.9) and




= kD[D]eNO − k0[NO]2 (2.10)
Schmidt et al. [121] showed changes in the NO level when the using NO donor
DEA/NO by plotting NO concentration according to simulation and experimentally
measuring DEA/NO phosphate buffer solution as shown in Fig. 2.6.
(A) (B)
Figure 2.6: NO concentration profiles of DEA/NO solution. (A) the calcu-
lated value by using kD = 1.4×10−3s−1, eNO = 1, k0 = 1.932×103M−1s−1,
(B)the measured value by using different concentrations of DEA/NO in-
dicated in the figure in 100 mM phosphate buffer (pH 7.4, 25◦). Direct
photocopy from [121]. The right of using the original images was kindly
granted by Springer, see Appendix C.
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Results showed that by using the NO donor, the NO level is variable and can be
determined by the initial donor concentration and time. In phosphate buffer solution,
this simulation prediction is accurate.
Applying this method to deliver NO to biological objectives, NO concentration varies
with time. The NO donors’ concentration alone does not directly reflect the real NO
level within the solution, since the NO level is highly depending on the generation
rate kD, (which can be very complicated since some NO donors have multiple and
uncontrollable NO generation mechanisms), as well as consumption routes (will prove
this statement in 4.2 and 4.3). So that by using soluble NO donors, it is hard to
maintain and track NO level during cell work in the actual biological conditions
and it is almost impossible to precisely manipulating NO level and duration. This
demonstrates the need to have a well controlled system that can provide cells more
controllable NO environment.
Again the simulation illustrating NO concentration changes with time and distance
to the source plane in a monolayer NO source model done by Laurent was inspiring
(Fig. 2.3). Is it possible to use a plane to generated NO? If the cells can be directly
cultured on this material, NO can be delivered to the cells directly (as shown in Fig.
2.7). More importantly, Compared with the traditional NO administration method,
this method overcomes several shortcomings.
First, NO level in traditional soluble NO donor system changes sharply with time,
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Figure 2.7: The confluent cell sheet is cultured directly on top of an NO
generating material, which allows NO produced from the polymer layer to
enter the cells directly, making this NO amount quantifiable.
while because of the steady-state, this new method can create a stable NO environ-
ment as long as the NO generating flux is constant.
Second, half-life of soluble NO donor in different buffer conditions widely varies so
that estimations in the level of NO are difficult ([122] and will be shown in 4.3).
However, in our system, cells directly adhere to the NO generation materials, if no
other initiators can be accessed by NO releasing group, uncontrollable NO generation
from the source can be limited and NO delivered to cells will be relatively stable, so
that a desirable NO environment can be created for substantial longer time.
Third, the NO flux experienced by cells cultured in the vicinity of NO source layer
can be directly adjusted by introducing control over NO generation rate from the
source.
Fourth, by using some materials where the NO donor was chemically cross-linked to
scaffold backbone, no other chemical components or side products are likely to be
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introduced to cells as is the case when using soluble NO donors. This limits com-
plicating the biological effects caused by other agents and mechanisms which may
confound analysis.
This new delivery strategy appears to be an excellent approach to satisfy all the re-
quirements needed for an ideal NO delivery system. One additional aspect of this de-
vice that needs to be investigated is the time resolution of the NO delivery. According
to Fig. 2.3 B and 2.4, steady-state conditions are reached, and the NO concentration
can change greatly within the first 5-10 min of the delivery, which brings about large
variation into the biological system. So in the initial stages of the delivery process, is
the NO accessible to cells controllable or not? It is noted that in our previous simula-
tion, all the calculation is base on ”auto-oxidation only” model, which might not be
true in the real case. This led to investigation of a more complicated model. Besides
the reaction with O2, other NO consumption route may exist in the real biological







− k1[O2][NO]2x,t − k2[O−2 ][NO] (2.11)
where k2= 5× 109M−1 • s−1 representing the reaction constant between NO and su-
peroxide [123]. By using the average superoxide concentration (70 nM in different vas-




2 ] are combined to k3= 350s
−1, and NO concentration at steady-state while
x = 0 became:
[NO]ss =
√
k20 + 4k3v − k0
2k3
(2.12)
















To illustrate the effect of this extra term, simulations were performed by using the
same assumptions and parameters previously described. The simulation result was
shown in Fig. 2.8. Compared with result in Fig. 2.4, it is obvious to see that if
more complicated NO consumption routes was considered, with the same total NO
generation rate from source, maximum NO concentration in this system was much
smaller, and the time needed to reach the steady-state NO levels became much shorter
(within several seconds).
The NO concentration gradient turned out to be much sharper as well (decreased to
less than half within 100 µm for both concentration and flux). This result indicated
that compared with auto-oxidation model, the high chemical reactivity of NO can
delivery stable flux of NO to cells without time delay once the NO flux is a constant.
So it is concluded that adjusting the total NO generation from the NO source plane
can achieve the change of NO flux/NO concentration that cells experience. New
delivery methods also have good time resolution. The high reactivity of NO limits
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(A) (B)
Figure 2.8: Modeling of the formation of the NO gradient close to
NO generating plane. According to Eqn(2.11), which is derived from
Fick’s second law and chemical reaction rate with the following parameters:
DDMEM = 4.5× 105cm2/s, k0 = 1.32× 103M−1/s and k2 = 5× 109M−1/s
[77, 114, 115, 117]. (A) the calculated theoretical NO flux value at dif-
ferent distances away from NO source; (B) the NO concentration gradient
formation against time and distance.
NO diffusion in static culture condition. Other cases such as irreversible reactions and
dynamic body fluid may either elongate half-life of NO or facilitate its consumption,
but those factors have a small influence to the static system developed here and will
not be discussed in this dissertation.
2.2.1 Controlled NO releasing polymer SNAP-PDMS for de-
velopment the devices
To develop the controllable NO delivery system, an NO plane source that generate
NO homogeneously and controllably is needed. As mentioned before NO(g) is hard
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to be bubbled directly into the culture cells. NO releasing material becomes a good
candidate to deliver NO.
There are many NO releasing materials developed for fundamental research and
biomedical applications. Several recent reviews summarized their chemical base and
related practical use [102, 107]. One of the most popular application is for wound
healing, since the proper NO level can promote endothelial cell proliferation and
modulate inflammation processes. NO releasing tissue engineering scaffold, espe-
cially hydrogels have been proved to be good tools to study NO’s effects on wound
healing [107, 127, 128]. For example Amadeu et al. [128] used a NO releasing ma-
terial Pluronic F-127 hydrogel, which was physically blended with 100µM GSNO,
to treat rat cutaneous wound every day till wound healing was achieved, showing a
better wound closure compared with hydrogel only treatment (S-nitrosoglutathione-
containing hydrogel accelerates rat cutaneous wound repair). Another paper intro-
duced the same material to the same animal model but at different wound healing
phases, they concluded that NO is important and has beneficial effect to wound heal-
ing at both inflammatory and proliferative phases, indicating a minimum of 7-day
long NO interference after injury can be applied to promote injury healing [129].
This is also a good example of temporal study of NO’s effect. However, for more
detailed quantitative study, NO levels need to be carefully controlled when using NO
incorporated cell scaffold which will be discussed in detail in Chapter 5.
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Both nitrite with acid and NO alone were shown to have broad anti-bacterial efficacy
[130, 131, 132]. NO releasing materials have be used to fight against bacterial infec-
tion. One collaboration work of our lab with Dr. Zhao, Michigan Tech, Houghton
MI, showed a SNAP chemically incorporated NO releasing gelatin nanofibrous ma-
trix, with a highest NO flux of 20 pmol/g/s, inhibits the growth of S. aureus and in
this process copper ion within the environment is preferred because it is contributing
to a higher NO flux [133]. A more quantitative analysis was shown by Friedman et
al. [134]. They took the advantages of the features of trehalose glassy matrices and
hydrogels, developed an innovative nanoparticle that releases long-lasting therapeutic
levels of NO in phosphate buffer by reducing nitrite to NO through reducing sugar
within the glassy matrix. The NO releasing rate was tuned by preparing particles with
different PEG size. Then this material was applied to a study looking for the mini-
mum NO level that is needed to treat superficial skin infection [135]. The minimum
working concentration for NO to inhibit methicillin-resistant SA (MRSA) strains and
methicillin-sensitive SA (MRSS) strains infection were found to be different (ranging
from 3.125 to 37.5 nM for MRSA and from 3.125 to 18.75 nM for MSSA).
Overall, for NO delivery, materials with long term and constant biologically relevant
level of NO releasing and the controllability of the NO releasing rate are of inter-
est. A large NO reservoir is also preferred to allow long term effects to be studied.
Meyerhoff’s group reported the first tunable NO-releasing microparticles (100-200
µm) [136]. The polymethacrylate-based polymer with different degree of secondary
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amine groups was converted into N-diazeniumdiolates with different NO storage un-
der sodium methoxide. So that the NO releasing from the polymer with different
amine contents would be different (ranging from 0.64 µmol/mg to 1.99 µmol/mg).
By incorporating different contents of such NO releasing particles with other polymer
matrix and using different alkylamines for the base of diazeniumdiolate, NO flux pro-
vided by the final material can be further tuned [102, 104]. However, normally the
limitation of NO releasing material is that once it is synthesized, the NO generation
rate cannot be further tuned under physiological condition. Romanowicz et al. did
some pioneering work developed a light triggered controllable NO releasing polymer
SNAP-PDMS (Fig. 2.9), whose NO releasing rate can be further tuned by exposing
the material to different light intensity [137].
The highly hydrophobic material PDMS was used as the backbone and NO donor
SNAP was chemically linked to the cross-linked PDMS through the reaction between
self-protected NAP and the PDMS cross-linker (3-aminopropyl)trimethoxysilane.
The primary amine on 3-aminopropylmethoxisilane provides important reaction site.
The detailed synthesis protocol was introduced in Romanowicz’s paper [137]. In brief,
1.6 g of silanol-terminated PDMS dissolved in 4 ml of toluene was mixed with 2 ml of
0.15 g/ml (3-aminopropyl)trimethoxysilane toluene solution (the cross-linker). Then
the mixture was vortex-mixed with 1.0 ml of dibutyltin dilaurate stock solution (25




Figure 2.9: SNAP-PDMS polymer and its chemical structure. (A)green
SNAP-PDMS and the control NAP-PDMS; (B) synthesis and chemical struc-
ture of SNAP-PDMS. Those are direct photocopied from [137]. The right of
using these materials was kindly granted by Elsevier; see Appendix C.
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stirred at room temperature for 24 h to allow for cross-linking. Thiolactone was syn-
thesized according to the method developed by Moynihan and Robert [138]. Then
50 mg of self-protected thiolactone, 1 ml of toluene, and 2 ml of the cross-linked
PDMS solution were mixed together and stirred for 24 h reaction. Thiol groups were
then nitrosated with 1 ml t-butyl nitrite, which was cleaned by repeatedly extraction
with 30 mM aqueous cyclam. The mixture was shaken for 40 min for reaction to
form a dark green colored SNAP-covalently linked PDMS polymer. SNAP-PDMS
solution and RTV-3140 solution were manually cast layer by layer to form RTV-3140
encapsulated 200-400 µm thick SNAP-PDMS film. Polymer was stored in dark at 4
◦C until use. Fig. 2.9 shows the produced polymer (A) and SNAP-PDMS chemical
structure (B). The maximum NO flux can reach around 5 × 10−10 mol/cm2/min
under 40× µW/cm−2 light stimulation at room temperature.
Light emitting diodes (Mouser C503B-BAN-CY0C0461, peak wavelength 470 nm)
were used as the modulator, where light energy impinged onto the polymer is pro-
portional to the NO releasing flux from the polymer film (Fig. 2.10).
SNAP-PDMS can be cast to thin films and shaped to the needed dimensions or dip-
coated to other materials or implants to release NO.
SNAP-PDMS has many advantages compared with conventional NO generation ma-
terials. PDMS has good biocompatible and has been widely used in biomedical field.
Since SNAP is chemically linked to the backbone, this prevents the leaching of small
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Figure 2.10: Measurement of NO surface flux from a 4.0 mm diameter,
100 µm thick film when drive current of the white LED (C503C-WAN-
CBaDb152) was varied to change the light impinged on the film. Different
steps correspond to different driven currents (in the order of 1 mA , 5 mA,
10 mA, 15 mA, 20 mA ad 30 mA).
SNAP molecule. High hydrophobicity of PDMS base protected SNAP, from contact-
ing with other species that may initiate the cleavage of S-NO bond. It is noted that
SNAP can readily generate NO once it is exposed to the decomposition triggers such
as metal ions in aqueous solution, reducing agents, thiols, etc. [95]. While SNAP-
PDMS is in the air, this potential passive NO release is essentially none. However,
when the whole structure is immersed into a complex aqueous solution, ions within
the solution is likely to attack the SNAP residues exposing to the surface of SNAP-
PDMS polymer and initiate great uncontrollable NO release. To avoid this, another




Figure 2.11: RTV-3140 coating prevents copper ion from attacking SNAP
residues in SNAP-PDMS bulk proved by Griess assay. (A) Experiment de-
sign, water and 100µM CuCl2 solution were used to immerse the polymers
to trigger the NO release; (B) the result of Griess assay; (C) Relative ab-
sorbance of each sample.
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the reactive ionic environment. In this case even in complex cell culture media en-
vironment NO release from SNAP-PDMS will be severely restricted (only thermal
degradation will trigger NO release).
To prove that with the extra PDMS layer coating uncontrolled NO release can be
eliminated, the Griess assay was applied (development of the dark pink color indicates
that NO decomposition products are accumulating). CuCl2 (100 µM) solution was
used to treat SNAP-PDMS film and RTV-3140 coated SNAP-PDMS film at 20 ◦C as
shown in Fig. 2.11 A. Deionized water was used as the control. After 90 sec solution
was removed and applied to Griess assay.
As shown in Fig. 2.11 B and C, without RTV-3140, copper initiated significantly
NO releasing, while the RTV-3140 coating eliminated this effect greatly to almost
the same level compared to the controls. Result clearly showed that without other
initiator, PDMS coated SNAP-PDMS will not deliver NO in a uncontrolled matter.
Now that other species in biological conditions are not likely to change the release of
NO, introducing light becomes a very efficient method to adjust the NO flux coming
out from the polymer surface, making SNAP-PDMS an ideal choice for NO delivery.
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2.2.2 PDMS surface modification
PDMS has high hydrophobicity, which makes it a poor substrate for growth of cells.
To make surface more favorable to cell adhesion, growth and proliferation, the PDMS
surface needs to be modified.
There have been many techniques used so far for material surface modification. Some
of them need UV or high temperature or other harsh conditions (reviewed in [139]),
which is not suitable for SNAP-PDMS. Since S-NO bond is very weak, such conditions
may lead to the cleavage of the bond causing great NO loss before actual use. For
example, temperatures higher than 50 ◦C may lead to a very fast NO releasing rate,
resulting in huge NO loss from the polymer reservoir (data not shown). To achieve
surface modification under mild condition, an intermediate polydopamine layer newly
developed by Lee et al. was applied [140].
Dopamine, the essential component of mussel adhesion proteins, undergoes auto-
polymerization on the targeting materials when oxygen is present in slightly basic
environment. This self-assembling dopamine coating is compatible with a wide range
of materials including inorganic metals, oxides and organic materials, even very hy-
drophobic materials like polytetrafluoroethylene (PTFE). The treatment procedure
is very easy, just simply dipping the materials of interest into the dopamine solution.
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The polymer does not chemically react with the materials, but forms a very thin (up
to 50 nm thick after 24 h) and stable polydopamine layer strongly attaching onto the
surface. The thickness of this polydopamine layer can be controlled by the immersion
time. And this layer is very sticky and can be readily further modified. The poly-
dopamine layer is very stable. Even in 1 N hydrochloric (HCl) acid [140] and 0.1 N
sodium hydroxide (NaOH)[141], this sticky layer still remains. Envision, one side of
this intermediate layer is attached to the PDMS surface, and the other side can be
further stick to the other layer, conferring good biocompatibility if ECM (extracellu-
lar matrix) was applied. This is extremely helpful for cell culture. The modification
strategy was illustrated in Fig. 2.12. Polydopamine layer has been proved to be
non-toxic, which is very important for biological application too.
Figure 2.12: Illustration of cells cultured on polydopamine and gelatin
treated PDMS/SNAP-PDMS.
To accomplish this, SNAP-PDMS was soaked in 2 mg/ml of 10 mM Tris buffer with a
pH of 8.5 for 48 h (according to [140], around 50 nm thick of polydopamine layer will
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be generated). After treatment sonication was used to remove the discrete polymer
particle aggregates attached on the surface. Then the polymer was sterilized by 70%
ethanol submersion for 20 min. Polydopamine layer was further soaked into 2 mg/ml
gelatin solution for 1 h. Then cell adhesion assay was applied. Since the layer that
directly interacts with polydopamine is RTV-3140, cover-slips cast with RTV-3140
were used in the assay first. The result is shown in Fig. 2.13 A-G. To quantify the
cell number per unit surface area, calcein-AM (2 µM) was used to stain the cells. Cell
counting was performed by Image-J software. The relative cell numbers are shown in
Fig. 2.13 H. Without dopamine treatment, cells can hardly grow on PDMS (B), even
with the gelatin treatment (C). However, after polydopamine treatment, cell adhesion
was improved (D). And with both polydopamine and gelatin treatment, cell adhesion
was significantly improved (E). Further controls were tested with this treatment to
confirm its utility for improving over all +cell adhesion for culturing cells on NAP-
PDMS as well (the material that has the same chemical structure with SNAP-PDMS
except for nitrosating -SH, so no NO release capacity). Data showed that there was
no statistic difference between the control and NAP-PDMS with polydopamine and
gelatin treatment. Overall, smaller cell number and cell size was observed in all these
groups compared with the control (glass cover-slip), it is suspected that the stiffness
of the material may also influence the cell growth. To minimize this effect other
adjustment was used in my research and will be discussed in 3.3.3.
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(H)
Figure 2.13: Cell adhesion to different surfaces. (A) to (G), MOVAS
was seeded on different substrates and cultured for 24 h. Then cells were
stained by 2 µM calcein-AM. Cells were cultured on (A) cover-slip coated
with gelatin, (B) PDMS, (C) PDMS treated with gelatin, (D) PDMS coated
with polydopamine, (E) PDMS coated with polydopamine then treated with
gelatin, (F) NAP-PDMS coated with polydopamine, (G) NAP-PDMS coated
with polydopamine then treated with gelatin; (H) shows the relative cell
numbers of each group; result obtained from the control, cover-slip treated
with gelatin, was arbitrarily set as 1; D stands for polydopamine and G for
gelatin treatment; ANOVA and Tukey HSD test were applied, showing no
significant difference exists between control and D-G-NAP group
2.2.3 Cell culture assay device for selecting proper SNAP-
PDMS concentration range
In order to establish the useful range of NO delivery for cells, a means was developed
to assess the general level of NO to be investigated. SNAP-PDMS synthesis was
performed according to the protocol introduced in 2.2.1. At 37 ◦C the newly prepared
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Figure 2.14: Multiple compartments Teflon mould for SNAP-PDMS cast-
ing. Each well is 1× 1× 1cm3
polymer will generate NO in a much higher (up to a flux of 100×10−10 mol/cm2/min)
than physiological level in the initial several hours, which is hard to control. This
high NO flux may bring about permanent cell damage. So it is necessary to find
a point (proper range of NO release) where cell can easily attached to the polymer
layer and at the same time SNAP-PDMS has enough NO storage for the future NO
administration and level adjustment.
To do this, SNAP-PDMS of different concentration was used for cell experiments.
Different SNAP-PDMS concentrations were prepared by diluting the produced SNAP-
PDMS solution with RTV-3140 solution with different ratio. Then the final polymer
mixture was cast into a device as shown in Fig. 2.14, so that a cell culture vessel with
different NO flux gradient grids can be established.
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Then RTV-3140 was cast onto the SNAP-PDMS layer as a top coat again to prevent
ion-initiated NO generation. After surface modification, cells (MOVAS cell here for
device test) were seeded into the device. Fig. 2.15 shows how cells grow on the
SNAP-PDMS with different concentrations, indicating 10% SNAP-PDMS may be
a good NO releasing polymer for NO delivery experiment. Further intensive and
accurate experiments can be designed according results obtained from this rough
estimation.
This grid design can be used to investigate NO’s effect on different cells by casting
same concentration of SNAP-PDMS and seeding different cell types, which may have
different sensitivity to NO (will discuss more in 6.4.2).
2.2.4 Cell culture on SNAP-PDMS
Since the multiple compartment device suggested proper SNAP-PDMS concentration
for cell culture, cells were cultured on 10% SNAP-PDMS again. To eliminate the
effect from other unpredictable factors that may influence final result, a NAP-PDMS
polymer with the same surface treatment processed was used as the control. Fig.
2.16 shows after dopamine and gelatin treatment, MOVAS cell succeeded in adhering
and growing on SNAP-PDMS.
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Statistic analysis showed no significant difference between NAP-PDMS and SNAP-
PDMS group. The hypothesis is that if initiators (light) that can be used to trigger
NO release from SNAP-PDMS polymer, NO’s effect on MOVAS cells can be studied.
The result and the detail procedure will be shown in 5.1.
2.3 Conclusion
NO real-time measurement and controllable NO delivery have been an on going re-
search challenges. In this chapter, the importance of comprehensive NO data presen-
tation and the critical role of real-time NO monitoring was described. A theoretical
treatment of the tow-chamber concept was presented. The mathematical models
showing that how NO flux generated from the culture cells can be real-time mea-
sured by cross-membrane measuring and how total NO generated from cells can be
calculated by using the two-chamber system was also presented. The problem of
uncontrolled NO delivery was also examined with the current NO administration
method (using NO donor). It is proposed the new method to control NO level dur-
ing experimental practice by using NO generating materials. Mathematical models
were introduced, showing how the new method is helpful for NO quantification study
and how this method may be able to control NO that cells experience in cell culture
experiment in terms of both NO level and duration. To achieve those concepts, the
components needed to fabricate the measurement and delivery devices were tested.
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This includes growing cells on hydrophobic PDMS substrate, which has very poor cell
adhesion normally. It was demonstrated that by using polydopamine as an interfacial
material, a gelatin layer could be formed on PDMS surface to allow cells to grow and
proliferate. NO measurement and NO delivery devices will be fabricated using this
information.
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Figure 2.15: MOVAS cell was seeded onto different concentrations of
SNAP-PDMS then cultured for 17 h. Cells were stained by calcein-AM and
examined at 40× magnification. 300 µl of SNAP-PDMS polymer cast in (A)
and the rest of the wells were 300 µl diluted SNAP-PDMS with RTV-3140
in a wt/wt ratio. (A) RTV-3140, (B) NAP-PDMS, (C) 1.5625% SNAP-
PDMS, (D) 3.125% SNAP-PDMS, (E) 6.25% SNAP-PDMS, (F) 12.5%
SNAP-PDMS, (G) 25% SNAP-PDMS, (H) 50% SNAP-PDMS, (I) 100%
SNAP-PDMS. All the wells were top coated with another RTV-3140 layer
then treated with polydopamine and gelatin.
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Figure 2.16: MOVAS cell was successfully cultured on SNAP-PDMS sub-
strate. MOVAS was seeded onto different gelatin treated substrates and
cultured for 24 h in dark. Cell was stained with 2µM calcein-AM; no sig-




Real-time NO Flux Measurement
from Living Cells1
The measurement of NO is not a new idea. Many methods with excellent specificity
and limits of detection have been developed for NO measurement in the controlled
laboratory experiments. However, similar success for the measurement of NO in
biological samples has not been attained. Measurement data has shown that NO
concentration varies several orders of magnitude while it functions in different roles
(many reviews have very detailed explanations on those methods [73, 74, 142, 143]).
In the human body NO synthesis is a precisely controlled process. Three isoforms of
nitric oxide synthase (NOS) are responsible for NO synthesis [32]. Different NOSs
1This chapter has be submitted to Nitric Oxide for possible publication in the near future.
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have their own tissue distributions [39] and may produce different quantities of NO
[38]. This free radical signaling molecule is extremely difficult to measure owing to its
high reactivity and diffusivity and the large number of biological molecules present
with which NO will react rapidly. The half-life of NO is on the order of seconds to
minutes in oxygenated solutions [76, 77], and is substantially shorter in the presences
of molecules such as hemoglobin [144, 145]. This chapter will present the design,
fabrication and validation of a two-chamber NO measurement device that achieves
real-time NO measurement in biological samples.
3.1 Background of NO measurement
Figure 3.1 illustrates the three work horse methods of measuring NO in biological
solutions. The colorimetric Griess assay, which measures the accumulation of nitrite
in oxygenated aqueous solution [142, 146], electrochemical detection, which measures
NO by recording the change of electric current due to the oxidation reaction of NO
dissolved in aqueous solution occurring on a probe surface [147, 148], and chemilu-
minescence detection of NO in the gas phase after its reaction with ozone [146, 149].
Each of these methods has significant limitations in quantitative measurement of
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Figure 3.1: Illustration of the 3 most common methods for detection of
NO in biological media.
NO from cells grown in culture. The Griess assay measures the accumulation of ni-
trite/nitrate over time and attributes the elevated levels to total NO generation. In
a study to determine accuracy of this method with a standard NO donor, Hunter,
et al. [146] reported that the Griess assay resulted in 30% less total NO detected
in phosphate buffered saline than the theoretical amount predicted by the concentra-
tion of PROLI/NO used. Different biological media that were also tested including
serum, plasma, and DMEM, with which there was even greater variation introduced.
Importantly, the level of variation was also dependent on the total volume of solution
used, making the offset in detection very difficult to calibrate. Another improper part
is in the assumption is that the elevation of nitrite/nitrate is only resulting from NO
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production, which might not be true. Meanwhile, there are some other absorbance
based methods too, such as oxyhemoglobin assay and NO trapping reagents, however,
neither can achieve real-time NO flux measurement.
Electrochemical detection relies on the electron transfer during the redox reaction.
This is a concentration based detection method and the results for quantitating the
highly reactive NOmolecule depend on a number of factors including distance between
the electrode and the cell surface (distance effect shown in 2.1.3), trapping effect
resulting from the size of the electrode, and stirring rate [150, 151]. Besides, the
calibration procedure is very time consuming and labor intensive, so that results
from using these probes can be skewed.
Chemiluminescence detection relies on the gas-phase reaction of NO with ozone to
generate an excited state NO2 molecule that relaxes to release a photon that can be
counted [149, 152, 153]. This is a highly sensitive method of direct NO detection but is
NO+O3 NO∗2+O2
NO∗2 NO2 + hv
limited by the requirement that NO has to diffuse out from the culture media and enter
the head-space above the cell culture dish and be swept into the chemiluminescence
analyzer. The bathing solution in this experiment ideally needs to be purged by an
inert bubbling gas in order to force NO out from the solution phase before it reacts
with molecules such as oxygen presenting in biological environment. So none of these
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current techniques have provided satisfactory results for determining the level of NO
that cells actually produce or experience in a real-time manner.
The method developed has made full use of the current chemiluminescent method,
manufactured a special cell culture vessel and guided NO out from the aqueous envi-
ronment, so that gaseous NO can be sampled for standard chemiluminescence quan-
tification. In addition to accurately knowing the level of NO cells produce or experi-
ence, it has become abundantly clear that temporal aspects of when NO is released
by cells and under what circumstances it is produces, as well as what the duration of
NO production that cells achieve are critical to understanding the roles NO plays in
normal and pathological processes. As an example, Thomas and co-workers published
a paper that demonstrated that the duration over which a dose of NO is delivered to
cells has a profound impact on the protein expression of the cells [154]. They showed
that the time frame over which NO was delivered to MCF7 breast cancer cells im-
pacted the level of HIF− 1α and phosphorylation of p53-Ser-15. A single, large bolus
dose of NO ( 1000 nmol) administered at time 0 showed increased production of p53-
Ser-15, which indicates apoptosis. While a larger dose of NO delivered from time 0
and continued over a 9 hours period ( 4000 nmol), showed a significant production
of HIF− 1α. When the NO dose ( 5000 nmol) was introduced later in the culture
period, such that the maximum NO was experienced by the cells at Hour 5, the ratio
of HIF− 1α and p53-Ser-15 was markedly different. The data clearly shows that
protein expression was affected by the amount of NO delivered and the timing of this
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delivery, highlighting the importance of understanding the temporal variable involved
in when cells experience NO as well as the duration over which a specific dose of NO
is delivered. Fortunately, the chemiluminescent method itself relies on continuously
sampling the gas and provides real-time NO flux information. Currently the fastest
commercial available NOA’s sample rate reaches 32 time/sec, which in theory can
track NO time variable accurately.
3.2 Experiment set-up I–preliminary design
Only considering a homogeneous cell layer that homogeneously produces a steady-
state level of NO, diffusion and consumption described by Eqn(2.4), intuitively the
NO gradient generated around the cell layer can be roughly described as Fig. 3.2 A.
The maximum concentration is in the vicinity of cell layer and it gradually decreases
along the z-axis. It is easy to see in the real case, where adhesive cells cultured at
the bottom of the culture vessel and covered by culture media, the NO gradient can
be modeled as Fig. 3.2 B.
Once NO escapes from the media and enters the headspace air phase, NO can be
chemiluminescently quantified by NOA sampling. According to this concept, a simple
experimental set-up (Fig. 3.3 A) was tested to measure the NO flux coming out from
a 100 ng/ml LPS and 10 ng IFN− γ stimulated mouse macrophage RAW264.7 cell
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(A) (B)
Figure 3.2: Illustration of NO gradient generated by the NO releasing cell
layer. (A) imaginary NO concentration gradient in an infinite big space; (B)
NO concentration gradient in the cell culture vessel.
line. The T-25 cell culture flask was directly concatenated within NOA sampling
line. Air in the headspace of flask was continuously sampled by NOA using air in
the incubator as the sweep gas and zero gas. And result was obtained as shown
in Fig. 3.3 B. This was the first real-time NO flux profile representing cellular NO
production due to the free diffusion of NO and measured by directly sampling NO
using chemiluminescent detector.
RAW264.7 is a good model for NO study, which produces very high levels of NO
(up to µM [65]) after endotoxin from bacterial and/or cytokine stimulation (so that
it can be used as positive controls in many circumstances) [155]. The NO genera-
tion time variable has also been investigated by many other methods such as iNOS
Western blot and electrode [28, 29, 156]. For example Noda et al. showed that iNOS
appeared 4 h after LPS treatment, which is well correlated with data obtained [156].
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(A) (B)
Figure 3.3: Illustration of measuring NO flux from the cultured cells in
T-25 culturing flask. (A) the experiment set-up; (B) real-time NO releasing
profile of 100 ng/ml LPS and 10 ng IFN− γ stimulated mouse macrophage
cell line RAW264.7.
This method achieved real-time NO monitoring (gaseous) with high time resolution,
introducing minimum interference to cells during measurement. And compared with
the current data [156], the produced NO profile trend is consistent with the reported
time-dependent behavior, suggesting directly measuring NO (gaseous) from the living
is feasible.
However, question came out when more quantitative analysis was applied. RAW264.7
has be reported to produce NO at an average rate of 2.6 pmol/106cell/s under condi-
tions of bacterial infection [29]. The Sievers 280i NOA utilized has a calibration con-
stant of around 0.1 pmol/PPB/s and should therefore have sufficient detection limit
to monitor NO production in RAW264.7. However, assuming a confluent RAW264.7
cell layer has a cell density of 5× 105 cell/cm2, experimentally determined values
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were around 1000 time smaller than the reported value! What could be the reason?
As introduced in 2.1.3, NO diffusion is free and can be in any directions, but it is
driven by concentration gradient; in a homogeneous model (Fig. 3.2 B) the net NO
moving is only considered in z direction; so to capture the NO signal, NO generated
by the cell layer needs to pass through the media layer and enter the head-space, then
be sampled by sweep gas; diffusion in aqueous solution is significantly slower than in
air, which takes a longer time for NO to be captured by the NO detector.
The net time needed for NO to pass through the media layer can be calculated by
Einstein-Smoluchowski equation [76], which describes the net molecule displacement,
∆x, versus time (t) as:
(∆x)2 = 2Dt (3.1)
where D represents the diffusion coefficient. NO reacts with different species during
diffusion. So with longer diffusion time t, a more complicated environment is not
favored for NO sampling, simply because NO will have more opportunity to be con-
sumed per unit time. To decrease such signal loss, one method is to minimize the
depth of the media and thereby reduce the diffusion distance (∆x) of NO before it
enters the gaseous environment. If so, the question would be how to accurately con-
trol the media depth and how to keep it constant during the hours long gas sampling.
However, it is almost impossible to do this because too small an amount of media is
not favored by cell culture and sampling process itself inevitably removes moisture,
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gradually drying and concentrating the media, which is both bad for cell growing and
NO measurement.
Over all, this experiment can successfully capture gaseous NO signal from the cultured
cells and do rough semi-quantification, and obtain cellular NO temporal information
with good resolution. But this method may interfere with normal cell growth and
cannot achieve absolute quantification due to the difficulty in estimating signal loss
during the sampling.
3.3 Experiment set-up II–two-chamber design
After evaluation of the short comings of the initial experimental design, the two-
chamber system introduced in 2.1.2 was fabricated and tested.
Recall that in Eqn(2.4), the cell layer generated NO creates an NO gradient. If
the bottom of the culture is replaced by a layer that is NO permeable but water
impermeable, NO will pass through the layer and enter a solution free space below,
where NO gas sampling can be carried out (Fig. 2.2 B). This idea shares the same
principle with Boyden chamber (Fig. 2.2 A). To realize this idea, an NO permeable
material is the essential components. And to minimize NO diffusion distance within
this material so that to minimize NO loss and increase the NO signal, it is needed to
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control and minimize the thickness of the NO permeable material (a consistent and
small diffusion distance) and find out the relationship between the detected NO and
the total NO to achieve absolute quantification.
3.3.1 NO permeable membrane fabrication
As mentioned in 2.1.3, PDMS was chosen for manufacturing the NO permeable, wa-
ter tight membrane. PDMS used in the beginning was room-temperature vulcanized
PDMS RTV-3140. RTV-3140 was dissolved in toluene (1 g/10 ml toluenen) and fully
vortex-mixed. The produced solution was manually cast (72 µl/cm2) on the top of
glass-fiber filter paper (with 0.2 µm pore size), and air-dried to let the organic solvent
evaporate in a chemical hood. This process was repeated 3 times then the produced
membrane composite was left at room-temperature for overnight curring. To under-
stand the actual structure of the membrane, the membrane was cross-sectioned for
SEM imaging (Fig. 3.4).
From the image, it is observed that PDMS polymer layer was formed on the top of
the filter paper, and both the thickness and surface are very even. However, PDMS
itself is not a very good cell adhesion substrate. So its surface needs to be further
treated to support cell growth. One method is polydopamine treatment [157]. To do
this, the composite membrane was soaked in 1 mg/ml dopamine solution (in Tris-HCl
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(A) (B)
Figure 3.4: SEM image illustrating the structure of the semi-permeable
membrane. (A) cross-section of PDMS coated glass-fiber filter paper; (B)
topographic image of PDMS coated glass-fiber filter paper
buffter pH=8.5) for 24 h. Then the product was sterilized by soaking in 70% ethanol
for 10 min and UV treatment for 30 min. Then the sterile membrane was top-coated
with 2 mg/ml gelatin solution (in PBS) for 1 h to further facilitate cell adhesion onto
the surface. Polydopamine is a novel bioadhesive layer, which acts as an intermediate
sticky layer so gelatin can easily attach to the substrate. Then cells can adhere to
the gelatin layer. The modified PDMS composite membrane will be ready for cell
culture.
More quantifiable examinations were applied shown in Fig. 3.5. SEM reveals polymer
layer thickness as 17.3 ± 3.2 µm, which is good for NO diffusion according to Einstein-
Smoluchowski equation and the previous simulations. AFM quantified the surface
roughness, root mean square (Rms) as 63.51 nm ± 19.60 nm, indicating a suitable
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(A) (B)
Figure 3.5: Membrane characterization. (A) cross-section of PDMS poly-
mer layer by SEM; (B)topographic image of polydopamine and gelatin
treated PDMS coated glass-fiber filter paper by AFM.
surface roughness for cell culture [158]. Different cell types were cultured on the
membrane to test whether cells will grow and proliferate normally on the membrane.
Fig. 3.6 showed the growth of, ARPE-19, primary tenocyte, fibroblast, and HAEC
on the produced membrane.
3.3.2 NO permeable membrane characterization and valida-
tion of time resolution
To validate the feasibility of the cross-membrane NO measurement and whether there
is enough time resolution by sampling NO in the lower chamber of the device, NO
release profile from controllable NO releasing material SNAP-PDMS were measured
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Figure 3.6: Membrane biocompatibility test by culturing different cell
types on the polydopamine and gelatin treated NO permeable membrane.
(A) ARPE-19, (B) primary tenocyte, (C) fibroblast, (D) HAEC. Cell was
stained with 2µM calcein-AM
cross-membrane. The experiment set-up is shown as Fig. 3.7.
A piece of prepared PDMS composite glass-fiber membrane (with dopamine treat-
ment) was fixed in between co-culture Kube chambers; a 4 mm diameter, 0.1 mm thick
SNAP-PDMS film was placed on the membrane in the upper chamber (as shown in
Fig. 3.7); LED light (VAOL-5GSBY4, Mouser electric, Mansfield, TX) was applied
to the polymer to trigger NO releasing. By simultaneously sampling NO from both
the upper and lower chambers using two identically calibrated chemiluminescence
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Figure 3.7: Lower chamber’s quick response towards NO generation in the
upper chamber. Bathing solution in the upper chamber damped NO signal
but will not have significant impact on the lower chamber signal. 4 mm
diameter 200 µm thick SNAP-PDMS disc was placed on the PDMS coated
filter paper, which separated Kube into two different chambers; LED light
was used to initiate the controllable NO releasing. Green arrows indicate
light-on, purple off. NO surface flux from both upper chamber and lower
chamber was monitored by two identically calibrated NOAs. 100 µl PBS
solution or DMEM cell culture media were applied onto SNAP-PDMS top
one after another. The polymer interface was fully immersed by the bathing
solution.
detectors, the NO signal change with time was obtained from both chambers. Once
NO releasing was triggered by light, the NO flux was detected (first increase, in both
blue and red line) at the same time from both chambers, indicating no time delay in
the cross-membrane NO measurement.
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To further compare direct measurement (sampling over the bathing solution) with
cross-membrane measurement when bathing solution is present, the same light in-
tensity was applied after PBS solution and DMEM media were added to the upper
chamber over the SNAP-PDMS disc with NO sampling continuing in both chambers
(solution height > 5 mm). The addition of the bathing solutions dramatically hin-
dered the gas phase measurement of NO flux in the upper chamber, while the NO
signal measured from the lower chamber remained relatively stable compared to the
initial measurement with no bathing solution as the light was turned on and off (sec-
ond and third increase in blue but not in red). Of particular importance, the NO
measured in the bottom chamber showed release that exactly corresponded to the
light being turned on and off, demonstrating that we maintained excellent temporal
resolution for the tracking of the production of NO in the lower chamber, regardless
of the addition of solution over the SNAP-PDMS disc in the upper chamber. From
these data, it is suggested that by applying cross-membrane measurement to cultured
cells we should be able to obtain NO signal and record the temporal aspect cellular
production of NO.
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3.3.3 Control over membrane properties
Since increasing the sensitivity of the NO measurement method relies on restricting
the thickness of PDMS layer, it is necessary to manufacture membranes with consis-
tent thickness (the thinner the polymer layer, the better for NO permeability without
allowing water leakage). Meanwhile, cell growth requires certain level of stiffness. If
a material is too soft cell migration and proliferation will be affected, which may
introduce significant variability in behaviors of standard cell-line models [159, 160].
So it is necessary to control and optimize the properties of PDMS layer.
To control the thickness of PDMS layer, different repeats of casting or different con-
centration of PDMS solution were applied. Still using different RTV-3140 solutions
(1 g/10 ml toluene and 1.25 g/10 ml toluene) and applying different numbers of layers
cast, NO permeable composite membranes with different thicknesses of PDMS were
generated (Fig. 3.8 shows the control over the PDMS layer thickness imaged by SEM;
B to E have different PDMS layer thicknesses, 17.3 ± 3.2 µm, 39.4 ± 4.7 µm, 53.8 ±
6.2 µm, 162.3 ± 9.5 µm, respectively. ).
To control the stiffness of PDMS, Sylgard PDMS was used. Different from RTV-
3140, the PDMS polymer base and the curing agent are supplied separately. By
using different base to curing agent ratio and different curing temperature, silicone
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Figure 3.8: The control over PDMS layer thickness on glass-fiber filter
paper. Cross-section SEM image of different thicknesses of PDMS membrane
by multiply casting different concentrations of PDMS solutions (for each
cast, 72 µl/cm2 solution was applied), scale bar: 150 µm. (A) glass fiber
filter paper; (B) 3 repeat of 1 g /10 ml RTV-3140 PDMS cast; (C) 1 cast of
1 g /10 ml RTV-3140 PDMS and 2 repeat of 1g / 8 ml RTV-3140 PDMS
cast; (D) 1 cast of 1 g /10 ml RTV-3140 PDMS and 3 repeat of 1g / 8 ml
RTV-3140 PDMS cast; (E) 1 cast of 1 g /10 ml RTV-3140 PDMS and 4
repeats of 1g / 8 ml RTV-3140 PDMS cast.
elastomer with different stiffness can be produced [161]. For the following adhesive
cell culture, a base : curing agent = 10 : 1 (w/w) was used, and the curing condition
was set to 52 ◦C overnight.
3.3.4 Measurement device manufacture
The whole purpose is to create two chambers that are separated by the gas-permeable
membrane as shown in Fig. 3.9. To do this, the bottom of 100 mm dia. × 20 mm
deep or 60 mm dia. × 15 mm deep commercially available polystyrene cell culture
dishes were removed, leaving a 2.5-3.5 mm wide rim around the bottom of the plate
(Fig. 3.9 A). The PDMS-glass-fiber filter paper composite membrane was adhered to
the culture dish, creating a PDMS/glass filter paper bottom. A second culture dish
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was attached under the PDMS-bottomed dish and two holes for NO sampling were
drilled in the wall of the lower chamber, creating a cell culture dish with two chambers
(Fig. 3.9 B). After liquid leakage examination, upper chamber was filled with 2 mg/ml
dopamine solution for 24 h for polydopamine coating (in 10 mM Tris buffer, pH=8.5).
For sterilization, the whole device was sterilized through ethylene oxide for 24 h and
then the polydomapomine surface was treated with a 2 mg/ml gelatin solution for 1 h,
after which the device is ready for cell culture (Fig. 3.9 C). Device was placed within a
cell culture incubator and the lower chamber was connected to the chemiluminescence
NO analyzer sampling line for real-time continuous NO measurement (Fig. 3.9 D).
3.4 Validation of two-chamber NO measurement
device
3.4.1 Investigating membrane NO permeability
Since all the fabrication work was manually completed in the lab and it has been
shown that NO enters the gaseous sampling chamber right after it was generated in
the culturing chamber, it is necessary to understand if NO gas is consumed in the




Figure 3.9: NOmeasurement device build-up. (A) PDMS coated glass fiber
filter paper was adhered to the bottom-removed conventional polystyrene cell
culture dish. (B) The main components of a single device, including the dish
cover, selective-permeable membrane and the upper and lower chambers. (C)
and (D) Cell culture experiment set-up. Cells were seeded within the upper
chamber (C) and the device was placed into culturing incubator for normal
cell culture and can be hooked up into sampling lines connecting to NOA
(D). NO sampling can be initiated and stopped at any time point during
cell culture according to specific needs.
First it is necessary to define an NO permeability for quantitative study. This is
depending on the experiment design shown in Fig. 3.10.
Assuming a source produces NO with a constant flux of Jp and NO diffusion is only in
the z direction. NO diffuses across the membrane, during which it might react with
90
oxygen dissolved in the polymer layer. The final detected value is JTr. Membrane





To achieve this, controllable NO releasing polymer SNAP-PDMS was cast on a cover-
slip and top coated with RTV-3140 PDMS layer. This SNAP-PDMS piece releases NO
at a certain constant rate at specific temperatures (due to thermal degradation). By
measuring NO flux when polymer layer faces up from the upper chamber, the original
NO flux coming out of the polymer (Jp) was obtained and facing down (polymer needs
to be tightly attached to the semi-permeable membrane), the NO diffusing across the
membrane was detected (JTr) (Fig. 3.10 upper and lower panels). At the edge of
SNAP-PDMS piece, water was applied to prevent NO from leaking.
By using NO measurement device with different polymer layer thickness (membranes
examined in Fig. 3.8 were used to manufacture the NO measurement device), it is
obvious to see that with thicker PDMS layer and the same Jp, JTr decreased (Fig.
3.11). This result also directly proved the conclusions from the simulation in 2.1.3.
So now the task would be to manufacture a membrane with the highest NO permeabil-
ity (where η = 1). The total PDMS amount applied onto the membrane was reduced
in the subsequent steps by decreasing PDMS solution concentration to 0.5 g/10 ml
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Figure 3.10: Experiment design of the evaluation of NO cross-membrane
signal dampening. Controllable NO releasing polymer SNAP-PDMS cast
on glass cover-slip was placed face-up and face-down in the NO measure-
ment device; the NOA was connected to the upper chamber or the lower
chamber to measure NO flux coming out from the polymer at 37 ◦C or NO
flux measured across the membrane while the same polymer was applied,
respectively.
toluene. Three layers were cast (72 µl/cm2). After 52 ◦C heating for overnight,
membrane was examined by both SEM and permeability test again.
Fig. 3.12 shows the cross-section and the surface of the new membrane. Compared
with previous membranes (Fig. 3.8), the new membrane does not have distinguished
polymer layer on top of the glass-fiber layer, instead the polymer coated the glass-
fibers, increased fiber diameter and formed a foam-like structure. The whole mem-
brane was homogeneous. After mounting this new composite membrane onto the
two-chamber device body, liquid leakage test shows no leaking of water. Permeability
test was run according to Fig. 3.10. The result is shown in Fig. 3.13.
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Figure 3.11: NO flux measurement influenced by the thickness of the NO
permeable membrane. SNAP-PDMS disc was used to release NO at a specific
flux rate, arrow A; then different NO measurement devices manufactured
from different membranes was used to measure the trans-membrane NO.
Arrow B to E correspond to the membrane shown in Fig. 3.8 B to E (with
a thickness of 17.3 ± 3.2 µm, 39.4 ± 4.7 µm, 53.8 ± 6.2 µm, 162.3 ± 9.5
µm, respectively).
Direct NO measurement and cross-membrane measurement produced almost identi-
cal NO releasing profiles. After 5 repeats, the NO flux value in steady state (after
1 h, the state where NO flux from SNAP-PDMS reached a plateau) were averaged.
Values were applied to paired t-test. Data showed that no detectable difference ex-
ists between using these two methods, indicating that when NO passes through the
membrane that was manufactured, there is no detectable signal loss. So that the
relative NO permeability η can be considered as 100%. This is important for later
NO calculation. Since the main idea for the NO real-time sampling method is to
estimating the total NO generation by accurately measuring a part of NO flux. So
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(A) (B)
Figure 3.12: Foam-like structured semi-permeable membrane manufac-
tured by casting Sylguard PDMS solution on the glass-fiber filter paper.
(A) surface (B) cross-section.
Figure 3.13: Permeability examination on foam-structured membrane. (A)
real-time NO flux data of both Jp and JTr; (B) comparison of direct measure-
ment and cross-membrane measurement. After 5-time repeats, the average
NO flux at steady-state (defined as the NO flux from time 60 min -70 min
after polymer was applied for measurement, where NO signal became almost
stable) was calculated; NO flux at steady-state measured by direct measure-
ment was arbitrarily set as 1 and the corresponding cross-membrane NO flux
was normalized to this value; P > 0.9 according to t-test.
precisely understanding the relationship of the detected NO and the total NO is im-
portant. Then it is necessary to understand NO’s fate and the consumption routes.
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Since there is almost no NO loss during NO crossing the membrane, the calculations
for the model become easier.
3.4.2 Quantifying NO coming out from the cultured cell layer
Since preliminary experiments have proved that NO can be measured by cross-
membrane measuring and the measurement result is not likely to be influenced by the
solution added above the NO source attaching to the gas-permeable membrane, it is
necessary to understand what the measured value actually means. What is the rela-
tionship of this measured value JTr and the total NO J0 generation by the source?
The next task is to find a mathematical expression J0 = F (JTr) to describe this
relation.
A series of experiments were designed to find the relationship between the detected
NO and the total amount of NO generated. PDMS coated SNAP-PDMS films were
used as the NO source again; the polymer disc (15 mm diameter SNAP-PDMS film)
was attached tightly on the prepared semi-permeable membrane, where different LED
drive currents were used to adjust the rate of NO generation; NO was sampled in
both the upper and lower chambers by using identically calibrated NOAs (Fig. 3.14
A). Since there is negligible NO loss when passing through the membrane, total




Figure 3.14: Linearity of the detected NO signal over the total NO gen-
erated in both gas-gas and gas-liquid chamber condition. (A) test set-up
and NO flux data. 0.2 mm thick, RTV-3140 top-coated SNAP-PDMS was
placed within the NO measurement device; NO fluxes in both upper and
lower chambers were measured by two identically calibrated NOAs simulta-
neously; different NO fluxes were controlled by changing the drive current
through a position fixed LED light; to assess the effect of bathing solution
on top of NO source, PBS was applied and the same current intensity val-
ues were repeatedly applied. The damper of NO flux signal due to bathing
solution was shown in the bubble; three independent experiments were run.
(B) Linear regression analysis. The slope reflects the detection sensitivity.
Red refers to the signal from the upper chamber, blue the lower chamber; ×
corresponds to before adding bathing solution, • after.
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measured from both upper and lower chambers, as determined by integrating the area
under the NO release curves. Data showed clearly that the tested NO flux across the
membrane (Fig. 3.14 A blue line before green arrow) changed in the same way the
NO flux change in the upper chamber (Fig. 3.14 A, the red line before green arrow),
indicating the NO flux tested in the lower chamber also changed the same way as the
total NO change. More importantly, after PBS was applied on top of the NO source
and the same LED driven current was used (same light energy was used to initiate the
same NO release), NO flux through the membrane remained constant (Fig. 3.14 A
blue line after green arrow). However, the NO signal sampled from the upper chamber
decreased dramatically (Fig. 3.14 A red line after green arrow). This is expected since
thick PBS layer slowed down NO diffusion such that NO auto-oxidation has more time
to occur, which also explained why the device membrane needs to be thin. Linear
regression analysis (Fig. 3.14 B) further demonstrated that the bathing solution on
top of NO source will not affect the NO flux into the lower chamber (Fig. 3.14 B,
blue slope remained after PBS addition), although it greatly decreased the detection
sensitivity from the top chamber (Fig. 3.14 B, red slope declined after PBS addition).
It is also worth pointing out that although the signal detected in the upper chamber
dramatically decreases, the NO production still increases linearly with increased LED
drive current (Fig. 3.14 B).
This data proved again the feasibility of cross-membrane measurement, and suggested
that NO signal measured from the lower chamber is linearly related to the total NO
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generated from the source, which is particularly important for later calculation, that
is, the measured NO value is directly proportional to the total NO. So J0 = k × JTr,
where k is a factor determined by system parameters (including membrane properties,
source properties and states, will be discussed later).
(A) (B)
Figure 3.15: Linearity of the detected NO signal over the total NO gen-
erated in culture conditions. (A) experiment procedure was the same as in
Fig. 3.14; complete culture media was used as the bathing solution in the
upper chamber; (B) linearity test of the detected NO signal to the total NO.
Media NO−2 levels quantitated by Griess assay were used to estimate the
total NO fluxed into the upper chamber, and the total NO generation was
represented by the sum of the total NO−2 cumulation in the upper chamber
and the total NO sampled by the NOA in the lower chamber.
To examine whether a linear relationship still exists in real cell culture conditions and
culture media above the NO source will influence the NO measurement by sampling
form the lower chamber, the PBS bathing solution was changed to normal complete
DMEM. As shown in Fig. 3.15 A, NO diffusion into the lower chamber and cross-
membrane measurement were not influenced by the applied culture media. Linear
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correlation of total NO generated and the NO sampled from the bottom was also
examined. Once the upper chamber was filled with media solution, the NO signal
cannot be directly measured by the NOA at this point. To quantify how much NO
entered the bathing solution, after NOA sampling the media was collected and applied
to Griess assay to calculate the cumulative NO−2 level. So that the total NO generated
was calculated as the sum of NO measured from the lower chamber and the total NO−2
quantified from the media sample. Result was shown in Fig. 3.15 B, showing that
when the upper chamber was filled with media, the NO signal obtained from the
lower chamber is also linearly related to the total NO generation.
3.5 Real-time measurement of NO from cultured
living cells
3.5.1 NOA calibration
The calibration process for measuring cellular NO requires slight modification com-
pared with measuring NO coming from a specific NO donors or NO releasing mate-
rials. For chemiluminescent detection, NO is continuously sampled into the reaction
chamber of NOA, where it reacts with excessive ozone (O3), converting sampled NO
into NO∗2. The relaxation of NO
∗
2 to its ground state results in the release of energy in
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the form of light (red and near-infrared, [87]). The final quantification is dependent on
the counting of light energy. However, if NO is consumed before entering the reaction
chamber, the NO results will be underestimated. To avoid this, the sampling process
needs to be carefully controlled. Once NO is generated, it needs to be carried by the
sweep gas immediately for the chemiluminescent reaction and the sweep gas needs
to be inert to minimize NO loss during sampling (usually several seconds depending
on the set-up). So before NO measurement occurs, the whole sampling line needs to
be swept by N2 for 10 min. However, this is not feasible for the NO measurement
from cell layers, because cells need a continuous supply of CO2 and O2 with their
aqueous environment. A dry sweep gas leads to changes of those parameters and cell
dehydration.
To prevent the potential oxygen tension reduction within cells media, ambient air (air
drawn from the cell culture incubator with 5% CO2 and high moisture) was used as
the sweep gas to carry NO into the NOA and zero calibration gas for the NOA in all
cell experiments. To investigate how different it is when using ambient air compared
with house nitrogen as the sweep gas, the NO flux from SNAP-PDMS films were
measured by using both pure nitrogen and ambient air.
Fig. 3.16 A shows the representative NO releasing profiles tested using nitrogen and
ambient air, respectively. Linear regression analysis showed linearity was good for




Figure 3.16: The effect of ambient air as sweep gas to NO signal. 15
mm diameter, 0.2 mm thick RTV-3140 coated SNAP-PDMS was exposed
under different LED light intensities by changing the LED drive current.
House nitrogen and ambient air were used as sweep gas for independent
experiments. (A) Representative curves of NO surface flux detected through
nitrogen and ambient air by the same NOA. Three independent experiments
were run. (B) Linear regression analysis of NO flux vs. LED drive current by
two different sweep gases. Though the slope values indicate around 3% loss
of signal by using ambient air, paired student t-test applied to each value
obtained at different drive current shows no significant difference between
the two groups.
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239.38 PPB/mA and 231.68 PPB/mA for N2 and ambient air, respectively); a slight
decrease of detection sensitivity (slope in Fig. 3.16 B, 3.2% decrease) was observed
in ambient air group. This is an indication that there is a tendency of losing some
NO signal by sampling with ambient air because of the autoxidation of NO. And
this effect might be more obvious if a trap (for collecting condensed water in the
sample line) was added. However, by paired student t-test there is no statistically
significant difference between the two groups (P=0.1926), indicating the feasibility
of using ambient air as the sweep gas for NO measurement. To obtain accurate NO
signal, it is highly recommended to run NOA signal constant calibration. 100 µl of
500 µM NaNO2 standard was injected in freshly prepared acidified Lugol solution
(acetic acid/Lugol solution 5:2 v/v).
2NO−2 + 2I
− + 4H+ 2H2O+I2 + 2NO
Scheme 3.1: NOA calibration.
The total NO signal (PPB) was calculated through integrating NO profile curve. The






3.5.2 The enhancement of NO signal by using new measure-
ment device
Direct NO sampling from the culture flask led to great NO loss, (explained and
proved in 2.1.1). The signal damper of NO generated from the cultured macrophage
cell line RAW264.7 has also be shown in 3.2. The reported average rate of NO
production following LPS and IFN-γ stimulation was 2.6 pmol/106cell/sec [29]. So
RAW264.7 cells were used again to test whether the new design can achieve real-time
NO measurement and the signal sensitivity can be improved.
RAW264.7 cells were cultured within the device (to 0.5-1×106cell/cm2) and stimu-
lated with both 10 ng/ml IFN-γ and 100 ng/ml LPS. Right after stimulation, the
device was connected to the NOA sampling inlet which was mounted in the cell cul-
ture incubator and connected to the NOA (Fig. 3.9 D). Collection of continuous NO
release data lasted for 24 h.
Figure 3.17 shows the NO profile measured by both directly sampling from the culture
flask (blue) and the lower chamber of the two-chamber system (red). From the raw
PPB data and the surface flux data (normalized to culture surface area, this will
be discussed in detail in 3.5.3), both methods achieved real-time NO measurement
and the NO generation trends are similar (NO flux peak occurred at around t=8 h),
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Figure 3.17: Validation of measuring NO generated by cells in real-time by
using the two-chamber system. Blue line represents directly sampling NO
from the T-25 flask; red shows data collected from the two-chamber device.
but the two-chamber system greatly increased the sensitivity of the measurement.
One obvious advantage is that when NO level is low at the initial stage (t=2 to 4
h), the two-chamber system still captured the signal and was able to track the NO
level change more readily. This is because of the thin NO permeable layer (<20
µm) minimally inhibited NO diffusion, therefore it experiences significantly fewer
consumption reactions compared with passing through the culture media (which is
normally at least several mm thick).
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3.5.3 NO flux calculation and NO data report
In most NO work, NO is normally described by its overall equilibrium concentration
mol/l, which is very useful to study its chemical properties. However, the duration
over which cells experience NO is important in determining the ultimate effect the NO
will have physiologically. But much NO research fails to discuss this variable because
such information is hard to obtain. This new chemiluminescent method achieves both
absolute NO quantification and tracking NO change with time. The raw data is given
by X PPB or PPM (volume ratio). Depending on the sampling rate, it is reported
as PPB/sec or PPB/min etc.
After calibration by known amount of NO−2 (mentioned in 3.5.1), the PPB (or PPM)
number can be convert to x1 mol/sec, where x1 = X × calibrationconstant (constant
mol/PPB/sec). When cells form a homogeneous layer, the culture surface will be
A cm2. It is noted that this is not the surface area of the cells themselves, and is
used (for more convenient and reproducible normalization) to calculate the NO flux
as X×constant
A
(mol/cm2/sec) or further converted to pmol/cm2/sec or mol/cm2/min,
which is a more widely used surface flux unit in characterizing NO generating ma-
terials. The use of this dimension with time parameters more accurately and com-
prehensively describes the NO status of the system. And this dimension is useful in
calculation as well, because this makes the measured value and the simulation result
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and NO delivery data comparable.
Another more practical dimension is pmol/106cell/sec for investigating cellular NO
production. It is easy to understand that his dimension is more useful in when
discussing NO and cell behavior. Cell number needs to be determined to obtain
such values. For example a batch of cells produces X PPB NO per sec; this time
using calibration constant to get X× constantmol/sec and normalized to cell number
(N cells) by X×constant
N
mol/cell/sec. Considering the calculated value will be very
small when only discussing one single cell, and also our measurement method does
not target one single cell, instead, it measures an overall fashion of all cells under
investigation, pmol/106cell/sec is used in the end, which may be more meaningful.
3.5.4 Repeatability examination of the new device
It is necessary to understand how different batches of manufactured devices affect the
final measured result. Is manual casting controllable enough to produce device with
consistent properties? To test the repeatability, RAW264.7 cells were cultured within
the different batches of device (for 1-2 days to allow the cells to be confluent to form
a relative uniform cell layer so that cell density could be relatively stable, normally to
0.5-1×106cell/cm2) and stimulated with both 10 ng/ml IFN- γ and 100 ng/ml LPS.
Recording of continuous NO release lasted for series of time duration depending on
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specific cases (usually 17-48 h for RAW264.7).
Figure 3.18: Macrophage cell-line RAW264.7 real-time NO releasing pat-
terns. Different colors show different repeats; data was collected by using
different batches of devices to culture RAW264.7 cells.
Fig. 3.18 (each color represents one culture replicate) summarizes real-time NO re-
leasing profiles, with similar peak shape, especially the time when the maximum NO
production occurred. Experimental data from the NOA was recorded as PPB/sec.
Then PPB raw data was converted to pmol/cm2/sec according to the method intro-
duced in the previous section. To further evaluate the repeatability of this method,
different sizes of device were also used for culturing cells. Normally the NO sig-
nal started to appear between 2-3 h. The decrease of NO generation rate after 8
h might be because the cell death rate increased significantly at hour 8 (according
to the live-dead assay). So that cells gradually lost NO generation ability. Overall,
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by using different devices manufactured through manually casting PDMS on glass-
fiber filter paper, the measured NO profiles showed very consistent results and good
repeatability.
3.5.5 NO generation rate normalized to cell number
To more precisely understand how much NO was produce by cells the rate of NO
generation was normalized to cell number. One of the drawbacks of the cell measure-
ment device is that although the cells can be observed through fluorescent labeling,
the current membrane is not compatible with conventional visible light microscopy.
However, by fluorescent staining, the number of cells that actively generate NO can
be determined and counted by applying NO staining.
(A) (B)
Figure 3.19: Normalization of NO releasing rate to cell number. (A) cell
NO releasing rate was measured by the NO measurement device, (B) NO
releasing cells were stained by NO staining DAF-FM-AD (5 µM) and cell
number was counted under microscope, scale bar: 30 µm.
108
To do this, after specific NO measurement operation (Fig. 3.19 A), cells were removed
from incubator and stained with the NO dye DAF-FM (or Calcein-AM and EthBr);
then cells were counted under the microscope (Fig. 3.19 B). DAF-FM diacetate
is very sensitive to low NO concentration and can passively diffuse across cellular
membranes and be deacetylated in cells so that the turned-on probe’s leaching from
cell is limited [162]. DAF-FM directly indicated which cells produce NO and was
used to determined the NO positive cell number.
Table 3.1
RAW264.7 cell NO generation rates stimulated by 100 ng/ml LPS and 10
ng/ml IFN-γ
Average St.d. 95% Confidence area
AVG Flux rate (pmole/106cell/sec) 1.73 0.63 1.73± 0.72
Max. flux rate (pmole/106cell/sec) 3.48 0.95 3.48±1.08
Adjusted AVG Flux rate (pmole/106cell/sec) 2.23 0.81 2.23±0.92
Adjusted Max. flux rate (pmole/106cell/sec) 4.47 1.22 4.47±1.38
Table 3.1 Row 1 and 2 summarize this data. This number only represents NO detected
from the lower chamber. To back calculate the total NO released, culture media was
collected from the upper chamber after NO sampling for analysis with the Griess
assay.
Since the total NO flux (ntotal) is directly proportional to the measured NO value in
the gas phase (nNO), it is needed to determine the ratio k (explained in 3.4.2). To
do this, NO entering the upper chamber (nNO−
2
, remained in the media as the form
of NO−2 ) was determined by measuring cumulative NO
−
2 through Griess assay. The
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ntotal = k × nNO (3.5)
In theory, with the same device quality and cell culture condition, this constant should
be the same among different devices. However, it was noticed that some variations
still exist between different devices. So each and every sample was applied to this
method to calculate a specific k to calculate the total NO production. The total NO
generated by the cells should be presented as in Table 3.1 Row 3 and 4, which is very
consistent with the previous report [28, 29, 156].
3.5.6 Factors that may influence observed NO distribution
In our system where NO is generated from the source plane, NO will only have two
routes, it will be trapped in the solution in the upper chamber or sampled by NOA
from the lower chamber. Source dimension (thickness of NO source), attachment
and membrane properties were studied to investigate how those factors influence NO
distribution. For quantifying NO entering the lower chamber, the NO release curve
obtained from the NOA was directly integrated, while for NO remained in upper
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chamber, the ultimate oxidization product of NO in the solution in upper chamber
was estimated through the Griess assay. Their relationship was presented in Fig. 3.20
(open circles), showing that more than half of the generated NO can be sampled by
NOA by using the device, while only 21.8% was trapped in the media.
Figure 3.20: Linearity test between NO captured by NOA and NO dis-
solved in the media. The total NO signal was calculated through integrating
the area under the curve. NO trapped within the media was quantitated
using Griess assay. Data points were plotted in the hallow circles. 35 µl of
SNAP-PDMS solution was dissolved within 1 ml toluene and cast onto the
60 mm NO measurement device and top-coated by 1 ml RTV-3140 solution,
which generated around 25 µm (by calculation) thin SNAP-PDMS layer as
the NO source, which mimicked the cell layer. Data points were represented
by the dark triangles.
This is contradictory to the previous observation, the result shown in Fig. 3.14 B,
where only 23.4% of NO were detected by the NOA, 76.5% remained in the media
when using SNAP-PDMS for device validation. It is suspected that the main reason is
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the thickness of the NO source. Compared with cell layer (for RAW264.7, less than 15
µm thick), the SNAP-PDMS film used was much thicker (over 200 µm). The effect of
a thicker film on the device membrane may influence the final distribution of NO (i.e.,
retarded NO diffusion into the lower chamber by effectively increasing the thickness of
the membrane through which NO will diffuse). So a thinner SNAP-PDMS layer (up
to 25 µm by calculation) was directly cast on the device and top coated with RTV-
3140 to mimic cell generating NO from a thin cell layer. PBS solution was applied
on top. Still NOA recorded the NO flux in the lower chamber across the membrane
and Griess assay tested the NO that entered the bathing solution. Then NO amount
in each repeat was summarized in Fig. 3.20 dark triangles. In this case similar NO
distribution to the cell culture experiment was observed (with 25.07% trapped in
bathing solution and 74.93% NO went to NOA), proving our hypothesis that the
thickness of the NO source can affect the final NO distribution during measurement
by using the device. Also this data validated the measured cellular NO result and
indicated that our method samples the majority of NO generated by the cells.
It was also noticed that when using NO releasing films, tighter attachment to the
device membrane resulted in higher measured value in the lower chamber. This is
easy to understand since the tighter attachment created larger concentration gradient
between the NO source and the NO permeable membrane, which is favored by faster
diffusion.
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Thicker device gas-permeable membrane can make the distribution ratio more com-
plicated. Since there might be significant consumption reactions taking place within
a thick membrane and thereby changing the fate of NO, NO’s fate changes. It not
only affects upper/lower NO distribution, but also changes the calculation to obtain
the total NO produced. So in our cellular NO experiment, we only use membrane
with 100% relative permeability.
Understanding the NO distribution ratio can be useful for understanding the quan-
tification principles and fate of NO within our measurement system. The result can
also be validated roughly by this ratio to avoid potentially serious errors.
3.5.7 More data validation by using Griess assay
To verify the NO results obtained by this new method, we also ran the Griess as-
say, a conventional NO measurement method, to measure the accumulated NO at
different time points in cultured media and compared these results. RAW264.7 cells
were cultured in both 6-well cell culture plate until confluent (around 107cell/well
) and our device (60 mm diameter, 1.07± 0.65× 107cell/device ). Then old media
was removed and 2 ml new DMEM media with 100 ng/ml LPS were applied to the
wells and 5 ml to the devices. The device was connected to NOA for real-time mea-
surement. The cumulative NO calculated from integrating real-time NO profile from
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the NOA was plotted in Fig. 3.21 (circles). While for the 6-well plate, samples of
the media was collected at different time points and tested with Griess assay. Fig.
3.21 squares show the time-dependent cumulative NO−2 within the 100 ng/ml LPS
stimulated media. Results show a similar trend, that is before t=4 h, NO−2 accu-
mulation is mild (0.35±0.51 nmol/106cell by Griess assay, 2.46±0.12 nmol/106cell by
NOA); there is a sharp increase of NO−2 from 4 h to 11 h (to 17.23±1.95 nmol/106
cell by Griess assay and 30.32±4.50 nmol/106cell by NOA); after 11 h, NO−2 signal
changed slowly, suggesting a slow-down of NO generation rate from 11 h to 16 h
(to 17.51±3.52 nmol/106cell by Griess assay and 33.30±3.30 nmol/106 cell by NOA),
which suggests the time response of our method is reliable. However, the total NO
generation determined by Griess assay were significantly lower (around 50% of the
result obtained with the two-chamber device). This is consistent with Hunter’s report
[146], indicating underestimation problem associated with using the Griess assay to
estimate the NO generation in biological application.
The reaction of NO in biological condition might be complicated and it is also not
safe to assume all produced NO and NO oxidation product is trapped in the media.
Our data showed directly that NO can escape from the media. Meanwhile, chemi-
luminescence has much smaller limit of detection compared with Griess assay and
provide time variable information directly.
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Figure 3.21: Validation of the new NO measurement method by comparing
our result with the result obtained by Griess assay using 100 ng/ml LPS
stimulated RAW264.7.
3.6 Investigation of the temporal profile of NO
production from RAW 264.7 cells
It has been shown that by using the measurement device the dose-dependent biological
effects of NO can be efficiently studied, but we still lack data that shows how the
temporal effect of NO plays a significant role in determining the ultimate biological
response. Here we demonstrate three examples showing how this NO measurement
device can help us understand the timing of NO generation, which can potentially
provide extra dimensional (time variable) information to NO studies.
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3.6.1 Investigating temporal aspect of NO production under
different stimuli
IFN-γ and LPS can stimulate NO in a synergetic manner because the total accumu-
lation of NO end-products is greater when both agents are used [156]. To understand
this statement, different combinations of stimuli (IFN-γ and LPS) were applied to
the same passage RAW264.7 cells. Right after adding the stimuli, cells were applied
to NOA sampling line for NO measurement.
Fig. 3.22 shows the real-time NO releasing profiles from the same batch of RAW264.7
stimulated by 10 ng/ml IFN-γ alone, 100 ng/ml LPS alone, and both added at time
zero. Fig. 3.22 B-D focus on the initial stage of NO profile after stimulation, showing
that in all the groups, NO generation started at around 2 h after stimulation, indicat-
ing that both pathways need at least 2 h to respond the stimuli to produce NO (the
NOA has a detection limit of 0.5 PPB, a 1 PPB increasing of the average rate was
considered to be the start of cellular NO generation; no significant difference among
groups in regards to time required to initiate NO production was observed).
Noda et al. [156] reported the 24 h iNOS expression pattern after stimulating
RAW264.7 by 100 ng/ml LPS using Western blot. Though this is an indirect NO
quantification method, iNOS catalyzes NO production in a Ca2+-independent way,
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Figure 3.22: Synergetic effect of LPS and IFN-γ to RAW264.7 NO gener-
ation. NO flux was normalized to surface area. (A) Representative profiles
of RAW264.7 NO releasing under different stimuli. 100 ng/ml LPS , 10
ng/ml IFN-γ or a combination of the two were applied to stimulate the
cells. The experiment and analysis were run by groups. The same group
means the same cell passage, the same seeding density, the same prepared
PDMS-coated filter paper and the same culturing time. (B)-(D) larger cul-
ture dishes (100 mm dia.) were used to increase the signal strength, showing
the time point when NO signal starts to be detectable is almost the same
among groups.
so it is agreed that the presence of iNOS means the presence of NO. The earliest
immunoblotting band was characterized at 4 h. But it was not clear whether there
was actual NO production before 4 h after LPS stimulation due to their lack of sam-
pling points and maybe detection limits. However, using much simpler experimental
operation procedures, it is proved here that the NO signal appeared 2 h after stimu-
lation. This method clearly showed how soon the stimulated cells begin to produce
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NO, the rate of NO production, the maximum level of NO produced by each stimuli
individually and how long the NO production persists under static culture conditions
(without media change after treatment).
More detailed quantification can be carried out according to the NO profiles as well.
For example, IFN-γ and LPS alone initiated NO production with maximal surface
flux reaching 2.4× 10−11mol/cm2/min after 18 hours and 1.2× 10−11 mol/cm2/min
after 22 h, respectively (measured value from the lower chamber only). When the
same amount of IFN-γ and LPS were added together, NO production reached a max-
imal surface flux of 4.2× 10−11mol/cm2/min (measured value from lower chamber)
after only 15 h. Real-time, experimental data directly showed the increase in NO
production when LPS and IFN-γ are added together is greater than either of them
used separately. Integrating the area under the NO release curves allows the total
dose of NO released to be calculated. Table 3.2 summarizes the integrated data from
the NO releasing curve, Row 1-3.
Compared with Noda’s report [156] (around 400 nmol/106cell and 100 nmol/106cell
for LPS with and without IFN-γ within 24 h respectively), these numbers (around
50 nmol/106cell and 35 nmol/106cell for LPS with and without IFN-γ within 24 h
respectively shown in Table 3.2) are far smaller. Cell viability tests indicated that in
our system cells started to die at a high rate after 8 h of stimulation; the pH indicator
in cell media also showed the pH changed greatly between 8 to 12 h after stimulation.
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Table 3.2
Total NO generation of RAW264.7 cell 24 h after treatment by using




100ng/mL LPS 35.37 2.90
10 ng/mL IFN-γ 30.29 14.4
100ng/mL LPS + 10 ng/mL IFN-γ 52.77 16.9
100ng/mL LPS + 10 ng/mL IFN-γ
405.6 54.7
(Low cell number) ⋆
100ng/mL LPS + Arg at 4 h ∆ 199.4 63.1
100ng/mL LPS + Arg at 8 h 63.10 17.3
100ng/mL LPS + Arg at 12 h 70.30 22.7
100ng/mL LPS + nor-NOHA at 8 h 45.20 8.41
101ng/mL LPS + L-NAME at 8 h 33.57 2.51
Result is from the integration of the NO releasing time-flux curve. NO
generation was normalized to cell numbers (106 cells). One way ANOVA
and Tukey’s test were run by R program. ⋆, P < 0.05, compared with all
the rest groups. ∆, P is close to 0.2, compared with all the other groups.
Others are > 2.
It is suspected that in current system, the relative cell number might be too high
compared with Noda’s model, which affected cell normal growth and suppressed NO
generation. So next, cell density was reduced and the measurement experiment was
repeated.
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3.6.2 Investigating NO production tempo change due to dif-
ferent cell density
Initially to obtain enough NO signal, high cell densities (to 5-10 ×105 cell/cm2) were
used in all experiment. High cell density led to fast cell death after NO stimuli were
added. This might result from a combination of fast nutrient consumption and too
high concentration of NO and other metabolic products which leads to fast change
of media pH. Since it is noticed that in low cell density environment, after the same
stimuli treatment, cell survived for longer periods of time, a systematic study on the
relation of cell density and NO profile was carried out. RAW264.7 were seeded and
cultured to 1-2 ×105cell/cm2. Then media with 100 ng/ml LPS and 10 ng/ml IFN-γ
was used to treat the cells. Right after LPS administration, cells were applied to
NOA sampling line for NO measurement.
Fig. 3.23 showed that using the same stimulants with a lower cell density
1.24± 0.18× 105cell/cm2 compared to 5.56± 0.33× 105cell/cm2 in Fig. 3.23), NO
release profile can be greatly altered. Compared with results in Fig. 3.18, NO signal
also started between 2-3 h, but the NO release profile was elongated. Additionally,
the rate of NO generation continued to increase until up to 18 h (red). Compared
with the high cell density groups, NO flux per unit cell in the lower density groups was
significantly increased (the maximum flux was 7.65±1.3) and the total NO generation
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Figure 3.23: Real-time NO releasing profiles of low cell density RAW264.7
cell culture. Cells were cultured within the NO measurement device (60 mm
diameter) to a total of 1.24± 0.18× 106 cell/cm2. Cells were stimulated
by 100 ng/ml LPS and 10 ng/ml IFN-γ at time zero. Three different colors
represent 3 repeats.
per unit cell (by integrating area underneath the curve from 0 to 24 h) also increased
greatly (summarized in Table 3.2). This phenomenon is important, because this data
directly shows how flexible NO production can be due to the change of one single
factor such as different cell densities. In this case the ultimate NO generation are two
times larger than Noda et al.’s report [156] but within the same order of magnitude.
Note that, parameters such as the on-set time, total NO generation, maximum NO
flux and signal duration of NO signal are dependent on cell numbers cultured in the
device and media conditions. Static culture may associate with great environment
changes especially after 24 h. So to study the on-set time, it is recommended to use
high cell density model that shown in Fig. 3.22 B to D. To study NO levels, defining
specific conditions is needed. Obtaining such information and discussing NO profiles
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need more precise control over the experiment conditions mentioned before, which is
beyond the scope of this study.
This might be one of the reasons why there were significant variations of NO gen-
eration rate reported by different groups. Cellular NO production rate can be very
sensitive to the cellular environment. This highlights the importance of real-time
measurement of every experiment and controlling the culturing conditions to obtain
consistent results in NO generation from these cells otherwise results from different
replicates or methods are not comparable.
3.6.3 Tracking the change of cellular NO production due to
administration of other chemicals
Modulating the NO level to recover normal biological functions is the ultimate goal
of all NO research. Currently, there is no standard method to test and quantify the
potency of certain drugs. Drug’s time-dependent potency and how much change in
NO levels can be introduced by those drugs are hard to evaluate. Since the new de-
vice directly targets the measurement of NO and provides quantitative and temporal
information, it may be a very useful tool to study the modulation of NO level.
Since arginine is the most important substrate for NO generation, we examined the
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relationship between NO generation and the arginine pathways. In RAW264.7 in vitro
cultures, high doses of NO were produced, consuming large amount of Arg. Also, as
a competing pathway, arginase catalyzes the urea cycle reaction which consumes
arginine to form urea [163], thereby shunting arginine away from the NO production
pathway. The arginine concentration might be an important limiting factor for NO
production. In our study, exogenous arginine (an additional 1 mM) was added; the
arginase specific inhibitor nor-NOHA (20 µM), and iNOS inhibitor L-NAME (50 µM)
were added to 100 ng/ml LPS stimulated RAW264.7 cells (cell density used was 0.5-
0.7×106cell/cm2) to show the ability of monitoring real-time NO generation changes
of the device.
One advantage of the two-chamber measurement system is that the cell culture and
NO measurement can be carried out independently but simultaneously. Treating
cells and sampling can be processed simultaneously without losing data or generating
confusing noise, so that the change in NO generation introduced by condition changes
can be tracked in real-time. After RAW267.4 cells were stimulated with 100 ng/ml
of LPS and applied to the real-time NO measurement system, arginine was added at
different time points into the cell culture media. Fig. 3.24 A-C show that, right after
Arg addition, the rate of NO production underwent a sharp increase. Considering
time as a factor, the degree of increase in NO production upon the addition of Arg
was significantly different at different time points of stimulation. When arginine was





Figure 3.24: Change of NO generation profile monitored by NOA under dif-
ferent chemical treatment. 100 ng/ml LPS was used to stimulate RAW264.7.
The curves at the up-right corner of each plot are the expanded plots focus-
ing on the change. (A)-(C) 500 mM Arg stock solution was added into the
media at different time points (indicated by blue arrows) during cell cultur-
ing (resulting in 1 mM exogenous Arg in the culture media). (D) Nor-NOHA
(final concentration of 20 µM) was applied to the culturing media (indicated
by green arrows). (E) L-NAME (final concentration of 50 µM) was applied
to the culturing media at about 8 h (indicated by red arrows). To allow a
homogeneous distribution of the chemicals, device was gently shaken after
chemical addition. To eliminate the possibility that the experiment proce-
dure itself may alter cellular NO production, control (F) was run by adding
PBS and shaking device gently (indicated by black arrows).
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pmol/106cell/sec (Fig. 3.24 A, by 28.9±4.1% on triplicates average), however, after
8 h and 12 h, NO production increased by 85.2±2.3% and 97.6±7.5%, respectively
(from 2.16 to 4.37 pmol/106cell/sec and from 1.12 to 2.37 pmol/106cell/sec, in Fig.
3.24 B and C). This could be explained by different limiting factors that occurred
relative to different points of stimulation. With the consumption of Arg in static
culture, after 8 h, the concentration of Arg might become the main limiting factor.
So replenishing the Arg substrate for NO production might significantly change the
NO producing profile. While at the initial stage, arginine was sufficient.
To further directly show that arginine accessibility determines the rate of NO pro-
duction can be easily observed by our device, arginase specific inhibitor nor-NOHA,
(which may potentially make more arginine accessible for iNOS), was applied. Fig.
3.24 D shows 20 µM of nor-NOHA was applied to RAW264.7 after 8 h of stimula-
tion, the NO production rate was increased from 1.99 to 2.30 pmol/106cell/sec (by
13.64.0%, based on triplicate average), but not as potent as supplying arginine, which
is around 1 fold. L-NAME’s hydrolysis product inhibits NO production by binding
with iNOS with high affinity. Fig. 3.24 E showed that after supplying 50 µM of
L-NAME, NO production indeed decreased from 1.68 to 1.07 pmol/106cell/sec (by
34.94.0%, based on triplicate average) within 20 min (see Table 3.2). To eliminate the
influence brought about by the experimental processes such as opening the incubator,
adding exogenous chemicals and shaking, 10 µl of PBS was applied to the cells as
well (shown in Fig. 3.24 F). Shaking will potentially increase the NO concentration
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gradient in the vicinity of the membrane and change the NO profiles. In fact, a small
sharp peak was observed in the real-time NO profile of the control group. The quick
increase and decrease of the NO signal might be because of the NO concentration
gradient was quickly changed but return to the previous status again after the appli-
cation procedure. The total NO releasing after 24 h stimulation was summarized in
Table 3.2.
Definitely more work need to be completed to fully understand which factors are
responsible for the changes in NO production in LPS stimulated RAW264.7 cells when
those chemicals are added. But this devise successfully demonstrated the degree and
time aspect of NO change introduced by different chemicals, which will be a good
example for NO pharmaceutical study and will allow the molecular biology to be
linked to direct NO measurement data, permitting the temporal aspect of NO release
to be investigated.
3.7 Discussion
NO has multiple biological functions, which may be both deleterious and benevolent.
The ultimate biological effects of NO might depend on many parameters, including
NO concentration, duration, and NO responding mechanisms within individual cells.
Many of the contradictory roles that NO has been reported to play may be in part
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rooted in failing to record the different temporal NO generation profiles caused by
variable environmental conditions (e.g. different cell densities). Because of the lack
of knowledge regarding the dose and duration of NO cells experience, attempting to
understand the roles NO plays is complicated.
Although attempts have been made to quantitatively determine the level of NO pro-
duced by cells or that cells experience, the problem remains unsolved because of the
drawbacks within the measurement methods themselves. Western blot directly shows
status of NOS isoforms, which have been used to indirectly indicate an increase or de-
crease in overall NO production. But this cannot be carried out in real-time and the
actual NO level can be greatly affected by various things such as enzyme modification
levels, Ca2+ level (for nNOS and eNOS), cofactors, NO consumption rate, competi-
tive reactions and levels of substrates and inhibitors, too. Immunohistochemitry or
immunocytochemistry reveals NOS subcellular localization, which may be indicative
and interesting in suggesting localized NO production, but in fact does not directly
represent the level or NO production or for what duration NO is actually generated.
Currently, immunohistochemical studies use NOS antibodies to evaluate NO’s role in
tumor development, which has been pointed out by many researchers as an indirect
method [22, 65], as the final NO production is not solely dependent on the enzyme
level. An interesting finding by Mehibel et al. [164] is that iNOS, instead of generating
NO in HT1080 and HC116 tumor tissue under hypoxic condition, may function as
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a reductase that activates the pro-drug into a topoisomerase inhibiter, showing how
important it is to target NO directly rather than focusing on NOS level alone while
discussing NO’s effect in cancer cell. NO fluorescent dyes such as DAF can hardly
reflect NO real-time status and most NO dyes reflect NO accumulation in subcellular
localization based on solubility, partition coefficients, structures of the dyes, and even
some less specific side-reactions. Other indirect measures of NO such as the Griess
assay measure oxidized products, which are very likely to underestimate the amount of
NO produced due to the escape of NO into cell culture vessel head-space and reactions
with other biomolecules [28, 146]. NO electrochemical microprobes have been used to
record NO concentration measurement and can achieve real-time measurement but
there is a great deal of variability in results when using probes of different sizes and
results are heavily influenced by how close the probe is placed to the actual surface
of cells under investigation [147].
It is necessary to improve the current measurement method. One interesting thing
is that currently the most sensitive electrochemical microsensors are able to detect
NO concentrations to as low as 1× 10−12 M [123], but NO measurement and data
report is still problematic. Instead of focusing on increasing detection limit, the new
method is trying to directly target NO itself, creating a biology-friendly interface, and
making full use of the current detection means. In the system presented here, due to
the biocompatibility and gas-permeability of PDMS based substrate, cells were able
to be seeded, grown, and tested in the same device without deviating from standard
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cell culture protocols. Dissolved NO was guided into gaseous phase and the flux was
directly recorded. This only relies on the correct calibration of the instrument and
the device. Different from measuring concentration, our signal can be enhanced by
increasing the sample size. Though NOA has its own detection of limit (0.5 PPB),
this limitation can be simply overcome by using larger device and higher cell number,
which makes this method very economic. With proper normalization calculation, the
final result will not be changed but the apparent resolution and sensitivity can be
improved.
Our goal is to standardize NO data presentation, obtaining as much information
as possible from the testing systems and making NO data from different laboratories
comparable. Some pioneers’ work reported NO generation rate in cytokine/LPS stim-
ulated RAW264.7 cells. Normally the calculation is based on monitoring the change
in NO and O2 concentration and assuming no other NO consumption routes exist
other than certain specified chemical reactions [28, 29, 96]. The range differed from
2.6±0.1 pmol/106cell/sec to 6.0±0.4 pmol/106cell/sec, which is close to but generally
a little less than our result. One reason could be the calculations only considered
the oxidation of NO by oxygen and superoxide, while in fact there are additional
side reactions that potentially affect the overall reaction too. We highly recommend
that NO quantitative data should be reported with the time variable and the specific
conditions if possible, so that NO data from different labs can be more comparable.
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One main problem of those results is that they reported only a single average value.
It is almost impossible to extract information on time related NO level change or
track the process of NO change due to the change of the factors (such as culture
condition, exogenous chemical) from that data. As shown in Fig. 3.23, NO generation
may be very variable. One single value may not be enough to describe this complex
process, over simplified data may in fact mislead researchers. The power of the device
developed in this work makes it overcome this problem, providing comprehensive time
related data covering the whole experiment. So that other results can be analyzed
based on the specific time points and NO status.
Wang et al. mentioned NO oxidation in the PDMS membrane of their NO delivery
system [165], which potentially could be one source of NO loss in our system too.
However, their membrane was around 500 µm thick, which is much thicker than the
membranes used in this system. To prove that in our system, NO loss during sampling
is negligible, we used controllable NO releasing polymer SNAP-PDMS to release NO
with a constant rate. NO rate was measured directly and across the membrane. Result
shows that there was no statistically detectable signal loss within the membrane. In
this method, close measurement is a key concept, which is achieved and well controlled
by fabricating the NO permeable membrane. So that NO undergoes the lowest level
of chemical consumptions between its generation and being captured after across the
thin PDMS layer.
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Any extra treatment to cell during measurement (such as stirring, probe placement,
adding extra chemicals and dyes) may potentially bring about contamination, cell
damage, or alter cell behavior. Our method was able to maintain cell sheet integrity
and cell growth condition during NO sampling. Cells were also easily treated with
stimulants and inhibitors (such as substrates and drugs), and the resultant changes
to NO generation were able to be monitored in real-time. It is clear that NO pro-
duction from cells depends on a series complex of factors. But it is unclear how
much each parameter contributes to this process. If all the cell work to date related
to NO generation had the corresponding direct, real-time NO measurement levels to
accompany the elegant molecular biology that has been completed in an effort to un-
derstand how various factors influence NO production, our level of understanding of
the normal and pathological roles NO plays in health and disease would be stagger-
ing. By accurately measuring both the dose and timing of NO production in cells and
tissues, we will be able to accelerate our understanding of the diverse and sometimes
apparently contradictory effects of NO in normal and pathological states.
3.8 Conclusions
A two-chamber NO measurement device that is capable of measuring the level of
NO produced by living cells in a continuous, real-time manner was fabricated. The
design of the device was inspired by Boyden chamber. NO generated by the cells
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diffuses through a hydrophobic, gas permeable membrane that serves as the bot-
tom of the culturing dish into a gaseous lower chamber that allows NO to be swept
to a chemiluminescence detector, thereby quantitating the level of NO produced by
cells in real-time. The measuring ability was validated by using NO-releasing poly-
mer (SNAP-PDMS) films that generate NO in a highly controllable manner, which
allowed the functional characteristics and potential utility of this device to be inves-
tigated. The device was successfully used to measure NO generation profiles from
macrophage cell line RAW 267.4 and investigate NO production changes because of
different stimuli and inhibitors. However, the application should not be limited to
measuring NO generated from the macrophage. Since the design is compatible for
general adhesive cells, different NO releasing cells/tissues can be studies by this device
too.
This is the first device to be reported that truly achieved real-time cellular NO flux
measurement without disturbing the cells under investigation or deviating from stan-
dard cell culturing protocols. This device may open up a huge potential for increasing
our understanding the role NO plays in both normal and pathological conditions in a
variety of tissues and could potentially accelerate our ability to design NO releasing
and generating therapeutic interventions by allowing quantitative understanding of
both the dose and temporal aspects of NO production in cells.
132
Chapter 4
Understanding Soluble NO Donor
by Using the Novel NO
Measurement Device1
The great potential of the two-chamber NO measurement device relies on taking
the advantage of free diffusion of NO to guide dissolved NO out from the aqueous
environment to gaseous space for chemiluminescent detection, making a gas-based NO
measurement possible from a solution. Moreover, this sampling process only uses the
molecule’s free diffusion, and minimally influencing other parameters in the solution
(i.e., the cellular culturing environment is not altered) This chapter will discuss the
1This chapter will be submitted to a journal for possible publication in the near future.
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application of the two-chamber device to monitor NO levels in different solutions, and
elucidate the NO environment cells actually experience when cells are treated with
soluble NO donors.
As mentioned before, NO is a very common immune regulator [24], critical neuro-
transmitter [19] and the most potent vasodilator [15]. NO abnormities can cause a
series of diseases in a varieties of tissues. NO deficiency is closely related to chronic
cardiovascular diseases such as hypertension, coronary heart diseases, and arterial
thrombotic disorders [75]. To restore the correct NO level, NO releasing chemicals
(NO donors) have been widely used for more than one hundred years. Currently
GSNO has been clinically used to prevent the formation of thrombosis [166]. Addi-
tionally SNAP derivatives have also shown considerable potential to maintain vascular
tone [167, 168]. However, caution needs to be exercised when using NO as a drug,
since NO potentially brings about fatal side-effect such as shock. Different labs have
their own requirements when choosing NO releasing chemicals according to their spe-
cific needs and expertise. Considering the wide range of different biological models,
in vitro or in vivo studies, different target cell types, and different animal species
potentially, observed results are at a minimum complicated but also contradictions
abound.
Some critical concepts associated with using NO donor molecules that need to be
recognized include:
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1. Regardless of using an in vitro or in vivo biological system, the NO donor’s
analytical concentration does not represent NO level that cells or tissues expe-
rience;
This can be explained by Eqn(2.4) or (2.10). It is easy to see that the ultimate
NO level is determined by the NO generation rate, NO consumption rate and the
distance between the NO source and site of interest if is not in a homogeneous
system. The half-life of NO donor determines the generation rate and greatly
affects the ultimate NO level. Using NO donors’ half-lives, NO level may be
estimated in a very rough way [121].
2. NO level that cell experiences is not determined only by the NO donor, but also
by species present within the buffer solutions and culture media;
NO is highly dynamic and reactive and biological systems are complicated,
species within the biological system react with NO to a significant extent. For
example in Eqn 2.12. the effect from both O2 and O
−
2 increased the consumption
as a result of oxidation, may significantly reduce NO that can eventually reach
cells.
3. NO donor treatment time does not accurately represent the true NO exposure
time, because the NO donor moiety must decompose to deliver NO, which can
be released within a shorter time period; (i.e. the donor molecule is not itself
NO)
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NO’s chemical properties make it impossible to always maintain its level once
it is generated in biological conditions. In different biological environments,
the half-life of NO varies from less than a second to minutes depending on its
concentration and specific environment. This means different from other stable
drugs, NO’s level is mainly determined by the generation process. So once the
generation process is over, there will be no further NO exposure.
4. NO donor’s biological effects should not be considered as equal to the effect of
NO.
NO donors contain not only the NO moiety but various functional groups and
residual by-products remaining after release. Additionally some chemistry that
affects cellular response may not be through NO such as direct S-NO transfer
[169]. These effects can easily be confused with the effect of NO, since these two
effects can be very similar and it was hard to observe the underline mechanisms.
Normal experimental conditions were unable to discern this difference, until
Singh et al. reported a method to detect the generation of free thiol radicals in
different RSNO decomposition mechanisms by using EPR [170].
Considering the aspects of NO donor behavior mentioned above, there is a great
need to understand how much NO is actually present at the cell layer during in vitro
culturing to fully understand NO’s roles and the factors that may affect NO levels.
It is necessary to reiterate here that NO related data needs to be accurately and
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comprehensively reported to avoid misunderstanding and misinterpreting data. The
new chemiluminescent-based NO measurement device described in Chapter 3 can
directly monitor NO level within solutions and also NO levels that cells experience
during the entire duration of experiments in real-time. The NO generation profiles of
different commonly used NO donors were directly measured and analyzed. Different
factors that influence these profiles including cell culture conditions, pH, free thiol
levels, oxidative stress and solution volume were examined in detail by using the
device.
Also presented is a demonstration of using this device to illustrate the potencies of
different NO donors in inhibiting MOVAS cell proliferation and observing the real-
time NO level that cells experience.
4.1 Definition and quantification of cell NO level
When soluble NO donors are applied to aqueous buffer or cell culture media, donors
begin to release NO. Once NO is generated, its consumption also begins. To describe
the NO level in the aqueous environment when using NO donors, Schmidt et al.
presented a straightforward method to calculate NO concentration by considering
the NO generation rate and NO auto-oxidation [121]. The detailed method has been
introduced in Chapter 2.2.
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The issue associated with this method is the calculation was only applicable to so-
lutions with simple compositions (NO consumption routes were limited), making
its application to real biological environments largely inaccurate. Herein, an NO
flux method is introduced, in the dimension of mole per surface area per time (or
pmol/cm2/sec or 10−10mol/cm2/min), which can be easily calculated by using the
two-chamber system introduced in 3.5.
As illustrated in Fig. 4.1, the upper chamber serves as a conventional cell culture
environment to which drugs (including NO donors) can be directly applied to cells
through using normal cell culture protocols. While NO is present in the cell environ-
ment, NO diffuses in all directions, and most importantly, through the gas-permeable
membrane into the lower chamber. Since the lower chamber is relatively indepen-
dent from the upper chamber, gas in the lower chamber can be sampled by sweep
gas for NOA quantification without influencing activities in the upper chamber. So
that once a solution with a specific NO donor is applied into the upper chamber, the
NO generation profile of this particular donor can be tracked in real-time through
chemiluminescent NOA .
Previously, measuring NO flux in aqueous solution was a conundrum, preventing
the wide-spread of using this in NO research. This system takes the advantage of
biocompatible polymer PDMS to guide dissolved NO within the solution out into
a gaseous chamber, making long-term real-time NO monitoring possible. The NO
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signal obtained from the lower chamber (the measured value) directly pointed to NO
level in the cell culture chamber.
The key question is what this measured value (NO level) means to cells cultured in
the device? To illustrate this, two models were shown below. First, assume a tightly
attached intact mono layer of cell is attached onto the device membrane to obtain
the cell sheet model (see Fig. 4.1 A):
(A) (B)
Figure 4.1: NO quantification in the confluent mono cell layer model (A)
and the nonconfluent cell culture model (B). Cells were cultured in the two-
chamber system device to either total confluent or a specific percentage
of confluency. The parameters used are labeled in the figures including:
NO flux entering the cell as J0; NO flux exiting from the cell as J1; NO
flux entering the semipermeable membrane as J2; NO flux exiting from the
semipermeable membrane as J3; NO signal measured by NOA as Jt.
Suppose J0 is NO flux entering the cell;
J1 is the NO flux exiting the cell;
J2 is the NO flux entering the semipermeable membrane;
J3 is the NO flux exiting the semipermeable membrane;
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and Jt is the NO signal measured by the NOA.
NO will be consumed through each interface such as J0 to J1. The decay is represented
as Jc, so:
J0 = J1 + Jc (4.1)
Predicting NO flux (Jt) at time (t) relative to J0 or J1 will allow the actual NO level
around cells to be known.
Because cells tightly attach to the membrane, J1 and J2 were considered to be equal,
so:
J1 = J2 (4.2)
Also since sampling process by sweep gas in the lower chamber is a continuous and
very fast process, it is considered that right after NO travels through the membrane,
the signal can be detected by the NOA, regardless of the sweep gas (N2 or air) used,
such that:
J3 = Jt (4.3)
The foam-structured PDMS treated glass-fiber membrane has a relative NO perme-
ability (η) of 100% (shown experimentally in 3.4.1), meaning the NO flux coming
out from the NO releasing polymer (Jp) showed no significant difference from the
measured NO flux across the membrane (JTr) (Fig. 3.13 A). So it is concluded that:
J1 = J2 = J3 (4.4)
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In this model, from Eqn(4.2), (4.3) and (4.5), it is reasonable to use Jt to represent
J1. So the NO level that is measured by the NOA is equivalent to the NO flux coming
from the cell sheet.
In the second model, if cells are not confluent (assume k% is the fractional area
covered in Fig. 4.1 B), since Eqn(4.3) and Eqn(4.5) are still valid here, it is easy to
obtain the following relationship to represent Jt:
Jt = J1 × k%+ J0 × (1− k%) (4.5)
In addition, while the cell coverage ratio is very low and considering that the thickness
of cell layer might be very small (around 0.5 µm thick for endothelial layer), NO can
quickly diffuse across the cells (<sec, estimated by Einstein-Smoluchowski equation
[76]) with negligible reaction occurrence (i.e. a very small Jc), such that Jt and J0
might be considered as equal in very low cell density model.
In summary, there is a theoretical basis to describe the two-chamber system’s utility
to measure NO diffusing out from the upper chamber. Once an adhesive cell is
cultured in the device, this measured NO flux Jt accurately reflects the NO coming
from the cell layer (J1) in cell layer model or a value that is closely related to J0 and
J1, represented by Eqn(4.5). And this value is the average NO flux experienced by
many cells growing on a relatively large area scale (cm2). In this chapter, this NO
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flux is used to reflects the NO level that cells actually experience (related to J0 and
J1) when exposed to NO donors in solution.
4.2 NO generation profile study
Different NO donors generate NO with different rates and stoichiometry. It is also
believed that NO generation from NO donors can be very sensitive to different buffers.
This section will focus on showing how different NO profiles generated by different
soluble NO donors were directly measurement and how the NO profile of a specific
NO donor differs in different buffer conditions. The hypothesis is that because of the
high reactivity and diffusivity of NO even using the same NO releasing chemical with
the same concentration actually results in different NO levels at the cell layer when
different solutions were used.
NO generation profiles of four different commonly used NO donors were examined
by using the NO measurement device. In order to elucidate the NO level in real
biological conditions, all the experiments were run at 37 ◦C in PBS buffer or complete
cell culture DMEM media. The same effective concentration of NO donors (i.e. such
that the same number of moles of NO were in theory generated) was used for easier
comparison.
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Biologically irrelevant concentration was avoided, so 50 µM of donor was used in most
of the following experiments. While PBS (pH=7.4) was used as the buffer, 10 ml PBS
with 50 µM of CySNO, SNAP and GSNO and 25 µM of DETA NONOate was applied
to NO measurement device (manufactured from 60 mm diameter dishes). The lower
chamber was sampled with atmospheric air as the sweep and zero gas. Considering
the reported NO donors’ half-lives [76, 171], it is estimated that these soluble NO
donor systems should not have an NO level that is likely to last days. Therefore we
only reported NO releasing profiles for the initial 24 h after adding donors, though
GSNO and DETA NONOate continued releasing detectable amounts of NO after 24
h under these conditions.
Fig. 4.2 A to D (blue traces) show their NO release profiles. According to the real-
time data, we detect the NO releasing duration and average/maximum NO generation
rates of each donor. By integrating the area under the release curve, the total NO
released in moles can be calculated. All those results were summarized in Table 4.1.
The reported half-lives of each NO donor are also summarized in Table 4.1 [169,
170, 172, 173]. Although half-life and NO generation duration are different concepts,
the overall trend can still be suggestive. Combining these two pieces of information,
CySNO did show the most rapid NO release, while GSNO and DETA NONOate
generated a gradual and long-term releasing pattern. However, both the reported




Figure 4.2: NO releasing profiles of three different RSNOs and DETA
NONOate in different buffer conditions. 10 ml of 50 µM CySNO, SNAP,
GSNO and 25 µM DETA NONOate prepared in PBS or DMEM was applied
to NOmeasurement device for NO flux real-time monitoring (A) CySNO, (B)
SNAP, (C) GSNO, (D) DETA NONOate. Under each condition, triplicate
experiments were run independently. Data was presented as the average
value of the three independent repeats; error bar represents the standard
deviation of the three values.
variations. Fig. 4.3 shows each individual repeats, which differs greatly from other
donors’ consistent and repeatable releasing profiles (see Fig. 4.2).
The inconsistencies of the release from SNAP also leads to the question:
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Table 4.1
Quantitative analysis of the NO releasing profiles of different NO donors
CySNO SNAP GSNO DETA NONOate









































































































































Effective concentration of all NO donors is 50 µM and the solution volume
is 10 mL; the total mole of NO was calculated through integrating area
under NO releasing curves; maximum NO flux was directly read from the
NO releasing profile; average NO flux refers to averaging the flux during
the lasting time; t1/2 is the half-life of donors; ∗ duration is longer than 24
h, however we only examined the initial 24 h. Data was presented as
average (Std.)
how rational it is to use half-life of each NO donor measured in phosphate buffer as
the references to predict NO level in real biological conditions?
NO donors were dissolved in 10 ml freshly prepared complete DMEM (with FBS and
pen/strep) and applied to the device at 37 ◦C incubator for real-time NO monitor-
ing. 5% CO2, which is a common condition for real cell culture, was considered as
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Figure 4.3: NO releasing profiles of 50 µM SNAP in 10 ml PBS. SNAP was
prepared by either dissolving SNAP crystal by diH2O to 2 mM stock and
further diluted by PBS obtaining the 50 µM solution (1-4), or direct dilution
from SNAP stock collected from the nitrosated N-acetylpenicillamine solu-
tion without recrystallization (5-8). Since the profiles showed big variation
among repeats, all repeats are presented for readers’ reference. Red marks
indicate the highest flux values, red arrows show sharp decrease of the NO
flux, green arrow, sharp increase.
an additional variable (since CO2 might potentially affect solution pH and carbonate
concentration). Fig. 4.2 shows that NO profiles of each NO donor differs greatly in
DMEM (red traces) in terms of both NO release rate and duration. At this specific
concentration (50 µM), NO release profiles of all NO donors differed greatly in PBS
from in DMEM (without CO2). In DMEM, the total NO that was captured by the
sweep gas was 5.4 times and 11.0 times lower for CySNO and DETA NONOate re-
spectively, while SNAP and GSNO both showed more (1.3 and 1.2 times, respectively)
NO passed through the membrane compared with in PBS group within 24 h (Table
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1). The change of NO flux rate also diverged; reduced in CySNO, SNAP and DETA
NONOate but increased in GSNO groups (Fig. 4.2 blue traces vs. red traces and
quantified in Table 4.1). Those results clearly demonstrated that different buffers do
significantly affect NO generation of all four NO donors examined.
In the presence of CO2, making the condition more representative to the real case,
NO generation patterns were further affected. In the presence of 5% CO2, all the
RSNOs showed longer NO generation duration compared with DMEM without CO2
(around 2 h longer release for CySNO and more than around 20 h longer for SNAP,
Fig. 4.2 B, red and green traces), while DETA NONOate released NO in a significant
faster fashion (Fig. 4.2 D, red and green traces). The results might be explained by
the lower media pH brought about by CO2. GSNO and DETA NONOate no longer
constantly released low level NO for over 24 h but released faster in the initial stage,
and after 24 h, the NO level became very low that can be barely detected. That might
be one of the reasons why the reported GSNO’s half-life is much longer than SNAP’s
but in some study their potencies did not follow away with this trend [169, 173]. All
the quantified results were summarized in Table 4.1.
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4.3 Factors that may affect NO generation profiles
of NO donors
Because a great difference of NO release profiles exists between using PBS and
DMEM, this complicated system was investigated by manipulating a single factor
at a time. As previously described, the NO level created by NO donors is determined
by both the NO generation and the NO consumption reactions. In first order kinet-
ics model, NO generation can be expressed by Eqn(2.9). And in NO auto-oxidation
model, NO level can be influenced by consumption described as in Eqn(2.2). Any
factors that can change generation, consumption or introduce other consumption
mechanisms will change the NO level obtained. Several mechanisms that can initiate
the generation of NO from RSNO have been proposed, including transition metal
ions mediated NO releasing, photocleavage, and ascorbate initiated NO release [95].
In addition to decomposition, RSNO can undergo transnitrosation reactions with nu-
cleophiles and other thiols without generating any NO, which produces new RSNOs
which may affect the NO generation profiles as well [95]. The influence of pH on
DETA NONOate decomposition was also investigated. The redox states of the solu-
tion environment was also examined to determine how ROS molecules affect the final
NO that cell may experience.
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4.3.1 The effect of transition metal irons
10 mM EDTA PBS solution was used as the NO donor buffer to eliminate the effect
of low level of transition metal ions that are ubiquitous contaminants in buffer salts.
Using the same experimental set-up and conditions, SNAP’s NO generation profile
under ion-free condition appeared to be significantly slower and more repeatable (red
traces in Fig. 4.4 A). This result suggested that transition metal ions mediated
NO releasing is the main releasing mechanism for SNAP decomposition in PBS, and
without transition metal ions, SNAP may be preserved for much longer time. (After
SNAP was placed in 37 ◦C incubator for 48 h in 10 mM EDTA PBS, 1 mM ascorbic
acid was applied to initiate NO release, which produced a huge amount of NO in a
very rapid fashion, indicating the stability of SNAP in solutions without transition
metal ions (data not shown)).
When transition metal ions were removed in CySNO and GSNO solutions, similarly,
significant decrease in NO generation was observed in both groups (blue and green
traces respectively in Fig. 4.4 A). After 1 h, NO generation in both CySNO and
GSNO became almost undetectable, but after adding ascorbic acid, NO generation
also recovered (one example was shown in Fig. 4.4 B). We then quantified how much
NO was generated in the initial 10 min by these three RSNOs in both normal PBS
and PBS with 10mM EDTA.
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(A) (B)
Figure 4.4: NO releasing profiles of 50 µM three RSNOs in 10 ml PBS
with 10 mM EDTA. (A) Real-time NO releasing profiles of RSNOs; three
independent experiments for each RSNO were run and data was presented
as the average of the three, error bar representing standard deviation. (B)
50 µM CySNO in 10 mM EDTA PBS applied to NO measurement device
from time 0 and NO releasing was real-time measured from time 0 to 1 h
(blue arrow shows the signal peak); at 1 h, 1 mM ascorbic acid was applied
(red arrow) and right after that rapid NO releasing was initiated.
Table 4.2 summarized that with transition metal ions RSNOs’ NO generation in-
creased to different degrees, where CySNO generated over 140 times more total NO
in the initial 10 min in normal PBS compared with PBS with EDTA , whereas the
total NO generation only increased by around 50 times and 10 times respectively
in SNAP and GSNO groups. This demonstrates that CySNO is more sensitive to
transition metal ions than SNAP and GSNO. Removal of the transition metal ions
from RSNOs environment (even CySNO, which is normally considered to be highly
reactive), can make RSNOs much more stable, which is consistent with Singh et al.’s
statement that SNAP’s stability can be significantly longer in transition metal ion
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Effective concentration of all NO donors is 50 µM and the solution volume
is 10 mL; NO mole was calculated through integrating area under NO
releasing curve between 2 specific time points; first 10 min was chosen
because CySNO’s NO releasing in PBS solution and all RSNOs’ releasing in
10 mM EDTA PBS became very low. Data was presented as average (Std.)
free solutions [170]. The NO generation from RSNOs may be mainly through the
transition metal ion mediated mechanism at 37 ◦C.
4.3.2 The effect of free thiols
GSH and CySH as free thiols were added to NO generating solutions to examine their
effect on the overall NO level cells experience. It is noted that high concentration
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Figure 4.5: NO level change by introducing GSH. 10 ml 100 µM DETA
NONOate solution was applied to the device for NO flux measurement until
signal reaches steady states. NO flux increase right after introducing shaking
but reduced sharply to normal level(as controls, red arrows), or plummet
significantly and stayed there for around 4 h and returned slowly to normal
(200 µM GSH added, blue arrows).
of thiol (mM rage) should be avoided, because it may change the system pH. So we
used a maximum of 500 µM CySH and GSH in the following experiments.
When GSH was directly added to a solution of DETA NONOate in PBS, which
releases NO in a continuous and near constant rate fashion at 37 ◦C, a significant
NO drop was observed (Fig. 4.5), suggesting the existence of NO-GSH or DETA
NONOate-GSH interaction. However, after approximately 4 h, the NO level started
to return to original levels, suggesting this inhibition of NO release was reversible.
To further show that thiol groups may indeed affect other donor’s NO generation
profiles, GSH was added to SNAP PBS solution, but no significant profile change was
observed (data not shown).
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But when CySH was added instead of GSH, there was a significant reduction in total
NO and average flux (Table 4.3). Obviously different total NO generation duration
and the pattern of releasing curves was observed (Fig. 4.6).
Figure 4.6: NO releasing profiles of 50 µM SNAP in 500 µM CySH PBS.
As mentioned before SNAP’s NO releasing profiles showed big variations
among repeats in PBS, to show the results more clearly three independent
repeats are directly shown here.
In PBS, one of the most noticeable NO release pattern from SNAP can be summarized
as rapid initial release and quickly diminishing level, meaning that all NO donors’
maximum release flux was detected at a relatively early stage, and in the last stage
of the releasing NO signal plummets to a very low level quickly. For example, the
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Table 4.3




Total NO (mol) 8.87E-08 (4.87E-08)
Average flux (mol/cm2/sec) 4.89E-13 (2.92E-13)
Max flux (mol/cm2/sec) 1.11E-12 (6.72E-13)
Duration (h) 4.04 (2.76)
CySH or CO2
Total NO (mol) 1.26E-07 (2.30E-9)
Average flux (mol/cm2/sec) 3.39E-13 (4.56E-14)
Max flux (mol/cm2/sec) 5.38E-13 (9.02E-14)
Duration (h) 7.54 (0.97)
Effective concentration of SNAP is 50 µM and the solution volume is 10
mL; NO mole was calculated through integrating area under NO releasing
curve. Data was presented as average (Std.)
maximum NO flux of the SNAP sample in examination (red traces in Fig. 4.3) nor-
mally appeared within the first two hours except one outlier, then dropped sharply
in the last stage (red arrows in Fig. 4.3). However, in PBS with CySH, the maxi-
mum flux was reached gradually and after that the NO flux plummeted immediately,
characterized as slowly increasing release with rapid decline.
Table 4.3 summarized the flux parameters, clearly showing that instead of greatly
changing those numbers -SH significantly reduced the variations, making results more
repeatable. Interestingly, in DMEM, NO generation of SNAP is normally observed to
be more repeatable and the profile increases slowly and decreases slowly, indicating
that thiols may be a factor that account for this slowly increasing NO release.
Free thiols are important NO reactants in body. They can elongate the effective
NO release and help with NO transportation [174]. They also serve as important
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regulators of protein nitrosation [120]. Understanding the relationship between NO
and thiols can help us understand the underlying mechanisms affecting NO levels
present in biological systems. This real-time tool can potentially help us separate
NO’s effect from RSNO, for example with GSH, NO generated by DETA NONOate
was low in the first several hours, during which NO’s effect might be limited and the
observed biological effect might be contributed to RSNO or –SH not NO.
4.3.3 The effect of pH and CO2
Different tissues have different pH levels, which may make NO generation profile
different [175, 176]. The device was used to directly investigate how different NO
levels generated by the same NO donor can be affected by different pH environments.
To do this PBS with different pH was prepared as the buffer solution to run the
experiment.
Fig. 4.7 showed 25 µMDETA NONOate’s releasing profile changed greatly in different
pH. At pH=6 although total NO that cells might experience was only around 1.4
times larger (within 24 h), the maximum NO flux was increased around 4.6 times
and NO release duration was shortened significantly to around 16 h. Considering the
biological effect of NO is determined by the level and duration of NO that specific cells
experience, this data indicates that different NO releasing drugs may have different
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potencies in different tissues or cell compartments based on the pH of the target tissue
and the structure of the NO donating moiety.
Figure 4.7: NO releasing profiles of 25 µM DETA NONOate in pH=7.4
and 6.0 PBS and pH=7.4 PBS with 5% CO2; three independent experiments
under each different conditions were run and data was presented as the
average of the three, error bar representing standard deviation.
Because blood is a pH buffered system that relies on the balance between CO2 and
HCO−3 , it is hypothesized that 5% CO2 within the incubator may exert similar effects
on the NO level by changing pH of the solution. To test this hypothesis, PBS buffer
was added into the device and placed into the cell culture incubator with 5% of
CO2. Result from VWR sympHony pH meter shows that the solution pH decreased
to around 6.6 within 90 min. Using pH=7.4 PBS buffer to prepare 25 µM DETA
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NONOate with 5% CO2, result is shown in Fig. 4.7 demonstrating that CO2 has a
significant effect on the NO generation profiles. One fold increase of total NO flux
and almost 3 times greater maximum flux rate compared with without CO2 were
observed (Table 4.4). After 24 h, only barely detectable NO signal remained.
Table 4.4




Total NO (mol) 9.30E-08 (1.30E-08)
Average flux (mol/cm2/sec) 8.11E-14 (1.14E-14)
Max flux (mol/cm2/sec) 1.19E-13 (1.32E-14)
Duration (h) more than 24 h∗
pH=6.0 PBS
Total NO (mol) 1.31E-07 (1.81E-08)
Average flux (mol/cm2/sec) 1.69E-13 (2.63E-14)
Max flux (mol/cm2/sec) 5.48E-13 (2.59E-14)
Duration (h) 15.86 (1.19)h
pH=7.4 PBS
with CO2
Total NO (mol) 1.86E-07 (3.76E-08)
Average flux (mol/cm2/sec) 1.47E-13 (2.96E-14)
Max flux (mol/cm2/sec) 3.62E-13 (7.37E-14)
Duration (h) more than 24 h∗
The concentration of DETA NONOate is 25 µM and the solution volume is
10 ml; NO mole was calculated through integrating the area under NO
releasing curve; ∗ duration is longer than 24 h, however we only examined
the initial 24 h. Data was presented as average (Std.)
The decomposition of diazeniumdiolates to generate NO has been shown to be pH de-
pendent [177]. The release of NO from diazeniumdiolates through the decomposition
to their parent diamine compounds and NO in aqueous solution is spontaneous. Fac-
tors that affect the dissociation rates include pH, its concentration and the presence
of metal ions [178, 179]. Protonation is necessary for the decomposition reaction and
depending on the pH, protonation can be single state or dual states, which makes the
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underlying mechanism very complicated and NO release hard to control [180]. How-
ever, at physiological conditions, NO generation from DETA NONOate is mainly
determined by the protonation of the secondary amine nitrogen [180].
These results pointed out that more careful re-evaluation is needed when using DETA
NONOate as the NO donor for the biological study. The statement that DETA
NONOate releases NO in a long-lasting fashion might be true only in conventional
buffer conditions. The micro-environments of many inflammation situation and tumor
masses can achieve relatively low pH value in vivo (even lower than pH=6 [176]),
which is very likely to greatly change the effective NO delivery duration. Although
diazeniumdiolates’ release duration can be shortened in lower pH, RSNOs are more
stable in lower pH [181], which should be considered when choosing the proper NO
donors for specific applications.
4.3.4 The effect of redox environment
Once NO is generated, oxidative condition may heavily influence the NO levels ob-
tained. It has been reported by many groups that elevated ROS levels suppressed
NO’s biological potency. The underlying mechanisms might be complicated. Some
ROS directly react with NO, decreasing the NO that cells can access and some are
through other mediators [182, 183].
158
The interaction of NO and the ROS (peroxide and superoxide) by real-time moni-
toring of the NO flux was investigated using DETA NONOate solution. Different
peroxide sources were used (H2O2 and di-tert-butyl peroxide(DTBP)) to complete
this examination.
Figure 4.8: NO level deceasing by introducing peroxide. (A) NO level
changes in accordance with the addition of peroxide (blue arrow) and PBS
shaking as the control (red arrow); (B) blue curve represents with peroxide,
red one the control. 10 ml 100 µM DETA NONOate solution was applied
to the measurement device for real-time NO flux measurement. Once NO
flux reached the steady state, t-butyl peroxide was added into the solution
(to the final concentration of 1 mM). All experiments were run at 37 ◦C.
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No significant NO level decrease was observed when H2O2 was applied (data not
shown) and only very mild NO decrease was observed when up to 1 mM DTBP was
applied into 100 µM DETA NONOate solution (Fig. 4.8). And NO level returned to
normal after around 0.5-1 h, indicating only a mild interaction of peroxide and NO
might exists.
Using the same principle, superoxide was applied to DETA NONOate solution by
using hypoxanthine-xanthine oxidase (HX/XO) system [184].
Figure 4.9: NO level deceasing by introducing superoxide. Hypoxanthine
(1 mM in blue and 100 µM in red) was added into 10 ml 100 µM DETA
PBS solution pH=7.4 (with 10mU/ml xanthine oxidase). All experiments
were run at 37 ◦C.
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Superoxide generation relies on the availability of the substrate HX. Different con-
centration (100 µM to 1 mM) of substrate was applied to the system to modulate
the amount and duration of superoxide. Data shows that immediately after apply-
ing superoxide, the NO signal quickly decreased, indicating that superoxide greatly
suppressed the resulting NO level (Fig. 4.9). The NO level could recover gradually
to the original level later, and the time needed for this recover is correlated to the
amount of hypoxanthine added, further confirming that superoxide and NO are in-
volved in certain reactions. And the present of superoxide in biological system can
greatly affect the NO level experienced by the cells.
4.3.5 The effect of solution volume
In in vitro experiments, quantitative study of NO is normally run through applying
media with specific concentration of NO donor. However, the volume applied to a cul-
ture well may differ from each other. The hypothesis is that different solution volume
(different bathing solution height) may lead to different final NO flux experienced by
cell layer at the bottom of the culture vessel due to the diffusivity and reactivity of
NO.
To investigate whether this hypothesis is true, 5, 10, 15 ml of 50µM CySNO DMEM
solution was applied to the device. Fig. 4.10 A showed the NO releasing profiles of all
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(A) (B)
Figure 4.10: Media volume’s effect on NO level experienced by cultured
cells. (A) NO releasing profiles of different volumes of 50 µM CySNO in
DMEM with 5% CO2; three independent experiments of each volume were
run and data was presented as the average of the triplicate, error bar repre-
senting standard deviation among different repeats; (B) the change of total
NO and NO flux experienced by cells along with the change of the media
volume. From ANOVA and Tukey-test, significant difference of maximum
NO fluxes that will be experienced by cells between 5 ml and 10 ml, and 5
ml and 15 ml is indicated by ∗ and ∆ respectively, while significant differ-
ence of total NO that will be experienced by cells between 5 ml and 15 ml
is indicated by ⋆.
different volumes. Under exactly the same other conditions, 5 ml solution generated
the highest NO flux (P=0.023, 0.022 to 10 ml and 15 ml group respectively shown by
∗ and ∆, P > 0.05 between 10 and 15 ml by Tukey-test). There is a decrease in NO
flux with increasing solution volume. But in terms of total accumulated NO that cell
experienced, the trend is reversed, summarized in Fig. 4.10 B (P=0.0370 between 5
and 15 ml groups shown by ⋆, P > 0.05 in other groups in Tukey-test).
These results directly proved that by using the same concentration of soluble NO
donor, but different total media volume applied into cell vessels resulted in different
NO level and total NO that cell ultimately experienced. And this trend can be
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generalized as the stretching of the NO releasing profile curve with increasing bathing
solution volume, i.e. less media (larger surface to volume ratio) higher NO flux (in the
initial states) but shorter duration time when cell may experience NO, and vice versa.
One explanation might be due to the gradual consumption of the NO donors and the
different reservoir capacities, the NO flux goes down faster in the larger surface area
to volume ratio group. So to strictly use consistent volumes of media in cell culture
vessels is important in NO experiments when treating cells with soluble NO donors.
4.4 Connecting NO profiles with cell work
After gaining a general understanding of factors that influence the flux of NO cells
experiencing with the four NO donors in DMEM under different conditions (37 ◦C
and 5% CO2), the potencies of different NO donors in biological applications was
examined. The effect of NO donors on smooth muscle cells was investigated, where
NO was reported as an important inhibiting signal of cell proliferation [185, 186, 187].
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4.4.1 Different NO donors have different ultimate effect on
MOVAS cells
A more precise way to understand how different NO donors determine the final bio-
logical effect of NO is to analyze each situation according to the corresponding NO
real-time profile. In the previous section, NO release profiles of the four NO donors
in real culture conditions (DMEM at 37 ◦C with 5% CO2) have been measured. With
information regarding predicted NO fluxes, MOVAS cell proliferation was studied.
Those four NO donors with the same effective NO concentration (50 µM for RSNOs,
and 25 µM for DETA NONOate) were used to treat MOVAS cells. After 24 h both
cell number and cell proliferation ratio were examined as shown in Fig. 4.11. Result
shows that DETA NONOate treatment had the least potent effect on restricting
cell numbers after 24 h treatment. All three RSNOs showed significantly greater
inhibitory effect on cell growth and proliferation as indicated by ANOVA (P<0.05
between CTRL and all three RSNOs and DETA NONOate between all three RSNOs
by ANOVA), however ANOVA did not suggest any statistic difference existed among
the three RSNO groups. This is difficult to explain in DMEM media. With CO2,
DETA NONOate did not show the lowest NO flux rate or the total cumulative NO.
Meanwhile cell proliferation assays indicated that after 24 h only SNAP treated cell
proliferation ratio differed significantly from the control group (P=0.0565 by ANOVA
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(A) (B)
Figure 4.11: Different NO donors’ effect on MOVAS cell proliferation. Cell
starting density was 10,000 cell/cm2 and before applying NO donors cells
were cultured overnight to allow recovery; 24 h after treatment, cells were
applied for live-dead assay and proliferation assay (A) Relative living cell
number. ∗∗ represents P<0.01 by ANOVA and Tukey-test compared with
the control (CTRL). (B) cell proliferation ratio. ∗ represents P=0.0565 by
ANOVA and Tukey-test but P<0.05 by t-test compared with the control
(CTRL). Data represents the average of the 3 independent repeats and error
bar represents standard deviation among repeats)
and P<0.05 by t-test), while cell proliferation ratios of all other groups were slightly
smaller but close to the control group (P>0.2 by ANOVA), meaning cell number and
cell proliferation rate did not match at 24 h.
Compared with CySNO, neither GSNO nor SNAP showed significant better potency,
which also does not correlate directly with the NO flux profile. Because from the
measured NO profile, CySNO showed significantly shorter releasing duration. And
DETA NONOate produced relatively larger flux compared with SNAP and similar
flux to GSNO (Table 4.1), but the ultimate cell number appeared significantly higher
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in DETA NONOate group (though t-test, compared with control, shows P<0.05,
ANOVA shows P is between 0.2 to 0.3). At this point, the real-time NO profile in
DMEM media with real culture condition does not fully explain different potencies
of NO donors in real biological cases.
However, considering NO generation from those NO donors is very sensitive to exper-
imental conditions, it is suspected that adding cells, is just like adding other variables
into the NO donor solution and may therefore change the NO releasing profiles of the
donors.
4.4.2 Real-time monitoring NO level that cells experience
during NO donor treatment
Because the pattern of measured NO release profiles did not align with the observed
effects on cell levels, the real-time NO release profile was recorded during cell culture
experiment. The device was used for cell culture, and at the same time real-time
NO measurement was made to obtain cell proliferation data that corresponded with
real-time NO data.
Cells were cultured using standard cell culture protocol in the two-chamber system.
Dissolved NO donors solutions were added to the culture media and real-time NO
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flux was recorded. Result and quantification analysis were summarized in Fig. 4.12
and Table 4.5. It is clearly showed that GSNO did not release NO in low and long-
lasting fashion as people normal think under actual cell culture conditions, but DETA
NONOate did. Instead GSNO’s release was more similar to CySNO, which released
most of its NO in the initial 4 h of the experiment.
Figure 4.12: Real-time measuring the NO levels that cells experienced
when cultured in the device and treated with NO donors. 10 ml media
was used to culture cells in the device with 50 µM CySNO, SNAP, GSNO
and 25 µM DETA NONOate respectively. Under each condition, triplicate
experiments were run independently. Data was presented as the average
value of the triplicate; error bar represents the standard deviation of the
three values.
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Compared with media only condition, the average and maximum flux of all RSNOs
increased significantly (around 2, 4, and 9 times more for CySNO, SNAP and GSNO
respectively), though the total accumulated NO experienced by cells did not change
too much (a little over 1 fold for CySNO and only 50 % more and 20 % less for SNAP
and GSNO). However, both NO flux rate and total NO diffusing to and through the
cell layer greatly decreased in the DETA NONOate treatment group (only 30% and
15% compared with media only conditions).
This data clearly proved that during actual cell culture the NO donors may release
NO in a very different manner than predicted from the release profile obtained from
the controlled experimental conditions. Simply knowing that different NO donors
have different NO releasing profiles is important but not enough to explain some
of their biological outcomes. It is also important to remember that a donor’s NO
delivery behavior is highly changeable, and may result in a totally different profile
when experimental conditions are changed slightly. For example, CySNO and GSNO
are normally considered as very different in stability. But actually both of them
released NO rapidly in the initial stage with a very high flux (> 1 pmol/cm2/sec,
Fig. 4.12), and no NO flux was detected 24 h after treatment. This result explained
data shown in Fig. 4.11 as to why cell number and cell proliferation ratio in CySNO
and GSNO group were very similar, and DETA NONOate’s least potency may be
resulting from the very low NO level generation during actual cell culture. SNAP
has intermediate NO level in real cell culture condition (around 0.4 pmol/cm2/sec)
168
and lasted a significant longer time compared with other RSNO (more than 9 h), this
might be one of the reason why after 24 h the smallest cell proliferation ratio was
observed in the SNAP group. But overall, the SNAP group did not show significantly
smaller cell number after 24 h compared with CySNO and GSNO. This observed
inconsistency between cell number and cell proliferation ratio may result from the
fluctuation of cell proliferation ratios within 24 h because of the changing of the NO
level. To better understand NO’s effect on MOVAS, instead of doing one single end-
point examination on cells, cells need to be examined at multiple intermediate time
points during the course of the 24 h experiment.
4.4.3 NO profile and cell proliferation at different time points
From the statement above, it is clear that the end-point test time point chosen for
biological assays needs careful evaluation, otherwise it may produce inconclusive or
contradictory data. To avoid this, the cell number and cell proliferation ratios were
examined at different time points. According to the NO profile data showed in Fig.
4.12, CySNO and GSNO’s NO release lasted for around 3-4 h, and at 11-12 h SNAP
finished its releasing, this lead to the examination of cells at 4 h and 12 h and 24 h.
Cell number data clearly showed that even though at 24 h cell numbers in three RSNO
groups were similar, the change of cell number/proliferation ratio was very different
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(A) (B)
Figure 4.13: Different NO donors inhibit MOVAS cell proliferation in dif-
ferent degrees at different time points. (A) relative cell numbers normalized
to cell number of control groups at 24 h. (B) MOVAS’s cell proliferation ratio
under different NO donor treatment at different time points. Cell starting
density was 10,000 cell/cm2 and before applying NO donors cells were cul-
tured overnight to allow recovery; 4, 12 and 24 h after treatment, cells were
strained for life-death assay and proliferation assay. Data represents the
average of 3 independent repeats and error bar represents sample standard
deviation.
at the intermediate time points(Fig. 4.13 A). The increase of cell number in CySNO
and GSNO groups was mainly after 12 h and between 4 to 8 h the increase is low,
however, SNAP showed a totally inversed pattern, where the increase was mainly
in the first 12 h. DETA NONOate has relatively stable and slow increase of cell
number. And these results are also consistent with the cell proliferation ratio data
(Fig. 4.13 B), where in CySNO and GSNO treatment the smallest proliferation ratios
were observed at 4 h, and in SNAP the value was at 12 h. DETA NONOate showed
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consistently high cell proliferation ratio, but the resultant cell number was still a little
smaller than the controls (Fig. 4.13 A). By using the device, it is shown that a flux
of around 0.4-1 pmol/cm2/sec on average showed good inhibition of smooth muscle
cell proliferation. A constantly high flux (around > 1.5 pmol/cm2/sec lasting for over
2 h) may kill the cells, which is very consistent with data presented in 5.4 of this
dissertation.
It has now been clearly illustrated that the actual NO status experienced during the
culture experiment is critical, not the empirical values determined or measured under
other conditions (for example, it is not recommended to use half-lives of NO donors’
measured in PBS or DMEM even with 5% CO2). The results presented here directly
show the significance of tracking the actual NO level generated by NO releasing drugs
in biological experiments and how useful the real-time measurement device is in such
studies.
To further show that different culture conditions did change the NO status cells
experience greatly, we tried different coating methods for cell culture. Dopamine-
gelatin treatment was used to surface-coat the device membrane; then cells were
cultured in those devices and the same NO donor treatment was applied.
Fig. 4.14 and Table 4.5 show that although the overall trend is similar to using the
collagen I treated device, difference still exists, such as when using polydopamine
coating SNAP showed much shorter releasing profile and around 1.2 and 1.4 time
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Figure 4.14: Real-time measuring NO levels that cells experienced when
cultured in the dopamine-gelatin treated device and treated with soluble NO
donors. 10 ml media containing 50 µM CySNO, SNAP, GSNO and 25 µM
DETA NONOate respectively was used to treat cells cultured in the device.
Under each condition, triplicate experiments were run independently. Data
was presented as the average value of the triplicate; error bar represents the
standard deviation of the three values.
higher NO average and maximum flux; DETA NONOate has around 4.2 and 3.4
times higher NO average and maximum flux, proving that only monitoring NO in
specific experiments is meaningful for specific analysis.
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Table 4.5
Quantitative analysis of the real-time NO generation profiles of different































































































Cells were cultured in collagen I top-treated device and dopamine-gelatin
treated device respectively. Effective concentration of all NO donors is 50
µM and the media volume is 10 mL; NO donors were dissolved into media
to 2× equal volume media to original cell culture media and applied to the
cultured cells. Data was presented as average (Std.)
4.5 Implications
Though NO’s biological roles became much clearer during the past several decades,
many controversies and enigmas still exist. One problem is that NO’s effect on cells
in cell culture is hard to be separated from the behavior of the NO donors. One sys-
tematic study on biological effect of different RSNO donors was reported by Mathews
et al.[169]. Considering the general idea that RSNO’s effect was through NO released
from the cleavage of S-NO bond, they designed gas-purging experiment which showed
that removing NO had negligible influence on smooth muscle relaxation, suggesting
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that at least other activation pathways to sGC exist. They also showed that the
correlation of RSNO decomposition first-order half-life and the degree of the smooth
muscle relaxation to be low. However, the half-life values they used were measured
within 0.5 mM physiologic saline solution, while the biological assays were in more
complicated systems. Wink et al. [188] showed NO’s cyto-protective effect on hydro-
gen peroxide stressed V79 cells and no protective effect on superoxide stress, even after
SOD was added. However, in the same paper they also showed different NO donors
of the same working concentration had very different potencies in counteracting per-
oxide mediated cyto-toxicity, showing that choosing the proper NO donor is critical.
Using a system with both XO-HX and RSNO showed more complicated behavior ac-
cording to Trujillo et al. [189], where peroxynitrite might form and stress cells when
simultaneously using these two chemicals in the same system. SNP was shown to be
cytotoxic because of the synergetic effect of peroxide and the release of other ions
such as CN− and iron complex [190], and SIN-1 may facilitate the accumulation of
H2O2 for cell cancer cytotoxicity [191, 192]. So tracking NO status is a key critical
step which will help researchers evaluate the net effect of NO in complicated systems.
Instead of using new NO donors, some groups developed NO delivery systems that
can directly deliver only NO(g) into the biological systems [165, 193, 194]. Though
problems still exist such as the controllability, consumption of NO through the bio-
logical system, biocompatibility and cyto-toxic effect of NO’s oxidative products, the
use of NO releasing polymer and device is still promising.
174
A huge number of potential biological species can react with NO, including ROS
[182, 183], thiols [27], lipid [30], DNA [63, 64], and proteins [62, 195, 196], which
makes the actual NO level present in cellular environments hard to predict. For
example, the effect of free thiol to NO is complicated. On one hand, thiols may react
with NO forming new RSNOs, which may increase the effective half-life of NO but
decrease the effective NO level. On the other hand, free thiols can facilitate RSNO
decomposition resulting in a more rapid NO generation [197]. And these processes
are very likely to be pH dependent. For RSNOs, lower pH potentially generates more
HNO2 and NO
+, which are strong nitrosating agents, preventing NO generation [198],
while for diazeniumdiolates NO releasing is through protonation, which favors lower
pH [180]. In biological system, cases can be more complicated because of different
environment such as ion strength [178], making final NO level difficult to predict.
By using our real-time NO measurement device, which directly showed that free
thiols may significantly affect the NO level, has provided the direct evidence showing
the correlation between thiols and NO exists. Although more complex experimental
design is needed to thoroughly study the underlying mechanism and determine the
optimal NO generation and effective NO level in the body.
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4.6 Conclusions
This chapter introduced an application of the two-chamber real-time NO measure-
ment device, to monitor NO levels in biological solutions and cell culture conditions.
This information allows the direct correlation of NO level (not NO donor concentra-
tion or NOS level) with the observed biological response. This device was used to
measure the NO generation profiles of different NO donors (CySNO, SNAP, GSNO
and DETA NONOate) at physiological relevant levels in different buffer conditions,
proving that NO generation profiles of all NO donors can be very dynamic affected
by their specific environments. It was shown that this measurement device can detect
the NO level change due to the introduction of free thiols, oxidative states, pH and
volume of the solution. In the end, cells can be directly cultured in the device so
that NO experienced by cells during the whole culture can be tracked; and the result
showed that NO experienced by cells cannot be simply predict or estimated by the
NO donor half-life or from a measured value obtained in PBS. To precisely study
NO’s biological effect, it is highly recommended to monitor and report real-time NO
level of each specific experiment to eliminate the reporting of complicating circum-
stances that lead to inaccurate results. The different effects of NO shown by different
NO donors on inhibiting MOVAS proliferation was studies by using this device, high-




Highly Controllable NO Deliver
System1
It has been established that, there is a need to develop a means to precisely deliver
specific and known levels of NO at defined times to study the potential treatment
of disease with NO. The chemical properties of NO and the aqueous environment of
biological systems make controlling how much NO cells experience very problematic.
Bubbling NO into a solution is not practical. A more viable approach was to exploit
chemicals that produce NO in vivo, both enzymatically and non-enzymatically. More
than 100 years ago, people began using glyceryl trinitrate (GTN) to relieve angina
pectoris [38, 123]. However, in addition to drug tolerance issues, NO delivered in
1This chapter will be submitted to a journal for possible publication in the near future.
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this manner is not precise and controllable and is very dependent on the individual’s
metabolism. Though using soluble NO donor is still one of the most widely used
methods to expose cells to exogenous NO, this method may produce confounding
and contradictory data. The information on the actual NO level and time variable
is almost impossible to trace. A third approach used is gene therapy to control NOS
level expressed in cells. NO levels in mammals relies on the normal function of NOS,
restoring NOS or knocking-down/out NOS gene expression can change cellular NO
level in such a way as mimics the normal biological events. However, this method
is costly, and more seriously, altering gene expression is hard to control so the dose-
dependent effect of NO, which is the most distinguished characteristic of NO, is
difficult to study systematically in this manner.
Then researchers started to develop NO delivery systems specifically for biological
research. Wang et al. [165] developed a gas-to-media NO delivery system for the
culture study. The idea is that NO is highly diffusible and can pass through gas
permeable polymers such as PDMS. So they submerged 500 µm thick PDMS tubes
with outer diameter of around 0.2 mm into culture media solution, flowed NO gas
into the tubes, stirred the solution with a magnetic bar within the culture solution to
generate a homogeneous system. This device achieved control over NO concentration
of the culture media. The NO level modulation depends on several factors, primarily
the partial pressure of NO and O2, which was supplied by a second PDMS loop. The
major NO consumption occurs close to the tube edge, the so-called the boundary
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layer, where excessive NO reacted with O2 to form N2O3. The problem with this
system is the potential of introducing high level of other nitrogen oxides and the
stirring process significantly affects the cell activity in the culture system.
Since 1990’s, S-nitrosothiols (RSNOs) have drawn more and more researchers’ atten-
tion as NO donors. S-nitrosothiols are endogenously produced and labile molecules
that are involved in NO delivery, storage and metabolism in vivo [93]. S-nitrosothiols
can achieve wide distribution within organelle systems as long as there is thiol-
containing substrate such as cysteine, glutathione and albumin. S-nitrosothiols func-
tion as the NO reservoir in vivo and there is great pharmacological potential of S-
nitrosothiols for the treatment of vascular diseases. The mechanism of NO release
from RSNOs is also relatively clear. In general, RSNO decomposition in physio-
logical condition can be both enzymatic and non-enzymatic. The related enzymes
include glutathione peroxidase, γ-glutamyl transpeptidase and xanthine oxidase [95],
while the non-enzymatic factors includes thermal and photochemical decomposition,
Cu+ initiating decomposition, and ascorbate initiating decomposition [198]. Different
from other NO donors, such as diethylamine NONOate (DEA/N2O2), which decom-
poses spontaneously in a nucleophile, pH dependent way in solution [93], and GTN,
which requires a series of enzymes and factors [199], S-nitroso-N-acetylpenicillamine
(SNAP), a commonly used RSNO, may be able to decompose in a regulated man-
ner through controlling the decomposition triggering factors. And this control was
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improved even more by covalently grafting SNAP onto hydrophobic polydimethyl-
siloxane (PDMS) [137]. It was clearly shown that by excluding transition metals and
other reducing equivalents, NO release can be well controlled using light to trigger the
decomposition of the RSNOs. This material will be used as the essential NO resource
and calibration tool of the following research.
In order to accomplish the goal of developing a robust NO delivery system, several
constraints need to be addressed: the NO delivery system should only deliver NO, not
NO generating chemicals or NO reaction products; some means to easily modulate
NO level is required; the structure of the system itself needs to be simple so that it
can be easily sterilized and applied to cell culture.
In this chapter, a cell culture system that is able to deliver NO in controllable levels
with temporal and spacial control is designed. The principle and calculation process,
the detailed validation techniques and its application are also presented. Achieving
delivering NO and the controllability relies on the controlled NO delivery polymer
and the two-chamber coupled to the NOA. The system is applied to real cell work,
that does not require deviation from the current cell culture protocols.
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5.1 Localized NO delivery to cultured cell
Fig. 2.4 and 2.8 illustrated how NO concentration and flux changes with time and
distance relative to the NO plane, proving that with appropriately increasing t, NO
level in the vicinity of source plane can be stabilized and both NO concentration
and flux decay to around half of the maximum value at a very small x value (within
micrometer range). Especially because biological condition are complex, the high
chemical reactivity of NO limits NO’s spreading into the static culture environment.
This result suggests that by using a plane of NO delivery, NO may be delivered in
a very localized fashion since the NO level decreased sharply along with its diffusion
pathway.
To experimentally show how localized NO’s potency is, two-chamber NO measure-
ment device introduced in Chapter 3 to measure NO flux at different distance away
from the source plane (experiment set-up as Fig. 5.1 A).
From our model introduced in Chapter 2, we predicted that NO flux would decrease
significantly when NO source was moving away from the measuring plane, and that
the amount of NO present will be different in different solutions because of the differ-
ent competing reactions (Fig. 2.4 and 2.8). Because of this, both PBS and complete





Figure 5.1: Measurement of NO decay with diffusion in buffer solutions.
SNAP-PDMS was cast on a glass cover-slip and top coated with RTV-3140;
the cover-slip was fixed at different positions in buffer solutions; NO flux
passing through the semipermeable membrane was measured by using the
NOA in real-time; all experiments were run at 37 ◦C. (A) experiment set-up;
(B) in PBS solution; (C) in complete DMEM medium.
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(A) (B) (C)
Figure 5.2: Visualizing NO’s localized effect by using SNAP-PDMS films
and NO fluorescent dye. (A) experiment set-up; (B) NO released from
SNAP-PDMS labeled by DAF-FM was stained to green; yellow dash-line
circle indicates where the disc was placed; (C) 2 mm diameter filter paper
piece soaked in 5 mM NaNO2 solution was placed on the DAF-FM plus
agarose gel (circled by yellow dash-line); NO−2 diffused out was labeled by
DAF-FM as well.
diffusion distance of NO through solution.
In PBS (Fig. 5.1 B), the NO flux decayed to half its original level at a distance of
approximately 180 µm away from the source, while in DMEM media (Fig. 5.1 C),
NO decay was much more rapidly, to half its original level at about 20 µm. These
results validated the modeling result, and also suggested that more complicated con-
sumption routes may exist in complete DMEM (or in the in vivo environment). More
importantly, since the source plane produced NO in a constant and stable fashion,
the detected NO signal was very stable and continuous, confirming the previous sim-
ulation conclusion that by using the polymer NO delivery system, it is possible to
create a stable NO environment with spacial control over where the NO is present.
To further test how localized NO’s effect can be with the polymer NO delivery system,
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a fluorescent dye was used to visualize NO’s potential effective range. To do this, a
SNAP-PDMS film was cut into 2 mm diameter disks and placed on to 1 % agarose
gel with 20µM NO fluorescent dye DAF-FM in 37◦C moisture incubator (experiment
set-up as shown in Fig. 5.2 A). After 4-6 h, gel relative fluorescent signal was imaged
under fluorescent microscope. Fig. 5.2 B showed the relationship between the position
of the SNAP-PDMS piece (yellow circle by dash line) and the surrounding fluorescent
signal. Fluorescent signal was observed only 2 mm away from the central polymer,
suggesting again at aqueous condition NO will not diffuse very far so that its effective
will be spatially limited. When the SNAP-PDMS disk was replaced by a piece of 5
mM NaNO2 soaked 2 mm diameter filter paper, the result was very similar (Fig. 5.2
C), suggesting that the fluorescent halo might mainly be due to the diffusion of the
activated dye. So that NO’s effect might be even more localized than the fluorescent
signal indicated.
To confirm this, a SNAP-PDMS film that released a relatively high flux of NO (up to
an average of 1.2×10−10 mol/cm2/min for 24 h) was cut into different shapes and
placed on top of cultured MOVAS cells for NO treatment (experiment set-up shown
in Fig. 5.3 A). Cell status was examined by calcein-AM staining as shown in Fig. 5.3
B to D, which showed sharp edges between NO releasing regions and regions without





Figure 5.3: Visualizing NO’s localized effect by observing the effect of NO
released from SNAP-PDMS to MOVAS cells. MOVAS cells were seeded
into the 6-well plate with a starting density of 4.0×104cell/cm2; 4 h after
seeding, SNAP-PDMS disks of different dimensions were placed onto the
cultured cells; after 24 h culture, cells were labeled with 2 µM calcein-AM.
(A) experiment set-up; (B) to (D) cell growth patterns.
5.2 Two-chamber NO delivery device for control-
lable NO delivery
To ensure that NO delivery can be systematically carried out, a tool that achieves
delivering controllable level and duration of NO was developed. Since the real-time
NO measurement device introduced in Chapter 3 allows NO generated from the cells
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cultured in the upper chamber to pass through the semi-permeable membrane into
the lower chamber for NO sampling, thinking of it in a reverse way, it should also be
applicable to use an NO source attaching to one side of the NO permeable membrane
to deliver NO to the cells cultured on the other side. This new method is based
on both SNAP-PDMS and the two-chamber cell culture system, so that NO flux
delivered to the cultured cells can be real-time tracked and adjusted according to the
real-time NO flux feedback.
Using MOVAS cells, it was demonstrated that the localized effect of NO resulted in
different cell fates. The NO level needed for preventing smooth muscle cell from hy-
perplasia was measured to be around 0.7− 0.9× 10−10 mol/cm2/min; and a higher
NO flux (2.0× 10−10 mol/cm2/min ) even for short time exposure (1 h) showed
permanent cell damage, which should be avoided when designing SMC related NO
releasing materials or using NO donors.
5.2.1 Device design
A new NO delivery set-up was designed to achieve controlled localized NO delivery
(Fig. 5.5)
Cells are grown on the membrane of the NO measurement system and NO releasing
polymers can be applied to the cultured cells from the other side of the membrane
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according to specific needs and then removed so that the NO flux is zero after the
defined delivery time. By connecting this system to the chemiluminescence detector,
actual NO delivered to the cells can be monitored. Ethidium bromide was introduced
to label the dead or dying cells for better understanding the cell status.
However while RTV-3140 and glass fiber filter paper was used to fabricate the NO
permeable but water tight gas-permeable NO membrane, it was noted that there were
some issues associated with the NO permeable membrane, including NO releasing
polymer SNAP-PDMS could not be easily applied to the membrane and the quality
of the fluorescent cell image and the stiffness of the produced film need to be improved
for adhesive cells. To improve the use of the device for NO delivery, the fabrication
process of the NO measurement device was modified.
Sylgard® PDMS replaced RTV-3140 reproducibly generates stiffer composite mem-
brane. Glass-fiber filter paper was replaced by PVDF (polyvinylidene fluoride) mem-
brane (pore size 2 µm). Compared with glass-fiber filter paper, PVDF has finer fiber
structure. After PDMS polymer was cast, the produced membrane displayed more
homogeneous and smooth surface, which is very important for fluorescent imaging.
To manufacture the membrane the mixture of Sylgard® PDMS base and curing agent
(10:1, w/w) dissolved in hexane was vortex-mixed to form 1:20 (w/v) PDMS solu-
tion. The solution was manually cast onto the PVDF membrane (72 µl/cm2/cast)
and air-dried. Three layers were cast to form a usable membrane. After the organic
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solvent was air-dried, the membrane was carefully transported into 52◦C heating oven
for overnight curing. The micro structure of the produced gas-permeable membrane
was examined by SEM shown in Fig. 5.4.
(A) (B)
Figure 5.4: SEM image showing the foam-like structure of the PDMS
coated PVDF membrane (A) surface, (B)cross-section.
5.2.2 NO delivery device fabrication
To manufacture the delivery device, a semipermeable membrane was attached to
plastic boxes to form the upper chamber of the device for cell culture as shown in
Fig. 5.5 A. Dopamine solution (1 mg/ml, in Tris-HCl buffter pH=8.5) was applied into
the upper chamber, soaking for 24 h to increase PDMS hydrophilicity; the chamber
was ethylene oxide sterilized and top treated with 2 mg/ml gelatin solution for 1
h to facilitate cell adhesion. Then the device will be ready for cell culture. The
lower chamber was produced by adding 2 ports onto a plastic box, so that the device
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can be easily coupled into NOA sampling line. Once the two chambers were placed
together, with the SNAP-PDMS polymer disk attached directly under the membrane,
NO was delivered into the upper chamber at a specified flux, which simultaneously
being quantified through sampling NO from the lower chamber as shown the Fig. 5.5
B and adjusted by the light source underneath the device.
(A) (B)
Figure 5.5: New controllable NO delivery system for in vitro cell culture.
(A) two-chamber device build-up, (B) experiment set-up for controllable NO
delivery.
Because the actual level of NO being delivered to the cells is monitored in real-time,
the NO generating rate can be modulated in real-time by adjusting light energy
impinged on the polymer.
Since NO flux will be mainly controlled by light, to create a system that will generate
homogeneous NO across the whole NO source plane, a homogeneous light source was
needed. With the help of Andrew DeRouin, an 7×7 LED light array by using (VAOL-
5GSBY4, Mouser, TX) LED bulb was fabricated. Blue light LED buds (593-VAOL-
5GSBY4, Mouser), was tin-soldered onto the printed circuit board (PCB) to form a
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(A) (B)
Figure 5.6: Characterizing homogeneity of the light source. (A) raw digital
photo of the light source; (B) analysis of signal intensity of each pixel of light
source; the picture was represented by using 8 bits greysacle.
7×7 LED array. LED diffuser kindly provided by Bright View Tech (Morrisville, NC)
was placed over the LED array to homogenize the light. To evaluate how homogeneous
the light from the source plane was, digital pictures of the light source plane were
taken with a black foam board placed on top of the light source to avoid light leaking.
ImageJ was used to analyze the digital photo of the light source (Fig. 5.6 A) and the
light intensity distribution is shown in Fig. 5.6 B. Signal strength of each and every
pixel of the picture indicated a good homogeneity of the light source.
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5.2.3 Controllable NO delivery device build-up
To confirm that the NO signal measured in the lower chamber and the NO entering the
upper chamber are linearly related and the change was synchronized, two identically
calibrated NOAs were simultaneously used to measure NO flux in real-time from both
chambers; different LED light intensity was used to manipulate the total NO flux
such that different NO levels in both chambers at different time points were recorded
in real-time. Linear regression analysis was performed to validate the relationship
between the flux levels measured from both chambers.
Note that NO released from SNAP-PDMS film either diffuses into the cell culture
device or remains in the lower chamber. The signal sampled by NOA does not actually
represent the NO flux experienced by the cells (the idea is the same with the two-
chamber NO measurement device). The current question is how to use the real-time
NO profile to calculate the NO flux experienced by the cells cultured in the device.
The following experiment was completed to determine the relationship between the
sampled NO flux and NO flux that the cultured cells will experience in the upper
chamber. The SNAP-PDMS disk (4 mm diameter, around 340 µm thick) was placed
under the PDMS membrane as the NO source. SNAP-PDMS film was exposed under
linearly changed light intensity by changing LED drive current linearly to generate
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different total NO fluxes while NO in both chamber was recorded via two identically
calibrated NOAs.
The NO flux pattern was recorded simultaneously (Fig. 5.7 A) and it can be seen from
the linear regression analysis that NO signals in both chambers did change linearly
with each other, R=0.9999 (Fig. 5.7 B). The difference of NO signals in the upper and
lower chamber is observed and the distribution rate is determined by the geometry
of NO releasing material, membrane properties and the attachment as explained in
Chapter 3 3.5.6. These results suggested that once there is NO generation in the
lower chamber by using SNAP-PDMS attached to the NO permeable membrane, cell
cultured on the upper chamber can experience NO immediately without time delay,
and the NO signal captured from the lower chamber and the actual NO delivered into
the upper chamber was indeed linearly related.
To investigate whether the solution within the upper chamber alters the linear rela-
tionship, 10 ml complete cell culture media was added into the cell culture chamber
and the linearity between NO remained in the lower chamber (integrated from NO
profile curves) and the total NO entered the upper chamber (measured by I−3 test)
was examined. SNAP-PDMS was used as the NO source to release NO for a series of
different duration (1 h – 24 h); then NO flux measured from the lower chamber and





Figure 5.7: Analyzing NO signal in the two-chamber system. (A) NO
measured in the upper and the lower chamber when using SNAP-PDMS for
NO delivery. Different NO releasing rates were achieved by adjusting LED
light intensity every 2 min (2.5 mA, 5 mA, 7.5 mA, 10 mA, 12.5 mA, by
using VAOL-5GSBY4 LED); two identically calibrated NOAs were used to
record the NO signal simultaneously from both chambers; (B) linear regres-
sion analysis of the NO flux signal captured in the upper and lower chambers
at different LED drive currents; (C) Complete cell culture media was added
to the upper chamber; the total NO entering the upper chamber was quan-
titated by measuring NO−2 accumulation in the upper chamber using the
tri-iodide assay [200]; total NO in the lower chamber was integrated from
the real-time NO profile. The measured NO and the NO delivered to the
cell culture chamber were indicated to be linearly related.
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After repetitively using SNAP-PDMS to deliver different amount of NO (by different
NO flux and time duration), the final result was summarized in Fig. 5.7 C, which
also showed a very good linearity between the measured NO value and NO delivered
into the cell culture chamber, though the distribution ratio differed greatly from the
value obtained without bathing solution.
To summarize:
Fluxupper ∝ Fluxlower or F luxupper = a× Fluxlower (5.1)
Fluxupper and Fluxlower represent the NO flux into the cell culture chamber and the
NO flux measured through NOA in the lower chamber at each time point, respectively
(mol/cm2/sec). Fluxlower can be directly measured by the NOA in real-time. And a
is the factor that represents the linearity ratio.
n1 ∝ n2 or n1 = a× n2 (5.2)
where n1 represents the total NO that entered the upper chamber (mol), which can be
quantified by NO−2 assays (tri-iodide assay was used), and n2 the total NO sampled






So that the factor a can be found from Eqn(5.2)and used in Eqn(5.3), Fluxupper(t)
at each time point can be obtained. The whole process is illustrated in Fig. 5.8.
Figure 5.8: An flow chart illustrating how real-time NO flux that cells
experience is calculated by using our NO delivery system.
By accurately measuring the NO level in the lower chamber and finding out the ratio
of the upper chamber and the lower, the NO flux entered the upper chamber can be
quantified and our device can achieve both NO delivery and the real-time monitoring.
It is important to understand that the ratio of signal captured in lower chamber to
the total accumulated NO in the upper chamber (the factor a) for each device set-up
and must be experimentally determined.
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5.2.4 Level and temporal control over NO delivery
To experimentally validate the procedure outlining in Fig. 5.8, complete cell culture
media was applied into the upper chamber (without cells at this time) and different
SNAP-PDMS was used to delivery NO. The SNAP-PDMS films were synthesized and
cast from the same batch of polymer (to 340±70µm thick) but NO was pre-released
from the polymers to obtain films with different NO fluxes at 37 ◦C, which are all
physiologically relevant NO levels. Then those polymer films were used to deliver NO
to the culture media applied in the upper chamber by using the device. Quantification
was done according to Fig. 5.8.
Fig. 5.9 A showed their real-time NO delivery patterns. Although NO flux shows a
decreasing trend in general, NO flux entering the upper chamber during the whole
24 h was much more stable (with around 30% to 70% decrease depending on the
starting flux) compared with commonly used soluble NO donors which release all the
NO within 4-16 h at physiological conditions (shown in Chapter 4).
NO releasing from SNAP-PDMS films can be precisely controlled by using light [137,
193]. By using this property, pulsed delivery of NO to cell culture chamber was
achieved by applying/removing extra light from the LED array periodically (by using





Figure 5.9: Examples of delivering physiologically relevant level of NO to
the cultured cells with both level and temporal control. (A) Examples of
overnight (maximum 24 h) NO delivery to the upper chamber; three lines
represent SNAP-PDMS films with different passive releasing rates to de-
liver different levels of NO to cells; (B) pulsed NO delivery by switching on
(yellow arrows) and off (purple arrows) LED light (add current/voltage) in
very 40 min; (C) the control over NO delivery to cells by timely introduc-
ing light (yellow arrows, by increasing forward voltage) to generate a more
physiological relevant and stable NO flux level.
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with a very controllable pattern. If it is noted that NO level is too low, by applying
different light energy onto SNAP-PDMS, desired NO levels may be reached. Fig. 5.9
C showed one example that when NO level was found to be too low, light was applied
onto NO releasing polymer (yellow arrows), so that a much more stable NO level can
be created during the whole treatment. From our previous work, no side-effect from
the light was observed (data not show).
5.3 MOVAS responses to different NO patterns
studied by the delivery device
This delivery system was then used to deliver NO to cultured MOVAS cells. Since we
have roughly estimated the NO level to inhibit the proliferation of cultured smooth
muscle to be 1× 10−10mol/cm2/min [113], we re-examined this system by using our
delivery system with real-time monitoring of the NO level experienced by cells during
the whole SNAP-PDMS treatment. The SNAP-PDMS film position was indicated
in Fig. 5.10 A to C imaged under bright-view light microscope. A 4 mm diameter
SNAP-PDMS disc was attached underneath the membrane. The NO real-time profile
was calculated according to Fig. 5.8.
Fig. 5.10 showed the relationship of MOVAS cell growing status and the correspond-
ing real-time NO flux profiles. Interestingly, it was found that A compared with
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Figure 5.10: Real-time NO monitoring along with NO delivery. (A) to (C)
indicate where SNAP-PDMS was placed (∗), ∆ indicates regions without
NO flux; (D) to (F) cell growth on the membranes, green indicates living
cells stained by calcein; red, dead cells by EthBr; (G) represents real-time
NO flux delivered to the cells in (D), (E) and (F) respectively; yellow arrows
represent introducing light to adjust the NO flux.
B had a slightly lower averaged NO flux for 24 h, but the ultimate cell status was
reversed compared with the observations in the previous section. However, from
real-time NO flux data (Fig. 5.10 Panels G), it is showed that cells in D (treated
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by polymer in A) experienced a maximum level of 1.4× 10−10mol/cm2/min NO flux
in the initial stage, without introducing light, NO flux decreased over 60% after 24
h. While cells in E (treated by polymer in B) experienced relatively stable NO flux
during the whole 24 h due to the introduction of light (yellow arrows Fig. 5.10 H).
Results indicates that the average NO level or total NO that cells experienced dur-
ing a long-term treatment was not enough to interpolate the ultimate result. NO
short-term fluctuation may have profound effect to cells so that it is important to
consider the time dependent change of NO level. Overall, while the NO flux was
larger than 1.0× 10−10mol/cm2/min, cells that experienced such flux for even a rela-
tively short period of time (4 h in this experiment) may undergo cell death (Fig. 5.10
D). An average of 0.7− 0.9× 10−10mol/cm2/min might be a good NO level to inhibit
smooth muscle cell over proliferation without killing them (Fig. 5.10 E). These data
might be important to develop proper NO releasing materials to prevent hyperplasia
of smooth muscle cells, antherosclerosis or thrombogenesis. Because both levels that
are too high or too low level (0.3− 0.4× 10−10mol/cm2/min is considered to be low,
Fig. 5.10 C, where no inhibition of cell proliferation was observed) were shown to
prohibit its anticipated function. One consistent phenomenon is that NO’s effect was
always shown to be local. There is a good evidence suggesting that by using bulk NO
releasing materials in real tissue, it is not likely to introduce NO’s deleterious effect
to other nearby cells unless those cells are within hundreds micrometers of the NO
source.
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It was appeared that an NO level higher than 1.0× 10−10mol/cm2/min might bring
about permanent damage to MOVAS cells. Using the device an experiment was
completed to deliver different levels of NO to cells for the same duration trying to
confirm the NO threshold. Currently it is also not clear what dose and duration of




Figure 5.11: High NO flux for 1 h treatment caused MOVAS cell death.
4 mm diameter SNAP-PDMS disc was attached underneath the device; (A)
cell status was examined by using live-dead staining 20 h after NO source
was removed and cells were imaged under fluorescent microscope; the average
NO flux was summarized under the cell image. The real-time NO flux was
shown in (B).
One preliminary experiment showed that high NO flux (up to
45.0× 10−10 mol/cm2/min) for 1 h treatment caused cell death (Fig. 5.11).
The flux was gradually decreased to below 1.0× 10−10 mol/cm2/min (the theo-
retical NO threshold) but the treatment time was held constant by using our NO
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delivery system to search for the threshold flux value. In detail, cells were seeded
into two-chamber NO delivery device at a starting density of 2× 104 cell/cm2, then
cultured for overnight for recovery. Cells were treated with NO from a SNAP-PDMS
film for 1 h and NO flux was real-time recorded with the NOA. NO flux was
adjusted by changing light energy impinged onto SNAP-PDMS disc using LED light
arrays underneath the cultured cells. 23 h after treatment, cells were stained with
2 µM calcein-AM and 5µg/ml EthBr and imaged with Olympus BX51 fluorescent
microscope.
As shown in Fig. 5.12 A, cells exposed to high NO level for 1 h underwent cell
death, generating an acellular culture region. Once the NO flux was close to
1.0× 10−10 mol/cm2/min, cells survive, but the eventual cell number was signifi-
cantly less than regions without exposing to NO (Fig. 5.12 B). When the flux was
further decreased (Fig. 5.12 C), cells showed no response to the NO compared with
control cells (both cell morphology and living and dead cell numbers). This indicated
that as for MOVAS cells an NO flux of 1.0× 10−10 mol/cm2/min might be a critical
value. Larger than this value, NO may kill MOVAS for 1 h exposure. See Fig. 5.13
for representative images of replicate culture experiment.
Then different treatment duration was investigated. 1.0× 10−10 mol/cm2/min for
30 min (Fig. 5.14 A) and 40 min (data not shown) was used, and cell growing
was observed as normal. After less than threshold treatment for 20 min (less than
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Figure 5.12: Quantitative study of NO flux threshold level that may kill
MOVAS cells. Real-time data represents NO profiles of each corresponding
sample above; (A) to (C), cell growth on the membranes, green indicates
living cells stained by calcein; red, dead cells by EthBr; (D) to (F) indicate
where SNAP-PDMS was placed; the location of NO releasing region was
indicated by ∗ and regions without NO was indicated by ∆. (G) shows
real-time NO flux delivered to the designated cells. Scale bar, 2 mm.
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Figure 5.13: Different repeats of around 1.0× 10−10 mol/cm2/min NO
flux for 1 h treatment to MOVAS cell. (A) to (C), cell growth on the mem-
branes, green indicates living cells stained by calcein; red, dead cells by
EthBr; (D) to (F) indicate where SNAP-PDMS was placed; the NO releas-
ing region was indicated by ∗ and regions without NO were indicated by ∆.
(G) shows the real-time NO flux delivered to the designated cells. Scale bar,
1 mm.
0.5× 10−10 mol/cm2/min), then close to 1.0× 10−10 mol/cm2/min treatment for
40 min, cell growth was also shown as normal compared with the control regions
(Fig. 5.14 B). However, if the NO flux was increased to very high (average of
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50× 10−10 mol/cm2/min), for even very short time (10 min), NO exposure also
caused cell death (Fig. 5.14 C). It is notice that even the highest NO flux rate goes
up to 200× 10−10mol/cm2/min, NO’s effect was still shown to be localized.
This data directly proved that both NO level and duration that cell experiences are
important to determine the final cell fate. Looking at only one phase of this molecule
cannot reveal its role or may even cause data misinterpreting. Neither conventional
NO administration methods nor data presentation can achieve detailed understanding
in these two dimensions, which limited the application of NO as a therapeutic tool.
The new in vitro NO delivery system, integrating the real-time NO measurement
device and NOA, and taking advantages of controlled NO releasing material SNAP-
PDMS, an unprecedented control of level and temporal-controlled NO delivery has
been achieved. Herein a systematical and quantitative study of the relation of NO
and smooth muscle cell fate was given as an example, which provided very useful
data to develop vascular implants and tissue repairing gels that release physiological
relevant NO level.
5.4 Implications
There have been many NO releasing materials developed for fundamental research
and biomedical applications. Several recent reviews summarized their chemical base
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Figure 5.14: NO treatment duration determined the final cell fate. (A) to
(C), cell growth on the membranes, green indicates living cells stained by
calcein; red, dead cells by EthBr; (D) to (F) indicate where SNAP-PDMS
was placed; the NO releasing region was indicated by ∗ and regions without
NO was indicated by ∆. (G) shows the real-time NO flux delivered to the
designated cells. Scale bar, 2 mm.
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and related practical use [102, 107, 201, 202]. One of the most popular applications
of these materials is for wound healing, since proper NO level is reported to promote
endothelial cell proliferation and modulate the inflammation process. NO releasing
tissue engineering scaffolds, especially hydrogels, have been shown to be a good tool to
study such NO property and help wound healing. For example, as mentioned in 2.2.1,
Amadeu et al. used a wound repairing hydrogel Pluronic F-127 with NO releasing
properties by incorporating 100 µM GSNO to treat rat cutaneous wound, indicating
that NO is important and has beneficial effect on healing at both inflammatory and
proliferative phases [128, 129]. This is a good example of temporal study of NO’s
effect, although they did not report the actual NO status in the biological system;
instead the GSNO decomposition rate was estimated in buffer solutions, which may
differ greatly from the actual biological environment (shown in Chapter 4 4.2 and
4.4). The NO level needs to be carefully controlled when using NO incorporated cell
scaffold. For instance, Xing et al. developed a SNAP conjugated gelatin hydrogel
which releases NO in a fast fashion (up to 30× 10−10 mol/cm2/min) in the first
2 h at physiological condition, where this hydrogel inhibited the attachment of the
hMSCs permanently [203]. Nablo et al. proposed NO releasing solgels as a coating
layer for inhibiting bacterial adhesion [204], and also suggested that the NO releasing
rate needs to be carefully controlled since 24 h exposure to NO fluxes to an average of
50 pmol/cm2/s was cytotoxic to L929 mouse fibroblast [205]. So only if we precisely
understand both NO level and temporal parameters, will NO’s detrimental effect be
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avoided and the beneficial functions can be utilized. Many current NO releasing tissue
engineering scaffolds produce high flux of NO in the initial stage due to the properties
of the NO generating functional groups used. Now that we understood the burst of
NO should be avoided, measures to limit this fast NO generation can be developed.
The light controlled NO releasing polymer SNAP-PDMS might be a good example,
which avoided uncontrolled NO releasing initiated by other species such as copper
ion, and achieves empirically tuning NO flux experienced by cells. And by using the
two-chamber system, NO delivery can be more controllable, flexible and measured in
real-time.
NO has pleiotropic effects on various physiological reactions. To clearly understand
the NO level and time parameters would be a very important step to establish the real
underlying cause-and-effect relationship of NO and the corresponding cell responses.
NO’s highly dynamic and reactive nature makes it difficult to predict and control its
level under actual biological conditions. The NO levels discussed herein directly refers
to NO flux that cell experiences, which can be calculated and measured by using our
modeling and new device.
208
5.5 Conclusion
A new two-chamber NO delivery device was developed and validated. The deliv-
ery system integrated the technologies of controllable NO releasing polymer SNAP-
PDMS, cross-membrane NO delivery and NOA chemiluminescent assay to achieve NO
local, level and temporal-controlled delivery. The device was used to directly show
how localized the effect of NO is in plane source model. By cutting SNAP-PDMS
films into different geometries, desirable cell growth pattern can be achieved. The
real-time data collected by NOA helped us understand the NO level during the whole
experiment. It was demonstrated that both the NO levels and exposure time affect
MOVAS cell fate, characterizing 1.0× 10−10 mol/cm2/min as the critical value; ex-
posing to such value for more than 1 h may cause MOVAS permanent damages. To
show this device is useful to study the importance of both NO level and time as-
pect, very high NO flux (an average of 50× 10−10 mol/cm2/min) and a little higher
than 1.0× 10−10 mol/cm2/min of NO were applied to MOVAS for different dura-
tion, resulting in MOVAS death after short time exposure (10 min) under high NO
flux treatment and no cell death was observed while 1.0× 10−10 mol/cm2/min was
applied for less than 1 h, respectively. NO’s double-edged-sword characteristic limited
its use in tissue repairing gels, though NO’s roles have been shown to be beneficial.
This is primarily because we lack the understanding to know at what point good
NO may switch from beneficial effect to damaging effect. This novel NO delivery
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device will be useful for fundamental research including mimicking physiological and




Conclusions and Future Direction
of NO Quantification Devices1
NO is one of the most important signaling molecules that plays a role in nearly every
organ. To ensure the balance of NO in the body, the biological level of NO needs
to be well regulated on many different aspects such as level, location and activity
of nitric oxide synthases (NOSs), accessibility to substrates (O2 and arginine) and
control of the NO environment (especially oxidative states). NO deficiency can cause
serious problems such as cardiovascular diseases [75, 206] and neurological disorders
[70, 71, 72]. Due to the high reactivity of NO, NO can react with many different
species in a very local fashion, which is why this simple molecule is able to serve
1Part of the content in this chapter will be submitted to a journal for possible publication in the
near future.
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so many different biological functions. These different biochemical reactions require
different NO levels and localized reactions to ensure the specificity of the reaction
at each specific site. The effect of NO was generalized as beneficial to cells at low
concentrations and detrimental at higher concentrations, however the reality is in fact
far more complicated in different scenarios. NO’s biologically relevant concentrations
vary greatly from sub-nano molar (such as promoting endothelial cell growing, esti-
mated from DETA/NO concentration [207]) to potentially up to micromolar range
(such as inactivation of MMP-9 measured by applying exogenous SPER/NO solution
[208], for more detailed review see [65]). It is also important to remember that NO’s
effective distance is short, otherwise its systemic side-effect would be fatal.
NO releasing materials have shown to be good tools for completing NO fundamental
research, especially materials with hydrophobic backbones which limit the materials’
interactions with the biological system and introduces more controllability over NO
releasing patterns. So the very important hypothesis is that by using such materials
to release biologically relevant levels of NO to achieve specific biological functions, the
necessary NO levels may be determined. Definitely it requires accurate measurement
of NO surface flux and material dimensions. For example Frost et al. estimated
the NO level to prevent thrombogenesis on intravascular oxygen sensing catheters to
be between round 1.0 to 2.5 ×10−10 mol/cm2/min by using DACA− 6/N2O2 − SR
coating [110]. However, such information is still lacking. Our lab did a great deal of
research to develop controllable NO releasing materials and NO delivery systems [137,
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194]. Currently an adjustment in the required NO levels can be dynamically controlled
because of the feedback from the real-time measuring, however, this was still done
empirically. One future direction could be combining the NO delivery system with a
feedback loop and remote light control system ([193]), so that a programmed smart
NO delivery system can be set.
The two devices introduced herein, just like the development of a microscope which
can be used to observe many different samples, have great potential to enable many
other applications. The ability to track NO in real-time and control the level through-
out different experiments can provide us a large amount of useful information. This
chapter will show some of the preliminary work and results, and examine how feasi-
ble and practical it is to apply the devices for different biomedical studies. Definitely
more in depth future work is needed.
6.1 Measuring NO generation from other biologi-
cal systems
Note that in different tissues, different NOSs generate NO at different rates, producing
different local NO concentration environments, which is the basis of the multiple
functions of NO. But the details of each situation might be more complicated than
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this statement. Is NO flux mainly dependent on types of cells or types of NOSs or
types of stimuli? What other biological molecules and conditions may influence the
ultimate NO flux? Even with the same NO generation rate, at different physiological
conditions such as different pH, oxygen tension, substrate accessibility, will the final
NO level change? By using the two-chamber NO measurement device, these questions
can be answered. One example was shown as follows.
Figure 6.1: NO generation from rat primary tenocyte. Blue tenocyte, red
fibroblast as the control.
An increase of iNOS experience has been discovered in the overuse of rotator cuff
tendons in a rat model [209] and NO’s roles on tendon healing, probably in different
tendon healing stages, was summarized in Sharma and Maffulli’s review paper [210].
NO generation from primary tenocytes, harvested from rat, were quantitated by the
214
NO measurement device.
Rat tenocytes were seeded into the two-chamber NO measurement device at a starting
density of 8,000 cell/cm2. Right after seeding, the device was connected to the NOA
sampling line for NO real-time NO measurement. The level of NO generated is shown
in Fig. 6.1. NO surface flux was calculated as introduced in 3.5.3. The result clearly
showed that the NO generation profile from the different cell types differed from each
other. Without extra stimulation, tenocyte harvested from the injury site showed
inherent NO production, indicating iNOS might have already been induced before
measurement. Tenocytes had a maximum of 1.4 pmol/106cell/s of NO, which is
significantly lower than RAW264.7 cell (shown in 3.5.5). However, further work is
needed to unveil the underlying reasons, which cannot be accomplished in this PhD
work. But this result indicates that theoretically all the adhesive cells can be possibly
applied to this NO measurement method. This simple method can be very useful for
understanding different NO levels in different scenarios.
6.2 Monitoring NO status in solutions
Since soluble NO donors are still the most widely used method to supply NO to cul-
tured cells, fully understanding the NO release patterns of those donors under real
application conditions can also help us explain previous data and data collected from
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different labs, which is also helpful for controlling NO to some extent. It has been
shown how the NO measurement device helped us analyze NO data in Chapter 4.
Other very useful quantitative studies can also be carried out with the similar prin-
ciple. One simple example is that to investigate what different donor concentrations
mean to cells? By using different concentrations of the donors, different NO concen-
trations are expected to be generated. So that many dose-dependent behaviors of
cell-NO interactions are based on this hypothesis. To examine whether this assump-
tion is valid, SNAP was dissolved in complete DMEM media at different analytical
concentrations. Media volume was fixed to be 10 ml. Right after the SNAP solu-
tion was added into the measurement device, the device was coupled into the NOA
sampling line. All the experiments were run under 37 ◦C without CO2.
Figure 6.2: Evaluating NO profiles generated by different concentrations
of SNAP by using real-time two-chamber NO measurement device.
216
Fig. 6.2 clearly shows the concentrations of SNAP not only determined the NO level
within the solution but also duration of NO present in the solution. It also clearly
proved that by using soluble NO donors to apply NO for cell culture, NO is only
present in the initial several hours of the incubation. Since it has been shown that
the time parameters are important to determine the ultimate cell fate in Chapter 5,
to analyze such dose-dependent data needs to comprehensively consider the duration
parameters. The data presented in this work directly proves that when analyzing
the dose-dependent phenomenon observed through using different concentrations of
soluble NO donors may not only result from a dose effect but also from different NO
exposure time. This implies that much of the previously reported data may need
more careful re-evaluation.
The biological environment of NO is complicated. NO generated from the NO source
can be consumed by varies reactions. Without directly tracking the NO level, the
study of NO reactions and the pharmaceutical applications cannot be accomplished.
In Chapter 4, I showed how oxidative stress, pH and -SH all influence the effective
NO level. The power of this measurement device is that it directly and in real-
time presents NO information to help us understand NO biochemical reactions. The
following example is that the device can be used is to study the relationship between
vitamin-c and NO.
The redox level strongly contributes to the NO level achieved. It is clear that NO
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reacts with superoxide, generating peroxynitrite. Strategies have been applied to
limit the level of superoxide to enhance the NO level. It was also widely believed that
applying ascorbic acid is beneficial for raising biological NO levels, because ascorbic
acid potentially consumes tissue superoxide so that more NO can be used for other
functions.
To examine this statement and for easier analysis, a simple composition buffer (PBS)
was used as the reaction system to dissolve DETA NONOate (up to 200 µM). Then
DETA NONOate solution was applied to the NO measurement device. Under these
particular conditions (PBS buffer pH=7.4, 37 ◦C, without CO2) it was shown that
DETA NONOate generates relatively low NO level in a continuous and stable manner.
If factors that can react with NO or influence NO generation from DEAT NONOate
are introduced into the system, the change of the ultimate NO level can be directly
observed by NOA. Freshly prepared (0.5 M stock solution) ascorbic acid was added
into the device and the device was shaken gently to homogenize the mixture and
right after adding ascorbic acid, NO flux started to plummet. To validate this result,
different final concentration of ascorbic acid solution was prepared. It is interesting
to observe the dose-dependent NO flux drop, directly proving that ascorbic may not
increase NO level, instead may decrease NO level (Fig 6.3).
Though the detailed chemistry is not clear, it was observed that with longer time,
the NO flux recovered (data not shown). The free radical scavenging property of
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Figure 6.3: NO generation by DETA NONOate influenced by adding dif-
ferent concentrations of ascorbic acid. Red arrows indicate adding exogenous
100 µM of ascorbic acid.
ascorbic acid is widely known, bearing the brunt of the active and stable oxygen
radicals in the human body [211]. The ultimate NO level has also been shown as
ROS level dependent (shown in Fig. 4.8 and 4.9). Increasing the superoxide level
by manipulating SOD was shown to increase the effective concentration of NO [212].
However, from the current data, to restore the correct NO level, there is still great
need to more carefully evaluate whether taking extra ascorbic acid is a good strategy.
To further unveil the mechanism of this reaction, other assays in different biological
models are necessary. But from this device, the conclusion can be drawn that using
ascorbic acid might not be helpful for restoring the correct NO level in our body,
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which is also consistent with the report from Jackson et al. [213].
6.3 Assisting cancer staging and investigating the
background NO within tumor tissues
The general trend is that high NO levels cause cytostasis and cytotoxic effects to
cancer cells, while low NO levels may assist tumor development through angiogenesis
and blood flow adjustment. To facilitate NO therapy, it is critical to find the threshold
values and understand how to clearly differentiate between NO that promotes tumor
growth from NO that inhibits tumor growth. Another on-going research project in our
lab utilizes the NO measurement and delivery devices is to use specific NO levels to
assist cancer killing without damaging the surrounding health normal cells. Different
from MOVAS (a threshold level slightly higher than 1.0× 10−10mol/cm2/min), it is
observed that the threshold NO level needed to kill breast cancer cell line MDA-MB-
231 was greater than an order of magnitude (10× 10−10mol/cm2/min). The devices
developed in this work will probe the roles NO plays in tumors and potentials on how
to use NO to achieve localized cytotoxicity for cancer therapy.
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6.3.1 Measuring NO from tumor tissues
NOS gene expression has been reported in a variety of tumor tissues [214]. Many
gene therapy models have been established to overexpress exogenous iNOS in can-
cer cells. But the treatment results seem paradoxical. For example, Jenkins et al.
[215] reported that a transfection of iNOS cDNA cassette into murine tumor cells,
instead of killing cancer cells, promoted tumor growth (human colon cancer DLD-1
cells generating 20 pmol/min/mg NOS protein), while iNOS microencapsulated cells
(producing up to 300±40 pmol/min/mg NOS activity) achieves almost 100% killing
of SKOV-3 ovarian tumor and half of DLD-1 tumor [214]. Meanwhile tumor cells’
genetic background may complicate this question. One example would be NO’s cyto-
toxicity was reported as p53-dependent. In wild-type p53 cells, NO, as an anti-tumor
drug, induces p53 phosphorylation, eventually causing apoptosis. However, in p53
mutant tumor cells favors NO for its VEGF inducing effect, which promotes tumor
angiogenesis. In addition, incorrect levels of NO can even potentially create a selec-
tion pressure for mutant p53 cells, making the mutants more NO resistant, worsening
the cases (reviewed by Xu et al. [22]).
Since NO’s effect in tumor tissue is always controversial, many studies evaluated the
correlation between NO and the tumor tissue development. For example, in human
ovarian cells, iNOS was only observed in tumor cells not normal ones [216]. Data also
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suggested that NO level is strongly correlated with breast tumor development stages.
Compared with non tumorigenic cells NO levels were found significantly higher in
cancer cells, especially in the more invasive grade III cells [217]. Besides cancer cells
themselves, tumor associated macrophages (TAMs) is another important source of
NO in the cancer tissues, whose status is closely related to cancer prognosis [218]. It
has been shown that the present of iNOS in TAMs in the stroma of breast carcinomas
also promotes tumor growth [219].
To fully explain these contradictions, it is pointed out that all the NO experiments
need better control in terms of the real NO status within the biological environment
created by NO donors or iNOS expression systems. Some control examples would be
Thomas et al. [154] showed MCF-7 cells exposed to different time spans and concen-
trations of NO resulted in totally different cell fates. And Hickok and Thomas [220]
showed totally different HIF-α accumulation patterns in MCF-7 cells because of using
different NO donors. However, in these experimental designs the NO measurement
method itself was still rough in terms of time resolution and NO delivery control was
not achieved.
Considering NO’s biological functions, such as angiogenic property and the potential
to activate matrix metalloproteinase, NO levels in a complex tumors can be variant
due to different tumor nutrients and metastasis. Meanwhile NO from macrophages
showed tumoricidal activity too [221]. The hypothesis is that there are NO thresholds,
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above which NO will perform as a tumor inhibitor otherwise as the cancer protector or
promoting signaling for angiogenesis. So that by measuring NO level not only cancer
cells might be correctly staged, more importantly cancer cells’ local environment, such
as blood supply status, oxidative states, potential chemo/radio resistance pathways,
and immune activity, can be more precisely understood.
Many studies have been done to add new data and knowledge on how NO’s level and
temporal status affect the cell fate (Reviewed in [65]). But there is no research that
has been done to systematically study this important biological event largely due
to the lack of a good study tools. The two-chamber NO measurement device with
the NOA real-time measurement may have great potential here. Different from the
traditional semi-quantitative measuring methods, the device developed has achieved
direct absolute NO surface flux quantification, without influencing the cell’s normal
growth. So that the same cells that were used in NO measurement experiments can
also be used for other biological assays if needed. In this case it achieved that every
single biological sample can have its own NO profile data and be analyzed even more
comprehensively by other biological assays.
A preliminary study on measuring NO from tissues was completed. Though simula-
tion of NO flux from a solid tissue is missing now, the work here circumvented this
difficulty by preparing a PEG-based SNAP grafted NO generating hydrogel. SNAP
was covalently linked to PEG hydrogel. NO generation was enhanced by shining light
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onto the gel. A 6 mm diameter 4 mm high hydrogel was attached onto our device
membrane. NO flux from the bottom can be measured as shown in Fig. 6.4. The
NO profile shows good time resolution upon the light stimulation. And according to
the simulation and the previous NO releasing polymer biocompatibility test, which
shows endothelial cell layer has an NO surface flux of about 1× 10−10mol/cm2/min
magnitude [113], the data presented here shows the device might be applicable to pro-
cess cancer studies on biologically relevant NO levels if tissue culture can be correctly
processed in the device.
Figure 6.4: NO flux measured from the light-initiated NO releasing PEG-
SNAP hydrogel. PEG-SNAP hydrogel was applied to the NO measurement
device and soaked within PBS; constant light intensity from an LED bulb
was applied to the material to initiate high NO dose releasing. Green arrow
indicates light on; red, off.
Since within many cancers, one major source of NO could be TAMs, which can be
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strongly correlated with a poor prognosis [218], macrophage RAW264.7 cells were
cultured on a 18 mm × 18 mm glass cover slip and stimulated with 100 ng/ml
LPS to mimic a cancer tissue with TAMs that releases NO. RAW264.7 cells were
seeded at a starting density of 80,000 cell/cm2 and cultured for overnight. Then cells
were stimulated with LPS. 12 h after LPS was added, the cover-slip was applied to
the NO measurement device for NO measurement. Figure 6.5 shows once cover-slip
was cell-side-down mounted to the measurement device, the NO signal was detected
almost immediately, suggesting good time resolution of the device and applicability
for measuring NO level associated with cancer tissues. Combing with the hydrogel
data, it is suggested by normal cancer cell and tissue culture the device may be able
to quantify tissue NO levels of interest.
Since real-time NO data will potentially indicate specific cancer stages very quickly,
the measurement device will definitely support the traditional assay data and make
pathological assays more accurate and quick to guide the diagnosis and treatment.
The future work can be focusing on measuring NO level in the cultured cancer cells
and tissues in real-time by using tissue culture standard protocols. Tumor microenvi-
ronment might be different from the normal tissue, which may influence the activity
of the NOSs and the efficacy of the anti-tumor drugs. Recent study has shown that
antineoplastic pro-drug Banoxantrone (AQ4N) can only be activated by NO generat-
ing macrophages under hypoxic conditions [222], suggesting that the importance of
understanding NO and oxidative status when studying the drug-tumor interaction.
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Figure 6.5: NO flux measurement of the macrophages (RAW264.7) cul-
tured on the cover-slip. Blue arrow indicates when the sample was placed
on the device.
The two-chamber system provides real-time NO information relatively independent
to cell culture and treatment processes. In this case the potency of each factors
that may affect cancer and NO behavior can be evaluated by using this device. For
example to study how NO determines cancer cell fate under normal, hyperoxic and
hypoxic conditions and environment with different reactive oxygen species (such as
superoxide and peroxide), it is simply needed to culture the cells in the device under
different conditions and apply the measurement methods.
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6.3.2 Localized delivery of NO to the breast cancer cell line
in a controllable manner
NO has almost all the good properties of an ideal anticancer molecule, including
small cytotoxicity effective distance, short acting time, and relatively safe ultimate
products. NOmay be an active chemosensitizing regulator in hypoxic tumor cells [223,
224]. NO donor, conjugated with other anti-cancer drugs, showed an enhancement
of drug efficiencies [225, 226]. NO was also used alone to inhibit cancer growth by
gene therapy methods [227]. Whether working synergistically with other drugs or
alone, a correct NO level is critical, where NO will not exert its other functions for
instance cytoprotection, angiogensis, or metastasis. If not, paradoxical results might
appear such as iNOS’s cancer promoting effect observed by Jeckins et al. [215] vs
cancer inhibition effect claimed by Xu et al. [214]. Although the control over the dose
and temporal variables of NO used for cell treatment has been emphasized for years,
in fact NO experimental procedures are still not well controlled. Quantitative work
was largely dependent on the experience of the operators or the estimation from the
kinetic equations.
It has been shown that the NO delivery device can be successfully used to inhibit
the proliferation of SMC cell line MOVAS cell by using NO releasing polymer for
localized NO delivery (As shown in Figure 5.3 and 5.10). Due to NO’s high reactivity,
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NO’s effective distance is only within then hundreds of micrometers range, where it
functions and also loses its functions. This will confine its effective range and minimize
the potential side-effect. By using the same principle, optimized therapeutic NO level
for killing or inhibiting cancer cells can be examined. To evaluate the feasibility, breast
cancer cell line MDA-MB-231 were applied for the NO delivery examination.
Cells were seeded into the NO delivery device at a starting density of 40,000
cell/cm2 and after overnight recovery the lethal NO level determined in 5.4
(1− 2× 10−10mol/cm2/min) was applied. Data showed this cancer cell line is more
NO resistant compared with the smooth muscle cell line (Fig. 6.6 A and C).
According to the previous reports, an initial high level of NO treatment for a relatively
short time is advised for cancer treatment [22, 214], but there is no quantitative
statement yet that defined how high and short this burst treatment should be. High
flux of NO (average 13.8± 2.1× 10−10mol/cm2/min ) was delivered to MDA cells for
only 30 min. Twenty-four hours after treatment, live-dead assay also shows MDA
cells survived such an NO treatment (Fig. 6.6 B and D).
Their corresponding real-time NO delivery patterns were shown in Fig. 6.7, respec-
tively. It suggests that a beneficial NO level for cancer-toxicity might be very high
(even higher than around 15× 10−10mol/cm2/min, which is normally very toxic to
MOVAS cells), or there might be certain scavenging pathways within MDA cells to
suppress the effective NO level that was actually experienced by the MDA cells.
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Figure 6.6: Controllable NO delivery to MDA-MB-231 cells. (A) and (B)
show where the NO releasing region is indicated by ∗ and regions without
NO by ∆. (C) and (D) show cell growth on the membrane corresponding to
(A) and (B), respectively.
Further increase of NO flux to up to 30× 10−10mol/cm2/min for the first 20 min
achieved killing MDA cells (Fig. 6.8), showing the cyto-toxicity of NO to MDA and
this effect is also very local.
These results are interesting. The NO threshold that can kill MDA cells is very dif-
ferent from the threshold for MOVAS cells, which directly proves the tissue specificity
of NO’s effect. Currently many NO studies use relatively complex models. Though
many results are intriguing and significant for medical applications, it might not be
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Figure 6.7: NO delivery to MDA-MB-231 cells. Sample 1 corresponds to
cells shown in Fig. 6.6 (A) and (C), while Sample 2 corresponds to Fig. 6.6
(B) and (D).
very helpful for elucidating the detailed underlying mechanisms since the variable
control is very difficult to achieve in such conditions. Separating factors and under-
standing the weight of each factor rely on the in depth NO quantitative investigation
in different simpler and controllable biological systems. By using the method pre-
sented here as an example, hopefully more fundamental researches can be carried-out
to unveil NO’s level, temporal, spacial and tissue-dependent nature.
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Figure 6.8: NO delivery to MDA-MB-231 cells to kill MDA-MB-231 cells.
(A) indicates where SNAP-PDMS was placed; the NO releasing region is
indicated by ∗ and regions without NO is indicated by ∆; (B) cell growth
on the membranes, green indicates living cells stained by calcein; red, dead
cells by EthBr; (C) shows real-time NO flux delivered to the designated cells.
Scale bar, 2 mm. The curve is the average NO flux pattern of the triplicate;
error bar represent standard deviation. Scale bar 2 mm.
6.4 Conclusions
Current biomedical research methods, especially chemistry and biology based exper-
imental assays, have many problems, such as they are hard to apply for in depth
quantitative analysis, not representative enough to the actual biological status, and
inevitably invasive. Studying the dose, temporal and spacial aspect of NO’s effect
is essential to precisely understanding the biological functions of NO and developing
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the related biomedical applications. Due to the high reactivity and diffusivity of NO,
this work has been challenging and poorly done for long. The design and applica-
tion of tools for NO quantitative study can push our understanding of the effects of
NO forward, leading to developments that will allow therapeutic interventions to be
utilized to help solve complex issues of biocompatibility and tissue regeneration.
By combining well understood materials, we were able to obtain a composite selective
membrane that achieves the specific requirements for both the NO measurement
system and NO cross-membrane delivery system. The design of the two-chamber
system is fully compatible with the current in vitro cell culture experimental protocols
and achieved real-time NO monitoring (in biological environment), which will not
affect the normal cell growth and other experimental procedures. These devices have
the potential to greatly increase our understanding of the temporal parameters of
NO generation, which were emphasized by various discussions but lacks the actual
real-time data for support, let alone the analysis method or statistical algorithms.
Superior to the conventional soluble NO releasing chemicals used in NO research,
the use of the novel NO releasing polymer SNAP-PDMS to deliver NO also makes
control over temporal NO parameters and absolute quantification of NO experienced
by cells possible. Hopefully by applying this device to additional biological models
(such as cancer cell lines and in vitro biological molecule reaction systems shown
in this chapter), more practical and standard methods can be developed. The big
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advantage of these two devices is that calibration is not affected by the complexity of
the biological system. So that calibration is much easier and more reliable compared
with the NO electrochemical probes. However, change of the parameters such as
composition of sweep gas, size of trap and membrane characters can have substantial
effect on the final calculation, which should be well controlled and clearly stated.
The measurement device can be used to understand the physiological NO level or
cellular NO level under different conditions, while the delivery system investigates
the effect of different exogenous NO level to cells, which can also mimic the cases
measured by the NO measurement device to validate each other. More specifically,
the NO generation profiles from the macrophage cell-line RAW264.7 stimulated by
100 ng/ml LPS and/or 10 ng/ml IFN-γ were recorded by the NO measurement device.
The factors that may potentially influence NO generation from the cells were studied
and discussed in detail, directly showing dependent natural factors that affect NO
generation from cells can be. The conventional report of an average flux or maximum
flux is not sufficient to represent the highly dynamic and reactive properties of NO
and not helpful for understanding NO’s dose and temporal dependent effects. LPS
and IFN-γ’s synergetic effect to RAW264.7 NO generation was also directly shown
and quantitatively analyzed by the device. The rate variation and response time of
RAW264.7 NO generation due to the exposure to extra L-arginine, nor-NOHA and
L-NAME were also studied by the device, especially the different potencies when the
same concentration of L-arginine was applied at different time points.
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Examples were also given to show the utility of the NO delivery device. To validate
the device, the well understood SMC–NO interaction was used as a model, and the
current data indicates that the device was able to deliver physiologically relevant
level of NO in a controllable manner (NO flux rate, release duration and spacial dis-
tribution). Cell data supports the idea that NO flux rate determines the cell fate.
Systematically manipulating NO levels that cultured cells experience by using the
NO delivery device showed that > 1.0× 10−10mol/cm2/min NO flux can be fatal
for MOVAS cell; around 0.7× 10−10mol/cm2/min was associated with inhibition of
MOVAS proliferation without observable cytotoxic effect; < 0.4× 10−10mol/cm2/min
was not sufficient to inhibit MOVAS proliferation. And these effective NO levels were
also directly proved to be time-dependent by using the novel NO delivery device.
For example, the MOVAS cytotoxicity was shown to require over 1 h exposure of
a little over 1.0× 10−10mol/cm2/min NO flux, and less than this duration did not
induce permanently damage to MOVAS cells. However, a very high NO flux (an
average of 50× 10−10mol/cm2/min, up to 200× 10−10mol/cm2/min) caused perma-
nent cell damage with 10 min treatment, directly showing the importance of precisely
controlling NO release profiles when using NO releasing biomaterials and chemicals.
Moreover, the local effect of NO was studied and localized NO delivery was achieved
by using this delivery system. This property is important for NO’s pharmaceuti-
cal application, because unlike the conventional drugs, the effective distance of NO is
highly limited (NO flux decreased to less than its half after 20 µm diffusion in DMEM
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from the data shown in Fig. 5.1), so that the surrounding health tissue is not likely
to be exposed to a potentially cytotoxic NO environment.
Some practical biomedical applications were also accomplished to further show the
usefulness and potentially wide applications of these two devices. To restore the
correct NO level, using NO donor is still a widely used method. But currently it is still
unclear about the different potencies of different NO donors and difficult to predict
the NO level that cells actually experience when using those donors. To overcome
these problems, the NO generation profiles of different soluble NO donors in different
solutions (in both PBS buffer and cell culture media, and these NO levels directly
represent NO that cells experience in cell culture) were studied by the real-time NO
measurement device, including CysNO SNAP, GSNO and DETA NONOate, proving
that NO release profiles of all NO donors were very condition dependent. The factors
that potentially affect the ultimate NO that cells experience were studied, including
pH, transition metal irons, redox level, free thiol and media relative volume. By
using MOVAS interaction with NO as a model, it is directly proved that different
NO donors (with the same effective concentration) inhibited MOVAS proliferation in
different degrees, and this inhibition was not consistent with the so-called stability
of NO donors, which is directly related to the t1/2 of the specific donors measured
in vitro in PBS, but was consistent with the actual NO generation profiles measured
when NO donors were actually applied to the cultured cells. This data indicates that
understanding the NO profiles of every single experiment is the key to understanding
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NO’s actual effect, and tracking individual NO profiles in different experiments is the
only way to avoid generating confusing data.
For future direction, it has been shown how the measurement device can be potentially
used to study the reaction kinetics of NO with other species such as ascorbic acid,
understand NO levels in different cell types and solid tissues if possible. Specifically,
NO releasing hydrogel and NO generating cells cultured on glass cover-slip were used
to mimic tissues that generate NO, hoping that if the correct tissue culture and device
calibration can be applied, NO generation from different healthy and pathological
tissues can be directly studied. Controllable delivery device was used to show that
the breast cancer cell line MDA-MB-231 was significantly more NO resistant than
MOVAS cells, which would be a good example for investigating the tissue specificity
of NO.
Currently, these methods have their own problems too. The systems are only com-
patible with in vitro cell culture models. Also, when discussing NO behaviors in
a subcellular level, those systems are not mature yet. Just like all the other in-
struments, every one of them has its own application scope and limitations. But
by correct adjustment and modification for specific uses problems are expected to
be solved or bypassed, which is the same as the case where the modification to the
dimension and surface of the old NO electrochemical probes solved the spacial reso-
lution, sensitivity and selectivity problems associated with the electrochemical probe.
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However, such development cannot be accomplished in one day. With further study,





[1] Priestly, J. Experiments and Observations on Different Kinds of Air, Vol. 1;
London, 1775.
[2] Prout, W. Medico-chirurgical transactions 1818, 9(Pt 2), 472.
[3] Mitchell, H.; Shonle, H.; Grindley, H. Journal of Biological Chemistry 1916,
24(4), 461–490.
[4] Green, L. C.; De Luzuriaga, K. R.; Wagner, D. A.; Rand, W.; Istfan, N.; Young,
V. R.; Tannenbaum, S. R. Proceedings of the National Academy of Sciences
1981, 78(12), 7764–7768.
[5] Green, L. C.; Goldman, P.; others. Science 1981, 212(4490), 56–58.
[6] Stuehr, D. J.; Marletta, M. A. Proceedings of the National Academy of Sciences
1985, 82(22), 7738–7742.
[7] Furchgott, R. F.; Bhadrakom, S. Journal of Pharmacology and Experimental
Therapeutics 1953, 108(2), 129–143.
239
[8] Furchgott, R. F. Journal of Pharmacology and Experimental Therapeutics 1954,
111(3), 265–284.
[9] Furchgott, R. F.; Zawadzki, J. V.; others. Nature 1980, 288(5789), 373–376.
[10] Hibbs, J. B.; Taintor, R. R.; Vavrin, Z. Science 1987, 235(4787), 473–476.
[11] Palmer, R. M.; Ferrige, A.; Moncada, S. Nature 1987, 327.
[12] Ignarro, L. J.; Buga, G. M.; Wood, K. S.; Byrns, R. E.; Chaudhuri, G. Proceed-
ings of the National Academy of Sciences 1987, 84(24), 9265–9269.
[13] Furchgott, R. F. Angewandte Chemie International Edition 1999, 38(13-14),
1870–1880.
[14] Murad, F. Angewandte Chemie International Edition 1999, 38(13-14), 1856–
1868.
[15] Ignarro, L. J. Angewandte Chemie International Edition 1999, 38(13-14), 1882–
1892.
[16] Loscalzo, J.; Welch, G. Progress in cardiovascular diseases 1995, 38(2), 87–104.
[17] Radomski, M.; Palmer, R.; Moncada, S. The Lancet 1987, 330(8567), 1057–
1058.
[18] Moncada, S.; Radomski, M. W.; Palmer, R. M. Biochemical pharmacology
1988, 37(13), 2495–2501.
240
[19] Schuman, E. M.; Madison, D. V. Annual review of neuroscience 1994, 17, 153–
183.
[20] Lo, H.; Hung, M. British journal of cancer 2006, 94(2), 184–188.
[21] Correa-Aragunde, N.; Graziano, M.; Chevalier, C.; Lamattina, L. Journal of
Experimental Botany 2006, 57(3), 581–588.
[22] Xu, W.; Liu, L. Z.; Loizidou, M.; Ahmed, M.; Charles, I. G. Cell research 2002,
12(5), 311–320.
[23] Ziche, M.; Morbidelli, L. Journal of neuro-oncology 2000, 50(1-2), 139–148.
[24] Bogdan, C. Nature immunology 2001, 2(10), 907–916.
[25] Chen, B.; Keshive, M.; Deen, W. M. Biophysical journal 1998, 75(2), 745–754.
[26] Thomas, D. D.; Miranda, K. M.; Colton, C. A.; Citrin, D.; Espey, M. G.; Wink,
D. A. Antioxidants and Redox Signaling 2003, 5(3), 307–317.
[27] Radi, R.; Beckman, J. S.; Bush, K. M.; Freeman, B. A. Journal of Biological
Chemistry 1991, 266(7), 4244–4250.
[28] Nalwaya, N.; Deen, W. M. Chemical research in toxicology 2005, 18(3), 486–
493.
[29] Chin, M. P.; Schauer, D. B.; Deen, W. M. Chemical research in toxicology 2010,
23(4), 778–787.
241
[30] Radi, R.; Beckman, J. S.; Bush, K. M.; Freeman, B. A. Archives of biochemistry
and biophysics 1991, 288(2), 481–487.
[31] Palmer, R. M.; Ashton, D.; Moncada, S. Nature 1988, 333(6174), 664–666.
[32] Nathan, C.; Xie, Q.-w. Cell 1994, 78(6), 915–918.
[33] Bredt, D. S.; Snyder, S. H. Proceedings of the National Academy of Sciences
1990, 87(2), 682–685.
[34] Yui, Y.; Hattori, R.; Kosuga, K.; Eizawa, H.; Hiki, K.; Kawai, C. Journal of
Biological Chemistry 1991, 266(19), 12544–12547.
[35] Pollock, J. S.; Fo¨rstermann, U.; Mitchell, J. A.; Warner, T. D.; Schmidt, H.;
Nakane, M.; Murad, F. Proceedings of the National Academy of Sciences 1991,
88(23), 10480–10484.
[36] Groves, J. T.; Wang, C. C. Current opinion in chemical biology 2000, 4(6),
687–695.
[37] Billiar, T. R. Annals of surgery 1995, 221(4), 339.
[38] MacMicking, J.; Xie, Q.-w.; Nathan, C. Annual review of immunology 1997,
15(1), 323–350.
[39] Fo¨rstermann, U.; Gath, I.; Schwarz, P.; Closs, E. I.; Kleinert, H. Biochemical
pharmacology 1995, 50(9), 1321–1332.
242
[40] Garthwaite, J.; Boulton, C. Annual review of physiology 1995, 57(1), 683–706.
[41] Prast, H.; Philippu, A. Progress in neurobiology 2001, 64(1), 51–68.
[42] Barouch, L. A.; Harrison, R. W.; Skaf, M. W.; Rosas, G. O.; Cappola, T. P.;
Kobeissi, Z. A.; Hobai, I. A.; Lemmon, C. A.; Burnett, A. L.; O’Rourke, B.;
others. Nature 2002, 416(6878), 337–339.
[43] Fukumura, D.; Gohongi, T.; Kadambi, A.; Izumi, Y.; Ang, J.; Yun, C.-O.;
Buerk, D. G.; Huang, P. L.; Jain, R. K. Proceedings of the National Academy
of Sciences 2001, 98(5), 2604–2609.
[44] Cai, H.; Li, Z.; Goette, A.; Mera, F.; Honeycutt, C.; Feterik, K.; Wilcox, J. N.;
Dudley, S. C.; Harrison, D. G.; Langberg, J. J. Circulation 2002, 106(22),
2854–2858.
[45] Wheeler, M. A.; Smith, S. D.; Garc´ıa-Carden˜a, G.; Nathan, C. F.; Weiss, R. M.;
Sessa, W. C. Journal of Clinical Investigation 1997, 99(1), 110.
[46] Melillo, G.; Musso, T.; Sica, A.; Taylor, L. S.; Cox, G. W.; Varesio, L. The
Journal of experimental medicine 1995, 182(6), 1683–1693.
[47] Iadecola, C.; Zhang, F.; Xu, X. American Journal of Physiology-Regulatory,
Integrative and Comparative Physiology 1995, 268(1), R286–R292.
[48] Iadecola, C.; Zhang, F.; Casey, R.; Clark, H. B.; Ross, M. E. Stroke 1996,
27(8), 1373–1380.
243
[49] Weinberg, J.; Misukonis, M.; Shami, P.; Mason, S.; Sauls, D.; Dittman, W.;
Wood, E.; Smith, G.; McDonald, B.; Bachus, K. Blood 1995, 86(3), 1184–1195.
[50] Pervin, S.; Singh, R.; Sen, S.; Chaudhuri, G. In Nitric Oxide (NO) and Cancer;
Springer, 2010; pages 39–57.
[51] Nagy, G.; Clark, J. M.; Buza´s, E. I.; Gorman, C. L.; Cope, A. P. Immunology
letters 2007, 111(1), 1–5.
[52] Bo¨hme, G. A.; Bon, C.; Stutzmann, J.-M.; Doble, A.; Blanchard, J.-C. Euro-
pean journal of pharmacology 1991, 199(3), 379–381.
[53] Togashi, H.; Sakuma, I.; Yoshioka, M.; Kobayashi, T.; Yasuda, H.; Kitabatake,
A.; Saito, H.; Gross, S.; Levi, R. Journal of Pharmacology and Experimental
Therapeutics 1992, 262(1), 343–347.
[54] Ling, L.; Karius, D. R.; Fiscus, R. R.; Speck, D. F. Journal of neurophysiology
1992, 68(5), 1910–1912.
[55] Meller, S.; Gebhart, G. Pain 1993, 52(2), 127–136.
[56] Huerta-Yepez, S.; Vega, M.; Jazirehi, A.; Garban, H.; Hongo, F.; Cheng, G.;
Bonavida, B. Oncogene 2004, 23(29), 4993–5003.
[57] Mitchell, J. B.; Wink, D. A.; DeGraff, W.; Gamson, J.; Keefer, L. K.; Krishna,
M. C. Cancer research 1993, 53(24), 5845–5848.
[58] Zhang, X.; Xu, Q. Melanoma research 2001, 11(6), 559–567.
244
[59] Greenblatt, M.; Philippe, S. K. Journal of the National Cancer Institute 1968,
41(1), 111–124.
[60] Eu, J. P.; Liu, L.; Zeng, M.; Stamler, J. S. Biochemistry 2000, 39(5), 1040–1047.
[61] Ischiropoulos, H.; Al-Mehdi, A. B. FEBS letters 1995, 364(3), 279–282.
[62] Schopfer, F. J.; Baker, P. R.; Freeman, B. A. Trends in biochemical sciences
2003, 28(12), 646–654.
[63] Wink, D. A.; Kasprzak, K. S.; others. Science 1991, 254(5034), 1001.
[64] Nguyen, T.; Brunson, D.; Crespi, C.; Penman, B.; Wishnok, J.; Tannenbaum,
S. Proceedings of the National Academy of Sciences 1992, 89(7), 3030–3034.
[65] Thomas, D. D.; Ridnour, L. A.; Isenberg, J. S.; Flores-Santana, W.; Switzer,
C. H.; Donzelli, S.; Hussain, P.; Vecoli, C.; Paolocci, N.; Ambs, S.; Coltonf,
C. A.; Harrisd, C. C.; . Robertsc, D. D.; Wink, D. A. Free Radical Biology and
Medicine 2008, 45(1), 18–31.
[66] Wink, D. A.; Miranda, K. M.; Espey, M. G.; Pluta, R. M.; Hewett, S. J.;
Colton, C.; Vitek, M.; Feelisch, M.; Grisham, M. B. Antioxidants and Redox
Signaling 2001, 3(2), 203–213.
[67] Kro¨ncke, K.; Fehsel, K.; Kolb-Bachofen, V. Clinical and experimental immunol-
ogy 1998, 113, 147–156.
[68] Lipton, S.; Stamler, J. Neuropharmacology 1994, 33(11), 1229–1233.
245
[69] Colton, C.; Gbadegesin, M.; Wink, D.; Miranda, K.; Espey, M.; Vicini, S.
Journal of neurochemistry 2001, 78(5), 1126–1134.
[70] Christopherson, K. S.; Bredt, D. S. Journal of Clinical Investigation 1997,
100(10), 2424.
[71] Heales, S. J.; Bolan˜os, J. P.; Stewart, V. C.; Brookes, P. S.; Land, J. M.; Clark,
J. B. Biochimica et Biophysica Acta (BBA)-Bioenergetics 1999, 1410(2), 215–
228.
[72] Knott, A. B.; Bossy-Wetzel, E. Antioxidants & redox signaling 2009, 11(3),
541–553.
[73] Hetrick, E. M.; Schoenfisch, M. H. Annual review of analytical chemistry (Palo
Alto, Calif.) 2009, 2, 409.
[74] Coneski, P. N.; Schoenfisch, M. H. Chemical Society Reviews 2012, 41(10),
3753–3758.
[75] Cooke, MD, J. P.; Dzau, MD, V. J. Annual review of medicine 1997, 48(1),
489–509.
[76] Lancaster, J. R. Nitric Oxide 1997, 1(1), 18–30.
[77] Lancaster, J. R. Proceedings of the National Academy of Sciences 1994, 91(17),
8137–8141.
[78] Sun, J.; Zhang, X.; Broderick, M.; Fein, H. Sensors 2003, 3(8), 276–284.
246
[79] Higuchi, K.; Motomizu, S. Analytical sciences 1999, 15(2), 129–134.
[80] Toda, K.; Hato, Y.; Ohira, S.-I.; Namihira, T. Analytica chimica acta 2007,
603(1), 60–66.
[81] Noack, E.; Kubitzek, D.; Kojda, G. Neuroprotocols 1992, 1(2), 133–139.
[82] Kleschyov, A. L.; Mollnau, H.; Oelze, M.; Meinertz, T.; Huang, Y.; Harrison,
D. G.; Munzel, T. Biochemical and biophysical research communications 2000,
275(2), 672–677.
[83] Kojima, H.; Nakatsubo, N.; Kikuchi, K.; Kawahara, S.; Kirino, Y.; Nagoshi,
H.; Hirata, Y.; Nagano, T. Analytical chemistry 1998, 70(13), 2446–2453.
[84] Davies, I. R.; Zhang, X. Methods in enzymology 2008, 436, 63–95.
[85] Liu, X.; Liu, Q.; Gupta, E.; Zorko, N.; Brownlee, E.; Zweier, J. L. Nitric Oxide
2005, 13(1), 68–77.
[86] Malinski, T.; Taha, Z. Nature 1992, 358(6388), 676–678.
[87] Sievers nitric oxide analyzer NOA280i operation and maintenance manual. GE
Analytical Instruments, 2006.
[88] Kikuchi, K.; Nagano, T.; Hayakawa, H.; Hirata, Y.; Hirobe, M. Analytical
chemistry 1993, 65(13), 1794–1799.
[89] Lancaster, J. R.; Langrehr, J.; Bergonia, H.; Murase, N.; Simmons, R.; Hoff-
man, R. Journal of Biological Chemistry 1992, 267(16), 10994–10998.
247
[90] Zweier, J. L.; Wang, P.; Kuppusamy, P. Journal of Biological Chemistry 1995,
270(1), 304–307.
[91] Hobbs, A. J.; Higgs, A.; Moncada, S. Annual Review of Pharmacology and
Toxicology 1999, 39(1), 191–220.
[92] Bennett, B. M.; Leitman, D. C.; Schro¨der, H.; Kawamoto, J. H.; Nakatsu,
K.; Murad, F. Journal of Pharmacology and Experimental Therapeutics 1989,
250(1), 316–323.
[93] Miller, M.; Megson, I. British journal of pharmacology 2007, 151(3), 305–321.
[94] Chen, Z.; Zhang, J.; Stamler, J. S. Proceedings of the National Academy of
Sciences 2002, 99(12), 8306–8311.
[95] Williams, D. L. H. Accounts of chemical research 1999, 32(10), 869–876.
[96] Napoli, C.; Ignarro, L. J. Annual review of pharmacology and toxicology 2003,
43(1), 97–123.
[97] Smith, D. J.; Chakravarthy, D.; Pulfer, S.; Simmons, M. L.; Hrabie, J. A.;
Citro, M. L.; Saavedra, J. E.; Davies, K. M.; Hutsell, T. C.; Mooradian, D. L.;
others. Journal of medicinal chemistry 1996, 39(5), 1148–1156.
[98] Tierney, T. S.; Clatterbuck, R. E.; Lawson, C.; Thai, Q.-A.; Rhines, L. D.;
Tamargo, R. J. Neurosurgery 2001, 49(4), 945–953.
248
[99] Chaux, A.; Ruan, X. M.; Fishbein, M. C.; Ouyang, Y.; Kaul, S.; Pass, J. A.;
Matloff, J. M. The Journal of Thoracic and Cardiovascular Surgery 1998,
115(3), 604–614.
[100] Shishido, S. M.; Oliveira, M. G. Photochemistry and photobiology 2000, 71(3),
273–280.
[101] Shishido, S. M.; Seabra, A. B.; Loh, W.; de Oliveira, M. G. Biomaterials 2003,
24(20), 3543–3553.
[102] Frost, M. C.; Reynolds, M. M.; Meyerhoff, M. E. Biomaterials 2005, 26(14),
1685–1693.
[103] Mowery, K. A.; Schoenfisch, M. H.; Saavedra, J. E.; Keefer, L. K.; Meyerhoff,
M. E. Biomaterials 2000, 21(1), 9–21.
[104] Frost, M. C.; Meyerhoff, M. E. Journal of the American Chemical Society 2004,
126(5), 1348–1349.
[105] Pulfer, S. K.; Ott, D.; Smith, D. J. Journal of biomedical materials research
1997, 37(2), 182–189.
[106] Zhang, H.; Annich, G. M.; Miskulin, J.; Stankiewicz, K.; Osterholzer, K.; Merz,
S. I.; Bartlett, R. H.; Meyerhoff, M. E. Journal of the American Chemical
Society 2003, 125(17), 5015–5024.
249
[107] Riccio, D. A.; Schoenfisch, M. H. Chemical Society Reviews 2012, 41(10), 3731–
3741.
[108] Frost, M. C.; Meyerhoff, M. E. Journal of Biomedical Materials Research Part
A 2005, 72(4), 409–419.
[109] Stasko, N. A.; Schoenfisch, M. H. Journal of the American Chemical Society
2006, 128(25), 8265–8271.
[110] Frost, M. C.; Rudich, S. M.; Zhang, H.; Maraschio, M. A.; Meyerhoff, M. E.
Analytical chemistry 2002, 74(23), 5942–5947.
[111] Boyden, S. The Journal of experimental medicine 1962, 115(3), 453–466.
[112] Mowery, K.; Meyerhoff, M. Polymer 1999, 40(22), 6203–6207.
[113] Vaughn, M. W.; Kuo, L.; Liao, J. C. American Journal of Physiology-Heart and
Circulatory Physiology 1998, 274(6), H2163–H2176.
[114] Laurent, M.; Lepoivre, M.; Tenu, J. Biochem. J 1996, 314, 109–113.
[115] Mo¨ller, M.; Botti, H.; Batthyany, C.; Rubbo, H.; Radi, R.; Denicola, A. Journal
of Biological Chemistry 2005, 280(10), 8850–8854.
[116] Malinski, T.; Taha, Z.; Grunfeld, S.; Patton, S.; Kapturczak, M.; Tomboulian,
P. Biochemical and biophysical research communications 1993, 193(3), 1076–
1082.
250
[117] Wise, D.; Houghton, G. Chemical Engineering Science 1968, 23(10), 1211–
1216.
[118] Cussler, E. L. Diffusion: mass transfer in fluid systems; Cambridge university
press, 2009.
[119] Wink, D. A.; Darbyshire, J. F.; Nims, R. W.; Saavedra, J. E.; Ford, P. C.
Chemical research in toxicology 1993, 6(1), 23–27.
[120] Kharitonov, V. G.; Sundquist, A. R.; Sharma, V. S. Journal of Biological Chem-
istry 1995, 270(47), 28158–28164.
[121] Schmidt, K.; Desch, W.; Klatt, P.; Kukovetz, W. R.; Mayer, B. Naunyn-
Schmiedeberg’s archives of pharmacology 1997, 355(4), 457–462.
[122] Feelisch, M. Naunyn-Schmiedeberg’s archives of pharmacology 1998, 358(1),
113–122.
[123] Feelisch, M.; Stamler, J. S. Methods in nitric oxide research; Wiley, 1996.
[124] Wali, M. A.; Suleiman, S. A.; Kadoumi, O. F.; Nasr, M. Annals of thoracic
and cardiovascular surgery: official journal of the Association of Thoracic and
Cardiovascular Surgeons of Asia 2002, 8(5), 286–290.
[125] Rocic, P.; Kolz, C.; Reed, R.; Potter, B.; Chilian, W. M. American Journal of
Physiology-Heart and Circulatory Physiology 2007, 292(6), H2729–H2736.
251
[126] Mesa´rosˇ, Sˇ.; Vanˇkova´, Zˇ.; Mesa´rosˇova´, A.; Tomcˇık, P.; Grunfeld, S. Bioelectro-
chemistry and bioenergetics 1998, 46(1), 33–37.
[127] Marxer, S. M.; Rothrock, A. R.; Nablo, B. J.; Robbins, M. E.; Schoenfisch,
M. H. Chemistry of materials 2003, 15(22), 4193–4199.
[128] Amadeu, T. P.; Seabra, A. B.; De Oliveira, M. G.; Costa, A. M. Journal of the
European Academy of Dermatology and Venereology 2007, 21(5), 629–637.
[129] Amadeu, T. P.; Seabra, A. B.; de Oliveira, M. G.; Monte-Alto-Costa, A. Journal
of Surgical Research 2008, 149(1), 84–93.
[130] Tarr, H. Nature 1941, 147(3727), 417–418.
[131] Liew, F.; Millott, S.; Parkinson, C.; Palmer, R.; Moncada, S. The Journal of
Immunology 1990, 144(12), 4794–4797.
[132] Denis, M. Journal of Leukocyte Biology 1991, 49(4), 380–387.
[133] Vogt, C.; Xing, Q.; He, W.; Li, B.; Frost, M. C.; Zhao, F. Biomacromolecules
2013, 14(8), 2521–2530.
[134] Friedman, A. J.; Han, G.; Navati, M. S.; Chacko, M.; Gunther, L.; Alfieri, A.;
Friedman, J. M. Nitric Oxide 2008, 19(1), 12–20.
[135] Han, G.; Martinez, L. R.; Mihu, M. R.; Friedman, A. J.; Friedman, J. M.;
Nosanchuk, J. D. PLoS One 2009, 4(11), e7804.
252
[136] Parzuchowski, P. G.; Frost, M. C.; Meyerhoff, M. E. Journal of the American
Chemical Society 2002, 124(41), 12182–12191.
[137] Romanowicz, G. E.; Nielsen, M.; Frost, M. C. Science and Technology of Ad-
vanced Materials 2011, 12(5), 055007.
[138] Moynihan, H. A.; Roberts, S. M. J. Chem. Soc., Perkin Trans. 1 1994, (7),
797–805.
[139] Zhou, J.; Ellis, A. V.; Voelcker, N. H. Electrophoresis 2010, 31(1), 2–16.
[140] Lee, H.; Dellatore, S. M.; Miller, W. M.; Messersmith, P. B. Science 2007,
318(5849), 426–430.
[141] Yin, X.; Liu, D. Journal of Chromatography A 2008, 1212(1), 130–136.
[142] Archer, S. The FASEB journal 1993, 7(2), 349–360.
[143] Taha, Z. H. Talanta 2003, 61(1), 3–10.
[144] Gladwin, M. T.; Ognibene, F. P.; Pannell, L. K.; Nichols, J. S.; Pease-Fye,
M. E.; Shelhamer, J. H.; Schechter, A. N. Proceedings of the National Academy
of Sciences 2000, 97(18), 9943–9948.
[145] Owusu, B. Y.; Stapley, R.; Patel, R. P. The Journal of physiology 2012, 590(20),
4993–5000.
[146] Hunter, R. A.; Storm, W. L.; Coneski, P. N.; Schoenfisch, M. H. Analytical
chemistry 2013, 85(3), 1957–1963.
253
[147] Bedioui, F.; Villeneuve, N. Electroanalysis 2003, 15(1), 5–18.
[148] Allen, B. W.; Liu, J.; Piantadosi, C. A. Methods in enzymology 2005, 396,
68–77.
[149] Bates, J. N. Neuroprotocols 1992, 1(2), 141–149.
[150] Privett, B. J.; Shin, J. H.; Schoenfisch, M. H. Chemical Society Reviews 2010,
39(6), 1925–1935.
[151] Lee, Y.; Yang, J.; Rudich, S. M.; Schreiner, R. J.; Meyerhoff, M. E. Analytical
Chemistry 2004, 76(3), 545–551.
[152] Fontijn, A.; Sabadell, A. J.; Ronco, R. J. Analytical Chemistry 1970, 42(6),
575–579.
[153] Dunham, A. J.; Barkley, R. M.; Sievers, R. E. Analytical chemistry 1995, 67(1),
220–224.
[154] Thomas, D. D.; Espey, M. G.; Ridnour, L. A.; Hofseth, L. J.; Mancardi, D.;
Harris, C. C.; Wink, D. A. Proceedings of the National Academy of Sciences of
the United States of America 2004, 101(24), 8894–8899.
[155] Schmidt, H. H.; Warner, T. D.; Nakane, M.; Fo¨rstermann, U.; Murad, F.Molec-
ular pharmacology 1992, 41(4), 615–624.
[156] Noda, T.; Amano, F. Journal of biochemistry 1997, 121(1), 38–46.
254
[157] Lee, H.; Dellatore, S. M.; Miller, W. M.; Messersmith, P. B. science 2007,
318(5849), 426–430.
[158] Xu, C.; Yang, F.; Wang, S.; Ramakrishna, S. Journal of Biomedical Materials
Research Part A 2004, 71(1), 154–161.
[159] Pelham, R. J.; Wang, Y. Proceedings of the National Academy of Sciences 1997,
94(25), 13661–13665.
[160] Peyton, S. R.; Raub, C. B.; Keschrumrus, V. P.; Putnam, A. J. Biomaterials
2006, 27(28), 4881–4893.
[161] Palchesko, R. N.; Zhang, L.; Sun, Y.; Feinberg, A. W. PLoS ONE 2012, 7(12).
[162] Kojima, H.; Urano, Y.; Kikuchi, K.; Higuchi, T.; Hirata, Y.; Nagano, T. Ange-
wandte Chemie International Edition 1999, 38(21), 3209–3212.
[163] Morris Jr, S. M. Annual review of nutrition 2002, 22(1), 87–105.
[164] Mehibel, M.; Singh, S.; Chinje, E. C.; Cowen, R. L.; Stratford, I. J. Molecular
cancer therapeutics 2009, 8(5), 1261–1269.
[165] Wang, C.; Deen, W. M. Annals of biomedical engineering 2003, 31(1), 65–79.
[166] Langford, E.; Wainwright, R.; Martin, J. Arteriosclerosis, thrombosis, and vas-
cular biology 1996, 16(1), 51–55.
[167] Megson, I.; Greig, I.; Gray, G.; Webb, D.; Butler, A. British journal of phar-
macology 1997, 122(8), 1617–1624.
255
[168] Megson, I.; Morton, S.; Greig, I.; Mazzei, F.; Field, R.; Butler, A.; Caron,
G.; Gasco, A.; Fruttero, R.; Webb, D. British journal of pharmacology 1999,
126(3), 639–648.
[169] Mathews, W. R.; Kerr, S. W. Journal of Pharmacology and Experimental Ther-
apeutics 1993, 267(3), 1529–1537.
[170] Singh, R. J.; Hogg, N.; Joseph, J.; Kalyanaraman, B. Journal of Biological
Chemistry 1996, 271(31), 18596–18603.
[171] Beckman, J. S.; Koppenol, W. H. American Journal of Physiology-Cell Physi-
ology 1996, 271(5), C1424–C1437.
[172] Maragos, C. M.; Morley, D.; Wink, D. A.; Dunams, T. M.; Saavedra, J. E.;
Hoffman, A.; Bove, A. A.; Isaac, L.; Hrabie, J. A.; Keefer, L. K. Journal of
medicinal chemistry 1991, 34(11), 3242–3247.
[173] Mooradian, D. L.; Hutsell, T. C.; Keefer, L. K. Journal of cardiovascular phar-
macology 1995, 25(4), 674–678.
[174] Stamler, J. S.; Simon, D. I.; Osborne, J. A.; Mullins, M. E.; Jaraki, O.; Michel,
T.; Singel, D. J.; Loscalzo, J. Proceedings of the National Academy of Sciences
1992, 89(1), 444–448.
[175] Wike-Hooley, J.; Haveman, J.; Reinhold, H. Radiotherapy and Oncology 1984,
2(4), 343–366.
256
[176] Tannock, I. F.; Rotin, D. Cancer research 1989, 49(16), 4373–4384.
[177] Hansen, T.; Croisy, A.; Keefer, L. IARC scientific publications 1981, (41),
21–29.
[178] Hrabie, J. A.; Keefer, L. K. Chemical reviews 2002, 102(4), 1135–1154.
[179] Keefer, L. K. Annual review of pharmacology and toxicology 2003, 43(1), 585–
607.
[180] Davies, K. M.; Wink, D. A.; Saavedra, J. E.; Keefer, L. K. Journal Of the
American Chemical Society 2001, 123(23), 5473–5481.
[181] Wang, P. G.; Xian, M.; Tang, X.; Wu, X.; Wen, Z.; Cai, T.; Janczuk, A. J.
Chemical Reviews 2002, 102(4), 1091–1134.
[182] Wink, D. A.; Hanbauer, I.; Krishna, M. C.; DeGraff, W.; Gamson, J.; Mitchell,
J. B. Proceedings Of the National Academy Of Sciences 1993, 90(21), 9813–
9817.
[183] Wink, D. A.; Cook, J. A.; Pacelli, R.; Liebmann, J.; Krishna, M. C.; Mitchell,
J. B. Toxicology letters 1995, 82, 221–226.
[184] Sawa, T.; Akaike, T.; Maeda, H. Journal of Biological Chemistry 2000, 275(42),
32467–32474.
[185] Garg, U. C.; Hassid, A. Journal of Clinical Investigation 1989, 83(5), 1774.
257
[186] Kariya, K.-i.; Kawahara, Y.; Araki, S.-i.; Fukuzaki, H.; Takai, Y. Atherosclerosis
1989, 80(2), 143–147.
[187] Tanner, F. C.; Meier, P.; Greutert, H.; Champion, C.; Nabel, E. G.; Lu¨scher,
T. F. Circulation 2000, 101(16), 1982–1989.
[188] Wink, D. A.; Cook, J. A.; Pacelli, R.; DeGraff, W.; Gamson, J.; Liebmann, J.;
Krishna, M. C.; Mitchell, J. B. Archives of biochemistry and biophysics 1996,
331(2), 241–248.
[189] Trujillo, M.; Alvarez, M. N.; Peluffo, G.; Freeman, B. A.; Radi, R. Journal of
Biological Chemistry 1998, 273(14), 7828–7834.
[190] Campbell, J. M.; McCrae, F.; Reglinski, J.; Wilson, R.; Smith, W. E.; Sturrock,
R. D. Biochimica et Biophysica Acta (BBA)-General Subjects 1993, 1156(3),
327–333.
[191] Gergel, D.; Misik, V.; Ondrias, K.; Cederbaum, A. I. The Journal of biological
chemistry 1995, 270(36), 20922–20929.
[192] Farias-Eisner, R.; Chaudhuri, G.; Aeberhard, E.; Fukuto, J. M. Journal of
Biological Chemistry 1996, 271(11), 6144–6151.
[193] Starrett, M. A.; Nielsen, M.; Smeenge, D. M.; Romanowicz, G. E.; Frost, M. C.
Nitric Oxide 2012, 27(4), 228–234.
258
[194] Romanowicz, G. E.; He, W.; Nielsen, M.; Frost, M. C. Redox biology 2013,
1(1), 332–339.
[195] Stamler, J. S. Cell 1994, 78(6), 931–936.
[196] Radi, R. Proceedings of the National Academy of Sciences 2004, 101(12), 4003–
4008.
[197] Hu, T.-M.; Chou, T.-C. The AAPS journal 2006, 8(3), E485–E492.
[198] Morakinyo, M. K. 2010.
[199] Torfg˚ard, K. E.; Ahlner, J. In Nitrates Updated; Springer, 1997; pages 21–56.
[200] Yang, B. K.; Vivas, E. X.; Reiter, C. D.; Gladwin, M. T. Free radical research
2003, 37(1), 1–10.
[201] Reynolds, M. M.; Frost, M. C.; Meyerhoff, M. E. Free Radical Biology and
Medicine 2004, 37(7), 926–936.
[202] Carpenter, A. W.; Schoenfisch, M. H. Chemical Society Reviews 2012, 41(10),
3742–3752.
[203] Xing, Q.; Yates, K.; Bailey, A.; Vogt, C.; He, W.; Frost, M. C.; Zhao, F. Surface
Innovations 2013, 1(4), 224–232.
[204] Nablo, B. J.; Rothrock, A. R.; Schoenfisch, M. H. Biomaterials 2005, 26(8),
917–924.
259
[205] Nablo, B. J.; Schoenfisch, M. H. Biomaterials 2005, 26(21), 4405–4415.
[206] Cai, H.; Harrison, D. G. Circulation research 2000, 87(10), 840–844.
[207] Isenberg, J. S.; Ridnour, L. A.; Perruccio, E. M.; Espey, M. G.; Wink, D. A.;
Roberts, D. D. Proceedings of the National Academy of Sciences of the United
States of America 2005, 102(37), 13141–13146.
[208] Ridnour, L. A.; Windhausen, A. N.; Isenberg, J. S.; Yeung, N.; Thomas, D. D.;
Vitek, M. P.; Roberts, D. D.; Wink, D. A. Proceedings of the National Academy
of Sciences 2007, 104(43), 16898–16903.
[209] Szomor, Z.; Appleyard, R.; Murrell, G. Journal of orthopaedic research 2006,
24(1), 80–86.
[210] Sharma, P.; Maffulli, N. Journal of Musculoskeletal and Neuronal Interactions
2006, 6(2), 181.
[211] Niki, E. The American journal of clinical nutrition 1991, 54(6), 1119S–1124S.
[212] Thomas, D. D.; Ridnour, L. A.; Espey, M. G.; Donzelli, S.; Ambs, S.; Hussain,
S. P.; Harris, C. C.; DeGraff, W.; Roberts, D. D.; Mitchell, J. B.; others. Journal
of Biological Chemistry 2006, 281(36), 25984–25993.
[213] Jackson, T. S.; Xu, A.; Vita, J. A.; Keaney, J. F. Circulation research 1998,
83(9), 916–922.
[214] Xu, W.; Liu, L.; Charles, I. G. The FASEB Journal 2002, 16(2), 213–215.
260
[215] Jenkins, D.; Charles, I.; Thomsen, L. L.; Moss, D.; Holmes, L.; Baylis, S.;
Rhodes, P.; Westmore, K.; Emson, P.; Moncada, S. Proceedings of the National
Academy of Sciences 1995, 92(10), 4392–4396.
[216] Thomsen, L. L.; Lawton, F. G.; Knowles, R. G.; Beesley, J. E.; Riveros-Moreno,
V.; Moncada, S. Cancer Research 1994, 54(5), 1352–1354.
[217] Thomsen, L.; Miles, D.; Happerfield, L.; Bobrow, L.; Knowles, R.; Moncada, S.
British Journal of Cancer 1995, 72(1), 41.
[218] Bingle, L.; Brown, N.; Lewis, C. The Journal of pathology 2002, 196(3), 254–
265.
[219] Pollard, J. W. Nature Reviews Cancer 2004, 4(1), 71–78.
[220] Hickok, J. R.; Thomas, D. D. Current pharmaceutical design 2010, 16(4), 381.
[221] Keller, R.; Geiges, M.; Keist, R. Cancer research 1990, 50(5), 1421–1425.
[222] Mehibel, M.; Singh, S.; Chinje, E. C.; Cowen, R. L.; Stratford, I. J. Molecular
cancer therapeutics 2009, 8(5), 1261–1269.
[223] Matthews, N. E.; Adams, M. A.; Maxwell, L. R.; Gofton, T. E.; Graham, C. H.
Journal of the National Cancer Institute 2001, 93(24), 1879–1885.
[224] Frederiksen, L. J.; Sullivan, R.; Maxwell, L. R.; Macdonald-Goodfellow, S. K.;
Adams, M. A.; Bennett, B. M.; Siemens, D. R.; Graham, C. H. Clinical cancer
research 2007, 13(7), 2199–2206.
261
[225] Williams, J. L.; Borgo, S.; Hasan, I.; Castillo, E.; Traganos, F.; Rigas, B.
Cancer Research 2001, 61(8), 3285–3289.
[226] Rao, C. V.; Reddy, B. S.; Steele, V. E.; Wang, C.; Liu, X.; Ouyang, N.; Patlolla,
J. M.; Simi, B.; Kopelovich, L.; Rigas, B. Molecular cancer therapeutics 2006,
5(6), 1530–1538.
[227] Juang, S.-H.; Xie, K.; Xu, L.; Shi, Q.; Wang, Y.; Yoneda, J.; Fidler, I. J. Human
gene therapy 1998, 9(6), 845–854.
[228] Campbell, N. A.; Reece, J. B.; Mitchell, L. G.; Taylor, M. R. Biology: Concepts
and Connections 4th Edition; Benjamine Cummings, 2002.
[229] Knowles, R. G.; Moncada, S. Biochemical Journal 1994, 298(Pt 2), 249.
[230] Wink, D. A.; Ridnour, L. A.; Hussain, S. P.; Harris, C. C. Nitric oxide: biology
and chemistry/official journal of the Nitric Oxide Society 2008, 19(2), 65.
[231] Stasko, N. A.; Fischer, T. H.; Schoenfisch, M. H. Biomacromolecules 2008,
9(3), 834–841.
[232] Kjeldahl, J. Fresenius’ Journal of Analytical Chemistry 1883, 22(1), 366–382.
[233] Murdaugh, L.; Wang, Z.; Del Priore, L.; Dillon, J.; Gaillard, E. Experimental
eye research 2010, 90(5), 564–571.
[234] Zhang, R.; Hrushesky, W. J.; Wood, P. A.; Lee, S. H.; Hunt, R. C.; Jahng,
W. J. International journal of biological macromolecules 2010, 47(2), 255–260.
262
[235] Crow, J. P.; Beckman, J. S. Methods 1995, 7(1), 116–120.
[236] Reed, J. W.; Ho, H. H.; Jolly, W. L. Journal of the American Chemical Society
1974, 96(4), 1248–1249.
[237] Jiao, K.; Mandapati, S.; Skipper, P. L.; Tannenbaum, S. R.; Wishnok, J. S.
Analytical biochemistry 2001, 293(1), 43–52.
[238] Hui, Y.; Wong, M.; Zhao, S. S.; Love, J. A.; Ansley, D. M.; Chen, D. D.
Electrophoresis 2012, 33(4), 697–704.
[239] Sripathi, S. R.; He, W.; Um, J.-Y.; Moser, T.; Dehnbostel, S.; Kindt, K.; Gold-
man, J.; Frost, M. C.; Jahng, W. J. Advances in Bioscience and Biotechnology
2012, 3(8).
[240] Antony, R.; Lukiw, W. J.; Bazan, N. G. Journal of Biological Chemistry 2010,
285(24), 18301–18308.





This part shows the code that I used to simulate NO concentration and NO flux
change with time and distance by using FlexPDE6s. Both auto-oxidations of NO by




Characterization of the NO
Biological Products
B.1 Nitrotyrosine detection by HPLC
Protein tyrosine kinase, one major type of cell membrane signaling molecules, binds
ligands from outside of the membrane and passes this signaling into the cells to
make cells respond appropriately to the outside chemical environment. Specific ty-
rosine residues within the protein tyrosine kinase undergo autophoshorylation once
their ligands are bound to its extra-membrane domain, which causes protein con-
figuration changes and activation/deactivation. Then the activated protein tyrosine
267
kinase can bind to SH2 (Src Homology 2) domain-containing protein, which further
delivers the ligand information to the inside of the cell [228]. Tyrosine nitration on
phenyl groups at position 3 generates greater steric hindrance, which inhibits the
phosphorylation process, leading to failure of functional modulation of the protein
kinase. In vivo, the production of nitrotyrosine (NO2Tyr) is from reactive nitrogen
species (RNS), with a MW of 226.19 Da. Similar to reactive oxygen species (ROS),
RNS can initiate many free radical reactions including inducing the formation of ty-
rosyl group free radicals. The eventual reaction occurs between tyrosyl group free
radicals and NO2•, forming NO2Tyr. The most important source of NO2• is NO•,
which can be innately generated by the body at very high production rates (esti-
mation of 1− 4× 10−10mol/cm2/min by blood vessel endothelium [113] and up to
9 pmol/106cell/sec from our data 3.6). NO is a free radical, which can be oxidized
easily by O2, O
−
2 , forming NO
−
2 , NO2• and ONOO−. ONOO− will produce NO2•
while pH is lower than 6.8 and CO2 is presenting [62]. Under pathological conditions,
because of inflammation, oxidative stress is generated either locally or within the
whole body, producing more O−2 , which make this reaction more likely to occur.
People have noted that huge increases of basal level of NO2Tyr in blood plasma
in rheumatoid arthritis, renal failure, and septic shock patients and aging models.
Murdaugh et al. [233] reported the accumulation of 3-nitrotyrosine and other nitro
group derived products within AMD sample. Zhang et al. [234] identified PP2A-a
tyrosine nitration under prolonged light stress within mouse retina. To understand the
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role NO plays in terms of concentration and tempo in PP2A tyrosine nitration process
and AMD development, it is needed to quantify NO2Tyr levels, examine specific
protein tyrosine sites and investigate the relationships between those quantitative
data and the NO levels and duration in the retina.
There are different assays which can be used to either qualitatively and/or quantita-
tively analyze NO2Tyr. NO2Tyr monoclonal antibodies are able to recognize NO2Tyr
residues within proteins with high specificity, where NO2Tyr signal quantity is directly
used to represent the change of the activity of the enzyme under investigation. How-
ever, the quality of those assays is highly dependent on antibody quantity. The related
assays which we are able to perform based on antibody techniques include Western
blotting, ELISA (Enzyme-linked immuno sorbent assay), even immunohistochemical
assay etc (reviewed in [241]). Their limitation is that they reveal neither site specific
information nor achieve absolute quantification.
According to the protocol from Crow et al. [235] with minor modification, phenyl-
derivatized reverse phase column with a mobile phase of 80% 50 mM ammonium
formate buffer, pH=3.5 and 20% acetonitrile was used to determine nitrotyrosine
content in a Perkin Elmer Series 200 HPLC-UV/Vis system. The phenol ring of
both tyrosine and nitrotyrosine contains an absorbance peak at 274 nm, however
nitrotyrosine displays another peak at 359 nm. The products are detected by Perkin
Elmer Series 200EP diode array detector.
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In preliminary experiments, a mixture of tyrosine and 3-nitrotyrosine solution was
injected to HPLC for method validation. As controls, tyrosine and nitrotyrosine
standards were applied to HPLC and they were clearly distinguished according to the
retention time (Fig. B.1 A upper panel, where tR for Tyr was shown to be 3.5 min and
tR for nitrotyrosine 7.6 min). By using the area under the peak, a calibration curve
was established and the detection limit was found to be 0.1-0.2 µM in the specified
system (Fig. B.1 B). To validate the nitration system, ONOO− was used to nitrate
whole cell protein, where whole cell protein was extracted by using RIPA lysis buffer,
hoping to obtain the nitration products. ONOO− stock solution was added into the
protein samples directly, making the final ONOO− concentration of 1mM. Then the
nitrated protein was applied to 6 M concentrated HCl for total hydrolyzation, at 110
◦C for 16 h [235]. The ultimate products were redissolved in phosphate buffer and
injected to the HPLC. Both 274 nm and 359 nm were used for signal test. Fig. B.1
A lower panel shows the chromatography result of HPLC UV/Vis. In both standard
and real reaction system, nitrotyrosine peak was shown in tR = 7.6 min.
To quantitatively understand the reaction between NO and tyrosine, the reaction
between tyrosine and NO was investigated. The reaction between tyrosine and per-
oxynitrite ONOO− [184] was used as the positive control. The reaction system was
100 µM tyrosine in 0.1 M sodium phosphate buffer (pH 7.0, containing 0.1 mM DTPA)
with different final concentrations of ONOO− (0.05-3.0 mM); the reaction time was
set as 2 min [184]. ONOO− preparation and quantification were completed according
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(A) (B)
Figure B.1: Identifying nitro-tyrosine by using HPLC. (A) The upper
panel shows the standards of tyrosine and nitro-tyrosine, and the lower panel
represents result from HCl hydrolyzed nitrated proteins; (B) relationship of
the nitro-tyrosine standard and the signal strength.
to Reed et al. [236]. The HPLC successfully separated 3-nitrotyrosine from the reac-
tion system and data illustrated that the increase of ONOO− concentration resulted
in the increase of product nitrotyrosine shown in Fig. B.2 with a regression line of
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y = 10.417x− 91.37 and R2 = 0.9717 (note that the overall trend of this plot is quite
similar to the published data by Sawa et al. [184]).
Figure B.2: The reaction of ONOO− and tyrosine examined by HPLC
system. Error bar stands for standard errors.
The tyrosine reaction with NO and superoxide was carried out using a SNAP-PDMS-
HX-XO system. Tyrosine solution (0.1 mM) with superoxide generator HX-XO was
applied to SNAP-PDMS with strong light, where Tyr is expected to be converted to
3-nitrotyrosine [184]. However, by using this system, no 3-nitrotyrosine signal was
observed even when the very high concentration of all reactants were used (2 mM HX
and 50 mU/ml OX). This might be because that the yield of nitrotyrosine through the
reaction of Tyr with NO and superoxide is too low so that the product concentration
is even smaller than the detection limit of the HPLC system used in this study(1-2
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µM for our system and less than 200 nM for Sawa et al.’s set-up [184]).
B.2 Tyrosine residue nitration detection by MS
Some HPLC systems with more sensitive UV detectors have very good limit of de-
tection, which are very useful for 3-nitrotyrosine chemistry study. But since the
chromatography provides indirect evidences, only according to the correct retention
time and comparison with standards, there might be large false signals from complex
biological samples. Other researchers managed to use LC-MS/MS of better LOD and
LOQ to measure NO2Tyr level of plasma or other tissue source. Hui et al. [238]
reported very inspiring results with plasma NO2Tyr level from patients receiving on-
pump coronary artery bypass grafting surgery by using Varian 1200L LC-MS/MS
system (Agilent Technologies). The claimed LOD, LOQ, and LLOQ (low limit of
quantification, a concentration at which the analyte peak is identifiable, discrete, and
reproducible with a precision of 20% and accuracy of 80120%) are 0.034 nM, 0.112
nM, and 0.625 nM, respectively. And their result was 1.494 ± 0.1065 and 2.167 ±
0.1770 nM for before and after the surgery. An MS method was also used to identify
site-specific nitrotyrosine.
Two interesting questions that can be addressed by MS are how much tyrosine will
be nitrated at different specific NO levels and whether there are specific NO sensitive
273
tyrosine sites that are prone to be nitrated, which makes nitration a specific process
(important for cell signaling). The following MALDI-TOF work is to target the
second question.
Jiao et al. studied the site specific effect of peroxynitrite to human serum albumin
by using HPLC and CID (collision-induced decomposition), showing that though to-
tal of 18 tyrosine residues are present in the entire HAS (human albumin serum)
molecule, only 2 nitro-tyrosine sites were detected. They were Y411 (in YTK
fragment, [M + H+]+=411.0 m/z) and Y140 (the second Y in YLYEIAR fragment,
[M + H+]+=927.5 m/z). To examine whether NO’s nitration is also site-specific,
bovine serum albumin (BSA) was selected as the standard and control. Albumin
nitration by ONOO− was carried out according to Jiao et al. [237]. 0.3 mM albumin
in 150 mM potassium phosphate/ 25 mM sodium bicarbonate buffer at pH 7.2 reacts
with 1 µM ONOO−. The product was then collected and applied to dialysis for 24 h
(molecular wright cut-off 12,000 Da). The NO releasing polymer SNAP-PDMS with
HX-XO (NO flux was up to 15× 10−10 mol/cm2/min, the concentration of HX was
1 mM, and 20mU/ml XO was used [184].) was used to nitrate BSA to mimic the
nitration of proteins in vivo in the inflammation site. Then the product proteins were
dialyzed and subject to trypsin for complete digestion in a 40:1 ratio (wt/wt) for
5 h at 37 ◦C [237]. Matrix alpha-Cyano-4-hydroxycinnamic acid (CHCA) was used
and samples were loaded with overlayer preparation method to MALDI-TOF sample
plate.
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Figure B.3: MALDI-TOF of trypsonized nitrated BSA.
From the MALDI-TOF data, one nitro-tyrosine residue site in YLYEIAR was clearly
observed, [M + H+]+=972.5 m/z. Data also shows its fragmentation at 956.5 m/z,
where one oxygen atom was missing(Fig. B.3). Other nitrated fragments were not
detected, indicating that nitration of tyrosine was indeed site-specific. However, no
nitrotyrosine containing fragment was found in BSA treated by SNAP-PDMS/HX-
OX, indicating tyrosine nitration may not be easy to occur and the yield was low.
Post-transcription modification of PP2A-a is crucial for its normal function. Since
it has been approved that NO is associated with RPE cell death [239, 240], un-
derstanding how NO level and duration will regulate the apoptotic pathways will
help us protect RPE from damaging and retina from degeneration. Future direction
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can be using more sensitive detection methods to identify and quantitate the post-
translation modification. Or considering the low amount of nitrotyrosine, examining
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